{"doc_id": 0, "doc": {"person_id": 115967211, "visit_occurrence_id": 51248592, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2012-10-19 00:00:00", "visit_end_datetime": "2012-10-19 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2011-05-09 12:40:00", "patient_last_visit_date": "2015-02-18 00:00:00", "end_obs_date": "2013-10-19", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 27, "cumulated_visit_num": 27, "cumulated_approximate_token_count": 12529, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-05-09 12:40:00, ended at 2011-05-09 19:32:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Headache\n- Blepharitis\n- Posttraumatic stress disorder\n- Visual disturbance\n- Keratitis\n- Myopia\n\n### Drug\n- hypromellose 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day.\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 0.5 cm to both eyes 2 times a day. For 5 days in each eye\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 08:00:34, ended at 2011-05-21 09:57:57\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-29 12:55:00, ended at 2011-05-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Finding of head and neck region\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-31 00:00:00, ended at 2011-05-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm of uncertain behavior of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:01:04, ended at 2011-06-14 17:43:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- atomoxetine 40 MG Oral Capsule, through Oral route, presumably until 2011-07-26. Instructions: take 40 mg by mouth 2 times a day.\n- aripiprazole 2 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 2 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:40:28, ended at 2011-06-14 17:43:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-06-14, presumably until 2011-07-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth as directed. Take 2 tablets every morning and 1 tablet every afternoon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-14 11:56:00, ended at 2011-06-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 76 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.03 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12 (microgram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 33 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-06-15 00:00:00, ended at 2011-06-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-15, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:44:00, ended at 2011-06-16 08:47:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Disorder of brain\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:48:00, ended at 2011-06-16 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-22 01:00:00, ended at 2011-06-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation\n\n### Condition\n- Finding of head and neck region\n- Benign neoplasm of pituitary gland and craniopharyngeal duct\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-22 10:30:48, ended at 2011-06-22 17:57:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 10 mg by mouth every bedtime.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2011-07-26. Instructions: 2 Puffs by Inhalation route as needed.\n- clonazepam 1 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 1 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-06-23 06:05:00, ended at 2011-07-26 14:23:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Base deficit in Blood: 1.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 366 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Prothrombin time (PT): N/A (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 39.0 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 94 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 51 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Osmolality of Serum or Plasma: 332 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.12 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: N/A (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.6 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 8 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78.6 (microgram per milliliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Osteoplasty of cranium with flap of bone\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computer assisted surgery with MR/MRA\n- Evaluation of speech, language, voice, communication, and/or auditory processing\n- Insertion of endotracheal tube\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Percutaneous endoscopic gastrostomy\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Other exploration and decompression of spinal canal\n- Evaluation of oral and pharyngeal swallowing function\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of venous blood by venipuncture\n- Venous catheterization, not elsewhere classified\n- Partial excision of pituitary gland by transsphenoidal approach\n- Computed tomography, head or brain; without contrast material\n- Controlled ventilation procedure and therapy, initiation and management\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Insertion of catheter into artery\n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n\n### Condition\n- Asthma\n- Cachexia\n- Disorder of nasal cavity\n- Disorder of pituitary gland\n- Obesity\n- Blind or low vision - both eyes\n- Diabetes insipidus\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Atelectasis\n- Episodic mood disorder\n- Pleural effusion\n- Visual disturbance\n- Acute respiratory failure\n- Finding of head and neck region\n- Panhypopituitarism\n- Abnormal findings on diagnostic imaging of skull and head\n- Bipolar affective disorder, currently manic, severe, with psychosis\n- Disturbance of consciousness\n- Hyperosmolality and or hypernatremia\n- Lung field abnormal\n- Malnutrition (calorie)\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Pulmonary congestion and hypostasis\n- Acquired hypothyroidism\n- Fever\n- Homonymous hemianopia\n- Anxiety state\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n- Disorder of posterior pituitary\n- Blindness AND/OR vision impairment level\n- Pneumonitis due to inhaled substance\n- Tobacco dependence syndrome\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-07-14, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 3 Tabs by mouth every morning.\n- hydrocortisone 100 MG Injection, started on 2011-06-23, presumably until 2011-07-04\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-06-24, presumably until 2011-07-07\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-07-12, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- desmopressin acetate 0.2 MG Oral Tablet, through Oral route, started on 2011-07-08, presumably until 2011-07-09\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 250 MG Oral Capsule, through Oral route, started on 2011-07-08, presumably until 2011-11-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth every bedtime.\n- levothyroxine sodium 0.2 MG Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-05\n- olanzapine 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-06-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2012-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-06-29, presumably until 2011-07-05\n- haloperidol 5 MG/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-05\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-24, presumably until 2011-06-30\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-18, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2011-06-24, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-07-01, presumably until 2011-07-06\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-07-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-07-07, presumably until 2011-07-21\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2011-07-03, presumably until 2011-07-03\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-06-29, presumably until 2011-07-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-06-28, presumably until 2011-06-30\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-06-23, presumably until 2011-06-23\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily before dinner.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-07-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- olanzapine 10 MG Injection, through Intramuscular route, started on 2011-06-24, presumably until 2011-06-30\n- hydrocortisone 20 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-06-30, presumably until 2011-07-03\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-01, presumably until 2011-07-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2011-07-15, presumably until 2011-07-15, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-03\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-07-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-06-27\n- cefepime 2000 MG Injection, through Intravenous route, started on 2011-06-27, presumably until 2011-07-07\n- atomoxetine 40 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-27. Instructions: take 40 mg by mouth 2 times a day.\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-28\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- lorazepam 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-06-26, presumably until 2011-06-28\n- desmopressin acetate 0.004 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-23, presumably until 2011-07-06\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-04\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- clonazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24. Instructions: take 1 mg by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-07-05, presumably until 2011-07-06\n- midazolam 1 MG/ML Injectable Solution, started on 2011-06-30, presumably until 2011-06-30\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-11. Instructions: take 2 mg by mouth Every Day.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2011-07-02, presumably until 2012-07-14, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every 2 hours.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2011-07-15\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-13 13:26:26, ended at 2011-08-13 14:48:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-13 17:32:00, ended at 2011-08-14 01:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Bipolar disorder\n- Neoplasm of uncertain behavior of pituitary gland\n- Visual disturbance\n- Postprocedural state finding\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2011-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:31, ended at 2011-09-13 12:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take  by mouth. 0.1 mg qhs, 0.05 mg in morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:48, ended at 2011-09-13 12:58:33\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 13:22:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.4 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 34 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-15 10:10:00, ended at 2011-11-15 14:42:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of pituitary gland\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:56:54, ended at 2011-11-15 15:37:29\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n- fluoxetine 20 MG Oral Capsule, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:57:10, ended at 2011-11-15 16:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-11-15 14:43:00, ended at 2011-11-16 15:45:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.23 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 57.3 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.0 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 28 (millimeter mercury column)\n- Body height: 5' 3\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 57 (nanogram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n\n### Condition\n- Edema\n- Seizure\n- Anxiety state\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Psychotic disorder\n- Acquired hypothyroidism\n- Blind or low vision - both eyes\n- Dysthymia\n- Low blood pressure\n- Panhypopituitarism\n- Insomnia\n- Diabetes insipidus\n- Hyperlipidemia\n- Visual disturbance\n- Cough\n- Disorder of pituitary gland\n- Failure to thrive\n- Heteronymous bilateral visual field defects\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 3 Tabs by mouth every morning.\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-01-03, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 250 MG Extended Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Cap by mouth 2 times a day.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth every bedtime.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-03 10:16:11, ended at 2012-01-03 11:43:09\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take 100 mcg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-03 11:51:00, ended at 2012-01-03 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-17 14:02:05, ended at 2012-04-17 17:12:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Adrenal cortical hypofunction\n- Disorder of pituitary gland\n- Diabetes insipidus\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route. Instructions: take 0.1 mg by mouth as directed. 0.05 mg po qAM, 0.1 mg po qhs \n- hydrocortisone 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth 2 times a day.  \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, presumably until 2015-02-17. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-17 15:50:00, ended at 2012-04-18 12:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prolactin [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: <0.01 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Blindness AND/OR vision impairment level\n- Diabetes insipidus\n- Disorder of nasal cavity\n- Disorder of visual pathways\n- Panhypopituitarism\n- Severe visual impairment\n- Essential hypertension\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-05-09 12:40:00, ended at 2011-05-09 19:32:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Headache\n- Blepharitis\n- Posttraumatic stress disorder\n- Visual disturbance\n- Keratitis\n- Myopia\n\n### Drug\n- hypromellose 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day.\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 0.5 cm to both eyes 2 times a day. For 5 days in each eye\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 08:00:34, ended at 2011-05-21 09:57:57\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-29 12:55:00, ended at 2011-05-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Finding of head and neck region\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-31 00:00:00, ended at 2011-05-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm of uncertain behavior of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:01:04, ended at 2011-06-14 17:43:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- atomoxetine 40 MG Oral Capsule, through Oral route, presumably until 2011-07-26. Instructions: take 40 mg by mouth 2 times a day.\n- aripiprazole 2 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 2 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:40:28, ended at 2011-06-14 17:43:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-06-14, presumably until 2011-07-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth as directed. Take 2 tablets every morning and 1 tablet every afternoon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-14 11:56:00, ended at 2011-06-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 76 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.03 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12 (microgram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 33 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-06-15 00:00:00, ended at 2011-06-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-15, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:44:00, ended at 2011-06-16 08:47:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Disorder of brain\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:48:00, ended at 2011-06-16 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-22 01:00:00, ended at 2011-06-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation\n\n### Condition\n- Finding of head and neck region\n- Benign neoplasm of pituitary gland and craniopharyngeal duct\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-22 10:30:48, ended at 2011-06-22 17:57:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 10 mg by mouth every bedtime.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2011-07-26. Instructions: 2 Puffs by Inhalation route as needed.\n- clonazepam 1 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 1 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-06-23 06:05:00, ended at 2011-07-26 14:23:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Base deficit in Blood: 1.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 366 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Prothrombin time (PT): N/A (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 39.0 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 94 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 51 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Osmolality of Serum or Plasma: 332 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.12 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: N/A (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.6 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 8 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78.6 (microgram per milliliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Osteoplasty of cranium with flap of bone\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computer assisted surgery with MR/MRA\n- Evaluation of speech, language, voice, communication, and/or auditory processing\n- Insertion of endotracheal tube\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Percutaneous endoscopic gastrostomy\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Other exploration and decompression of spinal canal\n- Evaluation of oral and pharyngeal swallowing function\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of venous blood by venipuncture\n- Venous catheterization, not elsewhere classified\n- Partial excision of pituitary gland by transsphenoidal approach\n- Computed tomography, head or brain; without contrast material\n- Controlled ventilation procedure and therapy, initiation and management\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Insertion of catheter into artery\n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n\n### Condition\n- Asthma\n- Cachexia\n- Disorder of nasal cavity\n- Disorder of pituitary gland\n- Obesity\n- Blind or low vision - both eyes\n- Diabetes insipidus\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Atelectasis\n- Episodic mood disorder\n- Pleural effusion\n- Visual disturbance\n- Acute respiratory failure\n- Finding of head and neck region\n- Panhypopituitarism\n- Abnormal findings on diagnostic imaging of skull and head\n- Bipolar affective disorder, currently manic, severe, with psychosis\n- Disturbance of consciousness\n- Hyperosmolality and or hypernatremia\n- Lung field abnormal\n- Malnutrition (calorie)\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Pulmonary congestion and hypostasis\n- Acquired hypothyroidism\n- Fever\n- Homonymous hemianopia\n- Anxiety state\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n- Disorder of posterior pituitary\n- Blindness AND/OR vision impairment level\n- Pneumonitis due to inhaled substance\n- Tobacco dependence syndrome\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-07-14, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 3 Tabs by mouth every morning.\n- hydrocortisone 100 MG Injection, started on 2011-06-23, presumably until 2011-07-04\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-06-24, presumably until 2011-07-07\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-07-12, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- desmopressin acetate 0.2 MG Oral Tablet, through Oral route, started on 2011-07-08, presumably until 2011-07-09\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 250 MG Oral Capsule, through Oral route, started on 2011-07-08, presumably until 2011-11-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth every bedtime.\n- levothyroxine sodium 0.2 MG Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-05\n- olanzapine 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-06-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2012-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-06-29, presumably until 2011-07-05\n- haloperidol 5 MG/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-05\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-24, presumably until 2011-06-30\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-18, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2011-06-24, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-07-01, presumably until 2011-07-06\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-07-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-07-07, presumably until 2011-07-21\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2011-07-03, presumably until 2011-07-03\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-06-29, presumably until 2011-07-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-06-28, presumably until 2011-06-30\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-06-23, presumably until 2011-06-23\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily before dinner.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-07-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- olanzapine 10 MG Injection, through Intramuscular route, started on 2011-06-24, presumably until 2011-06-30\n- hydrocortisone 20 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-06-30, presumably until 2011-07-03\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-01, presumably until 2011-07-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2011-07-15, presumably until 2011-07-15, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-03\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-07-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-06-27\n- cefepime 2000 MG Injection, through Intravenous route, started on 2011-06-27, presumably until 2011-07-07\n- atomoxetine 40 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-27. Instructions: take 40 mg by mouth 2 times a day.\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-28\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- lorazepam 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-06-26, presumably until 2011-06-28\n- desmopressin acetate 0.004 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-23, presumably until 2011-07-06\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-04\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- clonazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24. Instructions: take 1 mg by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-07-05, presumably until 2011-07-06\n- midazolam 1 MG/ML Injectable Solution, started on 2011-06-30, presumably until 2011-06-30\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-11. Instructions: take 2 mg by mouth Every Day.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2011-07-02, presumably until 2012-07-14, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every 2 hours.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2011-07-15\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-13 13:26:26, ended at 2011-08-13 14:48:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-13 17:32:00, ended at 2011-08-14 01:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Bipolar disorder\n- Neoplasm of uncertain behavior of pituitary gland\n- Visual disturbance\n- Postprocedural state finding\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2011-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:31, ended at 2011-09-13 12:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take  by mouth. 0.1 mg qhs, 0.05 mg in morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:48, ended at 2011-09-13 12:58:33\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 13:22:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.4 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 34 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-15 10:10:00, ended at 2011-11-15 14:42:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of pituitary gland\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:56:54, ended at 2011-11-15 15:37:29\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n- fluoxetine 20 MG Oral Capsule, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:57:10, ended at 2011-11-15 16:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-11-15 14:43:00, ended at 2011-11-16 15:45:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.23 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 57.3 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.0 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 28 (millimeter mercury column)\n- Body height: 5' 3\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 57 (nanogram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n\n### Condition\n- Edema\n- Seizure\n- Anxiety state\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Psychotic disorder\n- Acquired hypothyroidism\n- Blind or low vision - both eyes\n- Dysthymia\n- Low blood pressure\n- Panhypopituitarism\n- Insomnia\n- Diabetes insipidus\n- Hyperlipidemia\n- Visual disturbance\n- Cough\n- Disorder of pituitary gland\n- Failure to thrive\n- Heteronymous bilateral visual field defects\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 3 Tabs by mouth every morning.\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-01-03, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 250 MG Extended Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Cap by mouth 2 times a day.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth every bedtime.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-03 10:16:11, ended at 2012-01-03 11:43:09\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take 100 mcg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-03 11:51:00, ended at 2012-01-03 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-17 14:02:05, ended at 2012-04-17 17:12:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Adrenal cortical hypofunction\n- Disorder of pituitary gland\n- Diabetes insipidus\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route. Instructions: take 0.1 mg by mouth as directed. 0.05 mg po qAM, 0.1 mg po qhs \n- hydrocortisone 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth 2 times a day.  \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, presumably until 2015-02-17. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-17 15:50:00, ended at 2012-04-18 12:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prolactin [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: <0.01 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Blindness AND/OR vision impairment level\n- Diabetes insipidus\n- Disorder of nasal cavity\n- Disorder of visual pathways\n- Panhypopituitarism\n- Severe visual impairment\n- Essential hypertension\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e162d0a191d016a0fc6e7d0027afeb800783fe539f5b769d774b71f4ea97370c", "prompt_hash": "3f26335e6fc8c245a1aeb7b72492ba7d14732075a88a45b1fd5e232b1a48eaf7", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967769, "visit_occurrence_id": 159320772, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2020-05-17 00:00:00", "visit_end_datetime": "2020-05-17 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n", "approximate_token_count": 123, "patient_first_visit_date": "2012-03-31 14:46:00", "patient_last_visit_date": "2023-02-06 10:56:09", "end_obs_date": "2021-05-17", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 129, "cumulated_visit_num": 129, "cumulated_approximate_token_count": 24713, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "158c09c66bbc2808a3e20c763d96a3c5eed1be8e0ff71a701fa5d42ab1404da8", "prompt_hash": "6bf60947124d850a02bef8ae69cf1a048514b9e8ad0e854741c2113613f18757", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115967988, "visit_occurrence_id": 68382974, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-01-09 08:30:00", "visit_end_datetime": "2015-01-09 23:59:00", "visit_length_in_hours": 15.483333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 93, "patient_first_visit_date": "2013-10-15 08:07:00", "patient_last_visit_date": "2016-08-15 13:04:00", "end_obs_date": "2016-01-09", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 33, "cumulated_visit_num": 33, "cumulated_approximate_token_count": 7035, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-15 08:07:00, ended at 2013-10-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-16 00:00:00, ended at 2013-10-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-25 07:38:00, ended at 2013-10-25 13:50:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of intra-abdominal mass\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- CT of abdomen\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Biopsy, abdominal or retroperitoneal mass, percutaneous needle\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Neoplasm of uncertain behavior of soft tissues\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-10-25, presumably until 2013-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2013-10-25, presumably until 2013-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 10:38:00, ended at 2013-11-15 12:47:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 12:48:00, ended at 2013-11-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy\n\n### Condition\n- Disorder of peritoneum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 11:28:00, ended at 2013-12-04 17:01:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.85 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Excision or destruction of peritoneal tissue\n- Total splenectomy\n- Other partial pancreatectomy\n- Nephroureterectomy\n- Radiologic examination, chest; single view, frontal\n- Unilateral adrenalectomy\n\n### Condition\n- Headache\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of retroperitoneum\n- Obesity\n\n### Drug\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2013-12-04, presumably until 2013-12-04\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-12-01, presumably until 2013-12-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-04\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-11-28, presumably until 2013-12-04\n- sennosides, USP 8.6 MG Oral Capsule, through Oral route, started on 2013-12-04, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Caps by mouth every bedtime.\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-01\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-12-02, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2013-12-04, presumably until 2014-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-12-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-11-28, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-11-28, presumably until 2013-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2013-12-06, presumably until 2014-04-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-12-06, presumably until 2013-12-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-06 15:55:00, ended at 2013-12-06 20:41:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 189 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 518 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Ascites\n- Primary malignant neoplasm of retroperitoneum\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Postprocedural state finding\n- Primary malignant neoplasm of soft tissues\n- Abdominal pain\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2014-08-27. Instructions: take 200-400 mg by mouth daily as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-12-06, presumably until 2013-12-06\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-12-06, presumably until 2013-12-06\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2014-01-17. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-12-09, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-10 14:48:00, ended at 2013-12-10 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-17 08:44:00, ended at 2014-01-17 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 09:52:00, ended at 2014-04-18 12:30:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:31:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 10:14:00, ended at 2014-07-25 12:21:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 12:22:00, ended at 2014-07-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-27 00:00:00, ended at 2014-07-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-29 00:00:00, ended at 2014-07-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-13 10:23:59, ended at 2014-08-13 13:46:40\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Incisional hernia\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- omeprazole 10 MG Delayed Release Oral Capsule, through Oral route, presumably until 2016-03-03, with intended 0 refill(s). Instructions: take  by mouth daily.\n- lisinopril 10 MG Oral Tablet, started on 2014-06-12, presumably until 2015-12-29, with intended 0 refill(s). Instructions: daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Incisional hernia\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- cefazolin 1000 MG Injection, started on 2014-08-28, presumably until 2014-08-28\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-08-28, presumably until 2014-08-28\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-28 05:03:00, ended at 2014-08-29 18:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Laparoscopic incisional hernia repair with graft or prosthesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Acute postoperative pain\n- Morbid obesity\n- Spasm\n- Incisional hernia\n- Primary diagnosis: Postprocedural state finding\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Abdominal pain\n- Gastroesophageal reflux disease\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-28, presumably until 2015-08-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2015-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-10 14:07:36, ended at 2014-09-10 16:41:08\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-09 00:00:00, ended at 2015-01-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-15 08:07:00, ended at 2013-10-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3.386\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-16 00:00:00, ended at 2013-10-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-25 07:38:00, ended at 2013-10-25 13:50:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of intra-abdominal mass\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n- CT of abdomen\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Biopsy, abdominal or retroperitoneal mass, percutaneous needle\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Neoplasm of uncertain behavior of soft tissues\n- Neoplastic disease of uncertain behavior\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-10-25, presumably until 2013-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2013-10-25, presumably until 2013-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-11-06 00:00:00, ended at 2013-11-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 10:38:00, ended at 2013-11-15 12:47:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Intra-abdominal and pelvic swelling, mass and lump\n- Primary diagnosis: Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-15 12:48:00, ended at 2013-11-15 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 00:00:00, ended at 2013-11-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; adrenalectomy\n\n### Condition\n- Disorder of peritoneum\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-27\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-11-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-11-27, presumably until 2013-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-11-27 11:28:00, ended at 2013-12-04 17:01:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.85 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Body height: 5' 4\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Excision or destruction of peritoneal tissue\n- Total splenectomy\n- Other partial pancreatectomy\n- Nephroureterectomy\n- Radiologic examination, chest; single view, frontal\n- Unilateral adrenalectomy\n\n### Condition\n- Headache\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Primary malignant neoplasm of retroperitoneum\n- Obesity\n\n### Drug\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2013-12-04, presumably until 2013-12-04\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-12-01, presumably until 2013-12-02\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-04\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-11-28, presumably until 2013-12-04\n- sennosides, USP 8.6 MG Oral Capsule, through Oral route, started on 2013-12-04, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Caps by mouth every bedtime.\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2013-11-28, presumably until 2013-12-01\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-12-02, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n- 8 HR acetaminophen 650 MG Extended Release Oral Tablet, through Oral route, started on 2013-12-04, presumably until 2014-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-27, presumably until 2013-12-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-27, presumably until 2013-11-30\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-11-28, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-11-28, presumably until 2013-11-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2013-12-06, presumably until 2014-04-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n- 0.5 ML Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML Injection, through Intramuscular route, started on 2013-12-06, presumably until 2013-12-07, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-06 15:55:00, ended at 2013-12-06 20:41:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.5 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 189 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 518 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: 1.13 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.77 (thousand per microliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Ascites\n- Primary malignant neoplasm of retroperitoneum\n- Primary diagnosis: Intra-abdominal and pelvic swelling, mass and lump\n- Postprocedural state finding\n- Primary malignant neoplasm of soft tissues\n- Abdominal pain\n\n### Drug\n- ibuprofen 200 MG Oral Tablet, through Oral route, presumably until 2014-08-27. Instructions: take 200-400 mg by mouth daily as needed.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-12-06, presumably until 2013-12-06\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-12-06, presumably until 2013-12-06\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2014-01-17. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-09 00:00:00, ended at 2013-12-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-12-09, presumably until 2014-04-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-10 14:48:00, ended at 2013-12-10 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-17 08:44:00, ended at 2014-01-17 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-17 00:00:00, ended at 2014-04-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 09:52:00, ended at 2014-04-18 12:30:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n- Primary malignant neoplasm of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-18 12:31:00, ended at 2014-04-18 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.37\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-04 00:00:00, ended at 2014-05-04 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 10:14:00, ended at 2014-07-25 12:21:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-25 12:22:00, ended at 2014-07-25 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-27 00:00:00, ended at 2014-07-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-29 00:00:00, ended at 2014-07-29 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-13 10:23:59, ended at 2014-08-13 13:46:40\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of body wall\n- Incisional hernia\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- omeprazole 10 MG Delayed Release Oral Capsule, through Oral route, presumably until 2016-03-03, with intended 0 refill(s). Instructions: take  by mouth daily.\n- lisinopril 10 MG Oral Tablet, started on 2014-06-12, presumably until 2015-12-29, with intended 0 refill(s). Instructions: daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-28 00:00:00, ended at 2014-08-28 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Incisional hernia\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n- cefazolin 1000 MG Injection, started on 2014-08-28, presumably until 2014-08-28\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-08-28, presumably until 2014-08-28\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-08-28 05:03:00, ended at 2014-08-29 18:40:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Laparoscopic incisional hernia repair with graft or prosthesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Acute postoperative pain\n- Morbid obesity\n- Spasm\n- Incisional hernia\n- Primary diagnosis: Postprocedural state finding\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Abdominal pain\n- Gastroesophageal reflux disease\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-08-28, presumably until 2015-08-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-08-28, presumably until 2014-08-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML diazepam 5 MG/ML Auto-Injector, started on 2014-08-29, presumably until 2014-08-29\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-29\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-08-29, presumably until 2015-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2014-08-28, presumably until 2014-08-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-10 14:07:36, ended at 2014-09-10 16:41:08\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-09 00:00:00, ended at 2015-01-09 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-09 08:30:00, ended at 2015-01-09 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of retroperitoneum\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e2d5239cb3a08a651b0636502e6d6c8f7b26964641dcdfd990575ccdf9f4654c", "prompt_hash": "c06fdb8f8d9ea2967a1ed608d7d04ae6517776b3ac0703e460d6a67dac05f121", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115968081, "visit_occurrence_id": 180687774, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2021-05-08 06:57:00", "visit_end_datetime": "2021-05-08 23:59:00", "visit_length_in_hours": 17.033333333333335, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 118, "patient_first_visit_date": "2011-01-09 10:37:00", "patient_last_visit_date": "2023-02-04 11:16:39", "end_obs_date": "2022-05-08", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "recurrent", "liver_cancer_one_year_diagnosis": 1, "visit_sequence_number": 37, "cumulated_visit_num": 37, "cumulated_approximate_token_count": 9832, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-01-09 10:37:00, ended at 2011-01-29 15:45:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.7 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 415 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 32.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 96 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.73 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 61.8 (second)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Base deficit in Blood: 9.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Aortocoronary bypass of two coronary arteries\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Catheterization of both left and right heart\n- Operative external blood circulation\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary angiography\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of intra-aortic balloon counterpulsation\n- Single internal mammary-coronary artery bypass\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n\n### Condition\n- Congestive heart failure\n- Obesity\n- Obstructive sleep apnea syndrome\n- Postprocedural state finding\n- Acute respiratory failure\n- Peripheral vascular disease\n- Pulmonary congestion and hypostasis\n- Brachial radiculitis\n- Coronary arteriosclerosis\n- Essential hypertension\n- Glaucoma\n- Leukocytosis\n- Primary diagnosis: Acute myocardial infarction\n- Aortocoronary bypass graft present\n- Cardiomegaly\n- Hyperlipidemia\n- Acute combined systolic and diastolic heart failure\n- Cardiac arrhythmia\n- Chronic systolic heart failure\n- Hemorrhoids\n- Nuclear senile cataract\n- Sequelae of cardiovascular disorders\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction of anterolateral wall\n- Chronic ischemic heart disease\n- Pleural effusion\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-02-15, with quantity of 15.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-01-20, presumably until 2011-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-01-21\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-01-28\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-01-11, presumably until 2011-01-11\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-26\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-04-19. Instructions: take 25 mg by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-01-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-20\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2011-01-19, presumably until 2011-01-23\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2011-01-12, presumably until 2011-01-28\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2011-01-27, presumably until 2011-04-19, with quantity of 1.0, with intended 0 refill(s). Instructions: insert into the rectum as needed for Anorectal itching/discomfort. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2012-01-29, with quantity of 120.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2011-01-09, presumably until 2011-01-09\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-01-12, presumably until 2011-01-28\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-01-14, presumably until 2012-01-29, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-01-27, presumably until 2012-01-29, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-13, presumably until 2020-04-28. Instructions: inject subcutaneous (under the skin). \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-29. Instructions: take by mouth.\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-01-17, presumably until 2011-01-29\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-01-13, presumably until 2011-01-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-01-09, presumably until 2011-01-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-01-28. Instructions: take 20 mg by mouth daily.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-01-11, presumably until 2011-01-14\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-09, presumably until 2022-08-20. Instructions: inject subcutaneous (under the skin) 4 times a day before meals and bedtime. \n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-26\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-13\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2011-01-14, presumably until 2011-01-14\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2011-01-13, presumably until 2011-01-13\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-01-29, with quantity of 90.0, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily. Please have INR levels checked on Monday 02/01/2011 \n- pravastatin sodium 10 MG Oral Tablet, through Oral route, presumably until 2011-02-15. Instructions: take 20 mg by mouth daily. \n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2011-01-25, presumably until 2011-01-25\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-01-13, presumably until 2011-04-19, with quantity of 60.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed \n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2011-01-11, presumably until 2011-01-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2011-02-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-01-12, presumably until 2011-01-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-23, presumably until 2011-04-19, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-10 14:38:57, ended at 2011-01-10 15:15:45\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-18 09:29:44, ended at 2011-01-18 10:42:10\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-29 10:00:00, ended at 2011-01-29 23:59:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-29 00:00:00, ended at 2020-01-29 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cancer Ag 19-9 [Units/volume] in Serum or Plasma: 2 (unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-01 08:29:50, ended at 2020-02-01 10:34:41\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2020-01-28, presumably until 2020-01-28, with intended 0 refill(s). Instructions: take 1 Tablet (300 mg total) by mouth daily\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-23, presumably until 2019-10-23, with intended 0 refill(s). Instructions: take 1 Tablet (20 mg total) by mouth AM\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-12, presumably until 2022-11-09, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-10-25, presumably until 2022-03-01, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- vitamin B complex, through Oral route, started on 2012-07-25, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Capsule by mouth daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2019-07-23, presumably until 2019-07-23, with intended 0 refill(s). Instructions: take 1 Tablet (150 mg total) by mouth AM\n- dorzolamide 20 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-08-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day\n- spironolactone 25 MG Oral Tablet, started on 2017-08-15, presumably until 2017-08-15, with intended 0 refill(s). Instructions: Take one tablet by mouth one time daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-08-19, presumably until 2017-08-19, with intended 0 refill(s). Instructions: inject 60 Units subcutaneous (under the skin) 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-30, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-01-07, presumably until 2020-01-07, with intended 0 refill(s). Instructions: inject subcutaneous (under the skin) every 7 days Every Mondays\n- rosuvastatin calcium 20 MG Oral Tablet, started on 2019-08-24, presumably until 2019-08-24, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2019-11-15, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-01 10:33:00, ended at 2020-02-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.43 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 69.0 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 07:12:00, ended at 2020-03-31 08:24:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Liver cell carcinoma\n- Lumbar spondylosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 08:25:00, ended at 2020-03-31 10:25:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 13:22:00, ended at 2020-03-31 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Portal vein thrombosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-18 10:04:44, ended at 2020-04-18 10:16:59\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-22 07:47:00, ended at 2020-04-22 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n\n### Condition\n- Postoperative state\n- Steatosis of liver\n- Disorder of digestive system\n- Hepatosplenomegaly\n- Liver cell carcinoma\n- Acquired absence of organ\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 09:33:22, ended at 2020-04-28 10:35:04\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Malignant neoplasm of liver\n- Traumatic or non-traumatic injury\n- Obstructive sleep apnea syndrome\n- Generalized ischemic myocardial dysfunction\n- Hyperlipidemia\n- Primary diagnosis: COVID-19\n- Liver cell carcinoma\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, presumably until 2020-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Liver cell carcinoma\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- cefazolin 1000 MG Injection, started on 2020-05-01, presumably until 2020-05-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-01 08:40:00, ended at 2020-05-01 19:30:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Body height: 5' 6\" (inch (US))\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 223 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- Ablation, 1 or more liver tumor(s), percutaneous, radiofrequency\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aortocoronary bypass graft present\n- Steatosis of liver\n- Hyperlipidemia\n- Old myocardial infarction\n- Supraventricular tachycardia\n- Chronic systolic heart failure\n- Primary diagnosis: Liver cell carcinoma\n- Generalized ischemic myocardial dysfunction\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Obesity\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-04 10:32:19, ended at 2020-07-04 10:56:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n- Portal vein thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-05 07:00:00, ended at 2020-08-05 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:46:06, ended at 2020-08-06 09:13:34\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-07 00:00:00, ended at 2020-08-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 10:36:58, ended at 2020-08-15 11:02:37\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Liver\n- Portal vein thrombosis\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-05 07:10:00, ended at 2020-11-05 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 09:54:20, ended at 2020-11-14 10:11:20\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-12 00:00:00, ended at 2021-01-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.56 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-12 12:59:00, ended at 2021-02-12 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Portal hypertension\n- Splenomegaly\n- Liver cell carcinoma\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-13 10:28:20, ended at 2021-02-13 10:49:11\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-01-09 10:37:00, ended at 2011-01-29 15:45:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.7 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 415 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 32.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 96 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.73 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 61.8 (second)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Base deficit in Blood: 9.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Aortocoronary bypass of two coronary arteries\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Catheterization of both left and right heart\n- Operative external blood circulation\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary angiography\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of intra-aortic balloon counterpulsation\n- Single internal mammary-coronary artery bypass\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n\n### Condition\n- Congestive heart failure\n- Obesity\n- Obstructive sleep apnea syndrome\n- Postprocedural state finding\n- Acute respiratory failure\n- Peripheral vascular disease\n- Pulmonary congestion and hypostasis\n- Brachial radiculitis\n- Coronary arteriosclerosis\n- Essential hypertension\n- Glaucoma\n- Leukocytosis\n- Primary diagnosis: Acute myocardial infarction\n- Aortocoronary bypass graft present\n- Cardiomegaly\n- Hyperlipidemia\n- Acute combined systolic and diastolic heart failure\n- Cardiac arrhythmia\n- Chronic systolic heart failure\n- Hemorrhoids\n- Nuclear senile cataract\n- Sequelae of cardiovascular disorders\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction of anterolateral wall\n- Chronic ischemic heart disease\n- Pleural effusion\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-02-15, with quantity of 15.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-01-20, presumably until 2011-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-01-21\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-01-28\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-01-11, presumably until 2011-01-11\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-26\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-04-19. Instructions: take 25 mg by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-01-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-20\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2011-01-19, presumably until 2011-01-23\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2011-01-12, presumably until 2011-01-28\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2011-01-27, presumably until 2011-04-19, with quantity of 1.0, with intended 0 refill(s). Instructions: insert into the rectum as needed for Anorectal itching/discomfort. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2012-01-29, with quantity of 120.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2011-01-09, presumably until 2011-01-09\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-01-12, presumably until 2011-01-28\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-01-14, presumably until 2012-01-29, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-01-27, presumably until 2012-01-29, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-13, presumably until 2020-04-28. Instructions: inject subcutaneous (under the skin). \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-29. Instructions: take by mouth.\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-01-17, presumably until 2011-01-29\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-01-13, presumably until 2011-01-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-01-09, presumably until 2011-01-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-01-28. Instructions: take 20 mg by mouth daily.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-01-11, presumably until 2011-01-14\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-09, presumably until 2022-08-20. Instructions: inject subcutaneous (under the skin) 4 times a day before meals and bedtime. \n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-26\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-13\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2011-01-14, presumably until 2011-01-14\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2011-01-13, presumably until 2011-01-13\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-01-29, with quantity of 90.0, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily. Please have INR levels checked on Monday 02/01/2011 \n- pravastatin sodium 10 MG Oral Tablet, through Oral route, presumably until 2011-02-15. Instructions: take 20 mg by mouth daily. \n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2011-01-25, presumably until 2011-01-25\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-01-13, presumably until 2011-04-19, with quantity of 60.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed \n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2011-01-11, presumably until 2011-01-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2011-02-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-01-12, presumably until 2011-01-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-23, presumably until 2011-04-19, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-10 14:38:57, ended at 2011-01-10 15:15:45\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-18 09:29:44, ended at 2011-01-18 10:42:10\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-29 10:00:00, ended at 2011-01-29 23:59:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-29 00:00:00, ended at 2020-01-29 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cancer Ag 19-9 [Units/volume] in Serum or Plasma: 2 (unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-01 08:29:50, ended at 2020-02-01 10:34:41\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2020-01-28, presumably until 2020-01-28, with intended 0 refill(s). Instructions: take 1 Tablet (300 mg total) by mouth daily\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-23, presumably until 2019-10-23, with intended 0 refill(s). Instructions: take 1 Tablet (20 mg total) by mouth AM\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-12, presumably until 2022-11-09, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-10-25, presumably until 2022-03-01, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- vitamin B complex, through Oral route, started on 2012-07-25, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Capsule by mouth daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2019-07-23, presumably until 2019-07-23, with intended 0 refill(s). Instructions: take 1 Tablet (150 mg total) by mouth AM\n- dorzolamide 20 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-08-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day\n- spironolactone 25 MG Oral Tablet, started on 2017-08-15, presumably until 2017-08-15, with intended 0 refill(s). Instructions: Take one tablet by mouth one time daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-08-19, presumably until 2017-08-19, with intended 0 refill(s). Instructions: inject 60 Units subcutaneous (under the skin) 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-30, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-01-07, presumably until 2020-01-07, with intended 0 refill(s). Instructions: inject subcutaneous (under the skin) every 7 days Every Mondays\n- rosuvastatin calcium 20 MG Oral Tablet, started on 2019-08-24, presumably until 2019-08-24, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2019-11-15, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-01 10:33:00, ended at 2020-02-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.43 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 69.0 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 07:12:00, ended at 2020-03-31 08:24:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Liver cell carcinoma\n- Lumbar spondylosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 08:25:00, ended at 2020-03-31 10:25:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 13:22:00, ended at 2020-03-31 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Portal vein thrombosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-18 10:04:44, ended at 2020-04-18 10:16:59\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-22 07:47:00, ended at 2020-04-22 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n\n### Condition\n- Postoperative state\n- Steatosis of liver\n- Disorder of digestive system\n- Hepatosplenomegaly\n- Liver cell carcinoma\n- Acquired absence of organ\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 09:33:22, ended at 2020-04-28 10:35:04\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Malignant neoplasm of liver\n- Traumatic or non-traumatic injury\n- Obstructive sleep apnea syndrome\n- Generalized ischemic myocardial dysfunction\n- Hyperlipidemia\n- Primary diagnosis: COVID-19\n- Liver cell carcinoma\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, presumably until 2020-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Liver cell carcinoma\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- cefazolin 1000 MG Injection, started on 2020-05-01, presumably until 2020-05-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-01 08:40:00, ended at 2020-05-01 19:30:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Body height: 5' 6\" (inch (US))\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 223 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- Ablation, 1 or more liver tumor(s), percutaneous, radiofrequency\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aortocoronary bypass graft present\n- Steatosis of liver\n- Hyperlipidemia\n- Old myocardial infarction\n- Supraventricular tachycardia\n- Chronic systolic heart failure\n- Primary diagnosis: Liver cell carcinoma\n- Generalized ischemic myocardial dysfunction\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Obesity\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-04 10:32:19, ended at 2020-07-04 10:56:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n- Portal vein thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-05 07:00:00, ended at 2020-08-05 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:46:06, ended at 2020-08-06 09:13:34\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-07 00:00:00, ended at 2020-08-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 10:36:58, ended at 2020-08-15 11:02:37\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Liver\n- Portal vein thrombosis\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-05 07:10:00, ended at 2020-11-05 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 09:54:20, ended at 2020-11-14 10:11:20\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-12 00:00:00, ended at 2021-01-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.56 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-12 12:59:00, ended at 2021-02-12 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Portal hypertension\n- Splenomegaly\n- Liver cell carcinoma\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-13 10:28:20, ended at 2021-02-13 10:49:11\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "abfba416c551706ccd9b2ad7a2e8092272b4a5a72b4641e93b07d59ef6160e50", "prompt_hash": "b67f913166c00db2e0e637206257ad60dcff4361f1e68d6ea9d701abc8c9b848", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 4, "doc": {"person_id": 115969160, "visit_occurrence_id": 110298957, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2017-10-13 10:57:00", "visit_end_datetime": "2017-10-13 12:46:00", "visit_length_in_hours": 1.8166666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 10:57:00, ended at 2017-10-13 12:46:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Body height: 5' 10\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n\n### Procedure\n- Removal of Infusion Device from Great Vessel, External Approach\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2017-10-13, presumably until 2017-10-13\n\n", "approximate_token_count": 533, "patient_first_visit_date": "2016-08-05 09:14:00", "patient_last_visit_date": "2023-01-03 00:00:00", "end_obs_date": "2018-10-13", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 90, "cumulated_visit_num": 90, "cumulated_approximate_token_count": 31036, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-05 09:14:00, ended at 2016-08-05 11:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences\n- Cardiac magnetic resonance imaging for velocity flow mapping (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Rheumatic tricuspid valve regurgitation\n- Cardiomegaly\n- Aortic incompetence, non-rheumatic\n- Pulmonary incompetence, non-rheumatic\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-02 00:00:00, ended at 2016-09-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-04 11:00:00, ended at 2016-09-04 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-01 00:00:00, ended at 2016-10-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-01 11:00:00, ended at 2016-10-01 11:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-09 00:00:00, ended at 2016-10-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 00:00:00, ended at 2016-11-18 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac catheterization including coronary angiography and ventriculography (not to include Swan-Ganz catheter)\n\n### Condition\n- Congestive heart failure\n- Essential hypertension\n- Systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n- cefazolin 1000 MG Injection, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-11-18, presumably until 2016-11-18\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- midazolam 1 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 11:50:00, ended at 2016-11-19 11:55:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.04 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 53 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 18.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Base excess in Arterial blood by calculation: -6.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 161 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 83.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 20.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 40.3 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Measurement of Cardiac Sampling and Pressure, Bilateral, Percutaneous Approach\n- Dilation of Left Pulmonary Artery, Percutaneous Approach\n- Percutaneous transluminal pulmonary artery balloon angioplasty; each additional vessel (List separately in addition to code for primary procedure)\n- Dilation of Right Pulmonary Artery, Percutaneous Approach\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Percutaneous transluminal pulmonary artery balloon angioplasty; single vessel\n- Fluoroscopy of Left Pulmonary Artery using Low Osmolar Contrast\n- Fluoroscopy of Right Pulmonary Artery using Low Osmolar Contrast\n- Combined right heart catheterization and retrograde left heart catheterization, for congenital cardiac anomalies\n- Collection of blood specimen from a completely implantable venous access device\n- Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for pulmonary angiography (List separately in addition to code for primary procedure)\n\n### Condition\n- Stenosis due to any device, implant AND/OR graft\n- Postoperative state\n- Essential hypertension\n- Pulmonary artery stenosis\n- Adverse effect of prosthetic device\n- Obesity\n- Primary diagnosis: Tetralogy of Fallot\n- Complication of surgical procedure\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- famotidine 10 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2016-11-19, presumably until 2016-12-03, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-22 00:00:00, ended at 2016-11-22 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth.\n- losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 100 mg by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 14:12:00, ended at 2016-12-03 15:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary perfusion imaging (eg, particulate)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 15:38:00, ended at 2016-12-03 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 07:52:00, ended at 2016-12-05 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Ectasia of thoracic aorta\n- Complication associated with device\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-10 00:00:00, ended at 2016-12-10 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-12-11, presumably until 2017-01-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-11 20:54:00, ended at 2016-12-11 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 18.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.02 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 54.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 465 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Prothrombin time (PT): 14.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decompression fasciotomy, leg; anterior and/or lateral, and posterior compartment(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n\n### Condition\n- Tetralogy of Fallot\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Postoperative state\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-13 08:48:06, ended at 2016-12-13 14:10:03\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.882\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 13:22:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n- Cardiomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Prothrombin time (PT): 77.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Mixed venous blood: 0.53 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 8 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative state\n- Primary diagnosis: Illness\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin alfa 1000 UNT/ML Topical Solution, through Topical route, started on 2016-12-16, presumably until 2016-12-16\n- cefazolin 1000 MG Injection, started on 2016-12-16, presumably until 2016-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 06:55:00, ended at 2017-01-18 10:10:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] in Venous blood: 61.7 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Prothrombin time (PT): 77.7 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Arterial blood: 9.9 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Body height: 5' 9.882\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Methemoglobin/Hemoglobin.total in Blood: <1.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Zinc [Mass/volume] in Blood: 86 (microgram per deciliter)\n\n### Procedure\n- Medical team conference with interdisciplinary team of health care professionals, patient and/or family not present, 30 minutes or more; participation by physician\n- Closure of median sternotomy separation with or without debridement (separate procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Repair Right Pulmonary Artery, Open Approach\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Repair Atrial Septum, Open Approach\n- Repair of pulmonary artery stenosis by reconstruction with patch or graft\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Unlisted pulmonary service or procedure\n- Splitting of blood or blood products, each unit\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hemodialysis procedure requiring repeated evaluation(s) with or without substantial revision of dialysis prescription\n- Controlled ventilation procedure and therapy, initiation and management\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Oxygen uptake, expired gas analysis; rest, indirect (separate procedure)\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial re\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Hemodialysis procedure with single evaluation by a physician or other qualified health care professional\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Supplement Right Femoral Artery with Nonautologous Tissue Substitute, Open Approach\n- Repair Chest Wall, Open Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed\n- Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach\n- Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch\n- Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach\n- Bypass Right Ventricle to Pulmonary Trunk with Zooplastic Tissue, Open Approach\n- Repair of complex cardiac anomaly other than pulmonary atresia with ventricular septal defect by construction or replacement of conduit from right or left ventricle to pulmonary artery\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)\n- Extirpation of Matter from Right Femoral Artery, Open Approach\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Release Right Lower Leg Muscle, Open Approach\n- Transfusion of Nonautologous Frozen Plasma into Peripheral Vein, Percutaneous Approach\n- Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Replacement of Thoracic Aorta, Ascending/Arch with Synthetic Substitute, Open Approach\n- Replacement of Aortic Valve with Synthetic Substitute, Open Approach\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Removal of Infusion Device from Upper Vein, External Approach\n- Introduction of Nutritional Substance into Central Vein, Percutaneous Approach\n- Performance of Cardiac Output, Continuous\n- Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures \n- Performance of Cardiac Pacing, Continuous\n- Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, Continuous Positive Airway Pressure\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Repair Left Pulmonary Artery, Open Approach\n- Hospital discharge day management; more than 30 minutes\n- Restoration of Cardiac Rhythm, Single\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Performance of Urinary Filtration, Multiple (Deprecated)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Drainage of Left Lower Lobe Bronchus, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Repair blood vessel, direct; lower extremity\n\n### Condition\n- Acute combined systolic and diastolic heart failure\n- Aortic incompetence, non-rheumatic\n- Finding of urine output\n- Iatrogenic hypotension\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n- Obstructive sleep apnea syndrome\n- Polyneuropathy\n- Seizure\n- Supraventricular tachycardia\n- Transplanted heart valve present\n- Acute tubular necrosis\n- Bleeding\n- Disorder of pulmonary circulation\n- Drug-induced anaphylaxis\n- Low blood pressure\n- Open wound of front wall of thorax\n- Tetralogy of Fallot\n- Ulcer\n- Cardiac insufficiency following cardiac surgery\n- Compartment syndrome of lower limb\n- Gangrenous disorder\n- Iatrogenic disorder\n- Iron deficiency anemia\n- Primary diagnosis: Postoperative state\n- Postprocedural respiratory failure\n- Stenosis due to any device, implant AND/OR graft\n- Thromboembolus of artery of lower limb\n- Type 2 diabetes mellitus without complication\n- Atherosclerosis of arteries of the extremities\n- Atrial septal defect\n- Cardiac arrhythmia\n- Cardiogenic shock\n- Chronic kidney disease stage 4\n- Combined disorders of mitral, aortic and tricuspid valves\n- Congestive heart failure\n- Disseminated intravascular coagulation\n- Insomnia\n- Postoperative renal failure\n- Thromboembolism of vein\n- Acute hypoxemic respiratory failure\n- Acute renal failure syndrome\n- Atherosclerosis of artery of lower limb\n- Disorder of cardiovascular system\n- Heparin-induced thrombocytopenia\n- Open wound of ankle\n- Perioperative hemorrhage\n- Persistent pain following procedure\n- Renal failure syndrome\n- Disorder of bilirubin metabolism\n- Hepatosplenomegaly\n- Hypokalemia\n- Obesity\n- Rhabdomyolysis\n- Tonsil and/or adenoid hypertrophy\n- Abnormal breathing\n- Acute on chronic combined systolic and diastolic heart failure\n- Anemia in chronic kidney disease\n- Atresia of pulmonary valve\n- Blood coagulation disorder\n- Congenital heart disease\n- Dependence on enabling machine or device\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Late effect of complications of procedure\n- Malaise\n- Open wound of lower leg\n- Stricture of artery\n- Type 2 diabetes mellitus\n- Ventricular tachycardia\n- Atelectasis\n- Atrial flutter\n- Electroencephalogram abnormal\n- Hypertensive heart failure\n- Hypo-osmolality and or hyponatremia\n- Hypocalcemia\n- Open wound of knee\n- Pulmonary stenosis, non-rheumatic\n- Sepsis\n- Thoracic aortic aneurysm without rupture\n- Ventricular fibrillation\n- Autoimmune hemolytic anemia\n- Disorder of phosphorus metabolism\n- Heart failure\n- Hypervolemia\n- Pain in right foot\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (500 mg total) by mouth 2 (two) times a day.\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth 3 (three) times a day with meals.\n- 50 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-20\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2017-01-06\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-18\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-01-07, presumably until 2017-01-17\n- 150 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-25, presumably until 2016-12-27\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-12-23, presumably until 2016-12-23\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-23, presumably until 2017-01-17\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 20 mg by mouth daily.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth nightly as needed for sleep.\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-17\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2016-12-24, presumably until 2016-12-27\n- melatonin 5 MG Oral Tablet, through Oral route, started on 2016-12-26, presumably until 2016-12-26\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2016-12-19, presumably until 2016-12-19\n- folic acid, through Oral route, started on 2017-01-01, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet by mouth daily.\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2016-12-17, presumably until 2016-12-23\n- 50 ML argatroban 1 MG/ML Injection, through Intravenous route, started on 2016-12-21, presumably until 2017-01-14\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2016-12-28, presumably until 2016-12-28\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (15 mg total) by mouth daily.\n- heparin sodium, porcine 10 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-12-31, presumably until 2017-01-09\n- iodixanol, through Intravenous route, started on 2016-12-20, presumably until 2016-12-20\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2016-12-20, presumably until 2016-12-20\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-04, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 capsule (250 mg total) by mouth 2 (two) times a day as needed for constipation.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-23\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-01-01, presumably until 2017-01-01\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 2 tablets (8 mg total) by mouth every evening.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 tablets by mouth 2 (two) times a day.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth daily.\n- ketamine 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-26, presumably until 2016-12-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-09, presumably until 2017-01-09\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2017-01-06\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-01-04, presumably until 2017-01-18\n- 100 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-27\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-17\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-02, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 capsules (1,334 mg total) by mouth 3 (three) times a day with meals.\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 81 mg by mouth daily.\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-07, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Inject 1 mL (4,000 Units total) into the skin Tuesday, Thursday and Saturday.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-20, presumably until 2016-12-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2016-12-24, presumably until 2016-12-24\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth 3 (three) times a day.\n- ketamine 100 MG/ML Injectable Solution, started on 2016-12-17, presumably until 2016-12-17\n- melatonin 1 MG/ML Oral Solution, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: 10 mLs (10 mg total) by NG-Tube route at bedtime.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2017-01-01, presumably until 2017-01-17\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-19\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2017-01-06\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth every 4 (four) hours as needed.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2016-12-19, presumably until 2016-12-29\n- midazolam 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2017-01-06\n- 50 ML glucose 500 MG/ML Injection, through Intravenous route, started on 2016-12-26, presumably until 2016-12-27\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-15, presumably until 2017-01-17\n- phenylephrine hydrochloride 5 MG/ML Nasal Spray, through Nasal route, started on 2016-12-24, presumably until 2016-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of artery of lower limb\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of artery of lower limb\n- Primary diagnosis: Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2016-12-20, presumably until 2016-12-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Compartment syndrome of upper limb\n- Pain in toe\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thromboembolus of artery of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Edema\n- Localized swelling, mass and lump, lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Thromboembolus of artery of upper limb\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compartment syndrome of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-24 09:09:00, ended at 2016-12-24 14:44:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Localized swelling, mass and lump, lower limb\n- Pain in right foot\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Pain in toe\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-02 00:00:00, ended at 2017-01-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-02 13:00:00, ended at 2017-01-02 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-09 00:00:00, ended at 2017-01-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-20 00:00:00, ended at 2017-01-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-24 13:29:49, ended at 2017-01-24 15:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-01-24 17:46:00, ended at 2017-02-13 14:30:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: -1.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.88 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.25 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Osmolality of Urine: 257 (milliosmole per kilogram)\n- Oxygen [Partial pressure] in Arterial blood: 231.0 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Prothrombin time (PT): 21.9 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 21.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.13 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 110 (millimeter per hour)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 17 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 9.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.5 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 7.92 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Base excess in Blood by calculation: 4 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.6 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 53.69 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.75 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 6.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.6 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Extraction of Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Excision of Right Tibia, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Excision of Right Lower Leg Muscle, Open Approach\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Detachment at Right Lower Leg, Mid, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Amputation, leg, through tibia and fibula; open, circular (guillotine)\n- Splitting of blood or blood products, each unit\n- Radiologic examination, chest; single view, frontal\n- Excision of Right Fibula, Open Approach\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Amputation, leg, through tibia and fibula; re-amputation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Bacterial infection due to Pseudomonas\n- Hypokalemia\n- Necrosis of amputation stump\n- Rhabdomyolysis\n- Absence of lower limb\n- Postoperative state\n- Right bundle branch block\n- Type 2 diabetes mellitus without complication\n- Acquired absence of organ\n- Complication following amputation of limb\n- Infection by methicillin sensitive Staphylococcus aureus\n- Phantom limb syndrome with pain\n- Tachycardia\n- Transplanted heart valve present\n- Complication of procedure\n- Gangrenous disorder\n- Hypo-osmolality and or hyponatremia\n- Obesity\n- Primary diagnosis: Compartment syndrome of lower limb\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n- Gangrene due to type 2 diabetes mellitus\n- Peripheral angiopathy due to diabetes mellitus\n- Cardiomegaly\n- Electrocardiogram abnormal\n- Persistent pain following procedure\n- Acute renal failure syndrome\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus\n- Anemia\n\n### Drug\n- 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 500 mg by mouth\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-01-28, presumably until 2017-02-06\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2017-02-06, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 325 mg by mouth\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-02-10, presumably until 2017-02-11\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-31\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-31, presumably until 2017-02-05\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-24, presumably until 2017-02-12\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-02-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2017-01-29, presumably until 2017-02-05\n- sodium hypochlorite 1.25 MG/ML Topical Solution, started on 2017-01-31, presumably until 2017-02-11\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours\n- folic acid, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2017-02-09, presumably until 2017-02-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-01-24, presumably until 2017-02-09\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 15 mg by mouth daily\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-01-25, presumably until 2017-02-13\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-04-29, with intended 0 refill(s). Instructions: take 1 Peaslee by mouth every bedtime\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 2 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-01-27\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2017-02-05\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2017-02-06, presumably until 2017-02-11\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-02-03, presumably until 2017-06-17, with intended 0 refill(s). Instructions: by Topical route 2 times a day\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 10 mg by mouth \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-01-25, presumably until 2017-01-28\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-02-13\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-02-07\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-02-08, presumably until 2017-02-17, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-24\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1,334 mg by mouth 2 times a day\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-18, presumably until 2017-02-13, with intended 0 refill(s). Instructions: inject 4,000 Units subcutaneous (under the skin)\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-25, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-01-25, presumably until 2017-02-07\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-01-30, presumably until 2017-01-30\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-02-03\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-01-31, presumably until 2017-02-06\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 80 mg by mouth\n- melatonin 1 MG/ML Oral Solution, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: 10 mg\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 6 Caps by mouth 3 times a day\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-06-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-12, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-01-27, presumably until 2017-02-13\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2017-01-25, presumably until 2017-01-25\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of upper leg\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n\n### Condition\n- Transplanted heart valve present\n- Gangrenous disorder\n- Compartment syndrome of lower limb\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-01-25\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- cefazolin 1000 MG Injection, started on 2017-01-25, presumably until 2017-01-25\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Heart failure\n- Gangrenous disorder\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- ketamine 100 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; brachial plexus\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- midazolam 1 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Compartment syndrome of lower limb\n- Peripheral vascular disease\n- Essential hypertension\n- Gangrenous disorder\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2017-02-05, presumably until 2017-02-05\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n- Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 14:52:51, ended at 2017-02-17 16:16:11\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Acute renal failure syndrome\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 16:22:24, ended at 2017-02-17 16:22:37\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Absence of lower limb\n- Acute renal failure syndrome\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-24 15:03:43, ended at 2017-02-24 16:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 14:00:00, ended at 2017-03-17 16:45:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 54.7 (percent)\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:00:31, ended at 2017-03-17 16:34:55\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:02:20, ended at 2017-03-17 16:35:29\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart valve present\n- Electrocardiogram abnormal\n- Right bundle branch block\n- Tetralogy of Fallot\n- Postoperative state\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-03-17, presumably until 2017-07-17, with intended 3 refill(s). Instructions: take 2 Caps by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 16:46:00, ended at 2017-03-17 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 336 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-28 00:00:00, ended at 2017-04-28 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2017-04-28, presumably until 2017-04-28, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-29 00:00:00, ended at 2017-04-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-29, presumably until 2018-06-04, with intended 6 refill(s). Instructions: take 1 Fleischner by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-17 15:04:14, ended at 2017-06-17 16:50:01\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Absence of lower limb\n- Transplanted heart valve present\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-14, with intended 3 refill(s). Instructions: Take 2 caps by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-12 00:00:00, ended at 2017-08-12 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Primary diagnosis: Right lower quadrant pain\n- Injury of femoral artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-13 13:43:00, ended at 2017-08-13 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Right lower quadrant pain\n- Tetralogy of Fallot\n- Injury of femoral artery\n- Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iothalamic acid, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-08-14, presumably until 2017-08-14\n- iothalamate, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for procedures on arteries of lower leg, including bypass graft; not otherwise specified\n\n### Condition\n- Cellulitis of groin\n- Tetralogy of Fallot\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-14, presumably until 2017-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-08-14 12:09:00, ended at 2017-08-20 11:28:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.70 (thousand per microliter)\n- Base excess in Arterial blood by calculation: -2.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 21.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 167 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 325 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 48 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Prothrombin time (PT): 25.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 206.0 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Repair blood vessel, direct; lower extremity\n- Insertion of Infusion Device into Upper Vein, Percutaneous Approach\n- Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft\n- Collection of venous blood by venipuncture\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquire\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Excision of infected graft; extremity\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Replacement of Right Femoral Artery with Autologous Tissue Substitute, Open Approach\n- Excision of Left Saphenous Vein, Open Approach\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Postoperative state\n- Tetralogy of Fallot\n- Traumatic or non-traumatic injury\n- Abscess of groin\n- Abscess of skin and/or subcutaneous tissue\n- Complication associated with device\n- Complication of surgical procedure\n- Infection by methicillin sensitive Staphylococcus aureus\n- Infection of amputation stump\n- Postprocedural infection\n- Absence of lower limb\n- Aneurysm of artery of lower extremity\n- Primary diagnosis: Cellulitis of groin\n- Complication following amputation of limb\n- Transplanted heart valve present\n- Acquired absence of organ\n- Localized infection of skin AND/OR subcutaneous tissue\n- Obesity\n- Obstructive sleep apnea syndrome\n- Sepsis\n- Secondary pulmonary hypertension\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-19\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2022-04-24, with intended 0 refill(s). Instructions: take 10 mg by mouth every Wednesday\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2022-04-24, with intended 1 refill(s). Instructions: take 5 mg by mouth every Monday\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-17\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-10-13, with intended 2 refill(s). Instructions: 2 g by Intravenous route every 8 hours\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-19\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-08-16, presumably until 2017-08-18\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-14, presumably until 2017-08-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2018-01-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day \n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2017-08-14, presumably until 2017-08-17\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-09-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-20, with intended 3 refill(s). Instructions: 100 mL by Intravenous route every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n\n### Condition\n- Tetralogy of Fallot\n- Cellulitis of groin\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2017-08-19, presumably until 2017-08-19\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-26 09:09:25, ended at 2017-08-26 10:59:39\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 500 mg by Swish & Swallow route\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2017-03-10, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1 Application by Topical route\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2017-08-26, with intended 0 refill(s). Instructions: 20 mg by Swish & Swallow route\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 81 mg by Swish & Swallow route\n- gabapentin 300 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-26, with intended 0 refill(s). Instructions: One qhs\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1,334 mg by Swish & Swallow route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-26 13:30:00, ended at 2017-08-26 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Laceration - injury\n- Cellulitis of groin\n- Transplanted heart valve present\n- Open wound of anterior abdominal wall\n- Injury to blood vessels of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-02 08:10:47, ended at 2017-09-02 09:04:28\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Open wound of inguinal region\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-05 00:00:00, ended at 2017-09-05 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 09:31:07, ended at 2017-09-09 10:26:49\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:19:51, ended at 2017-09-09 16:25:24\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Open wound of anterior abdominal wall\n- Tetralogy of Fallot\n- Right bundle branch block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:20:09, ended at 2017-09-09 16:25:32\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-10 09:06:39, ended at 2017-09-10 10:05:44\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abscess of groin\n- Infection by methicillin sensitive Staphylococcus aureus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-16 09:57:09, ended at 2017-09-16 11:04:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-23 09:52:28, ended at 2017-09-23 10:25:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-30 09:55:42, ended at 2017-09-30 10:51:41\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-01 10:51:35, ended at 2017-10-01 12:00:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-03 00:00:00, ended at 2017-10-03 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 10:57:00, ended at 2017-10-13 12:46:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Body height: 5' 10\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n\n### Procedure\n- Removal of Infusion Device from Great Vessel, External Approach\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2017-10-13, presumably until 2017-10-13\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-05 09:14:00, ended at 2016-08-05 11:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences\n- Cardiac magnetic resonance imaging for velocity flow mapping (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Rheumatic tricuspid valve regurgitation\n- Cardiomegaly\n- Aortic incompetence, non-rheumatic\n- Pulmonary incompetence, non-rheumatic\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-02 00:00:00, ended at 2016-09-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-04 11:00:00, ended at 2016-09-04 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-01 00:00:00, ended at 2016-10-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-01 11:00:00, ended at 2016-10-01 11:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-09 00:00:00, ended at 2016-10-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 00:00:00, ended at 2016-11-18 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac catheterization including coronary angiography and ventriculography (not to include Swan-Ganz catheter)\n\n### Condition\n- Congestive heart failure\n- Essential hypertension\n- Systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n- cefazolin 1000 MG Injection, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-11-18, presumably until 2016-11-18\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- midazolam 1 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 11:50:00, ended at 2016-11-19 11:55:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.04 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 53 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 18.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Base excess in Arterial blood by calculation: -6.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 161 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 83.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 20.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 40.3 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Measurement of Cardiac Sampling and Pressure, Bilateral, Percutaneous Approach\n- Dilation of Left Pulmonary Artery, Percutaneous Approach\n- Percutaneous transluminal pulmonary artery balloon angioplasty; each additional vessel (List separately in addition to code for primary procedure)\n- Dilation of Right Pulmonary Artery, Percutaneous Approach\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Percutaneous transluminal pulmonary artery balloon angioplasty; single vessel\n- Fluoroscopy of Left Pulmonary Artery using Low Osmolar Contrast\n- Fluoroscopy of Right Pulmonary Artery using Low Osmolar Contrast\n- Combined right heart catheterization and retrograde left heart catheterization, for congenital cardiac anomalies\n- Collection of blood specimen from a completely implantable venous access device\n- Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for pulmonary angiography (List separately in addition to code for primary procedure)\n\n### Condition\n- Stenosis due to any device, implant AND/OR graft\n- Postoperative state\n- Essential hypertension\n- Pulmonary artery stenosis\n- Adverse effect of prosthetic device\n- Obesity\n- Primary diagnosis: Tetralogy of Fallot\n- Complication of surgical procedure\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- famotidine 10 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2016-11-19, presumably until 2016-12-03, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-22 00:00:00, ended at 2016-11-22 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth.\n- losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 100 mg by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 14:12:00, ended at 2016-12-03 15:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary perfusion imaging (eg, particulate)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 15:38:00, ended at 2016-12-03 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 07:52:00, ended at 2016-12-05 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Ectasia of thoracic aorta\n- Complication associated with device\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-10 00:00:00, ended at 2016-12-10 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-12-11, presumably until 2017-01-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-11 20:54:00, ended at 2016-12-11 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 18.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.02 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 54.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 465 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Prothrombin time (PT): 14.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decompression fasciotomy, leg; anterior and/or lateral, and posterior compartment(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n\n### Condition\n- Tetralogy of Fallot\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Postoperative state\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-13 08:48:06, ended at 2016-12-13 14:10:03\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.882\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 13:22:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n- Cardiomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Prothrombin time (PT): 77.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Mixed venous blood: 0.53 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 8 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative state\n- Primary diagnosis: Illness\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin alfa 1000 UNT/ML Topical Solution, through Topical route, started on 2016-12-16, presumably until 2016-12-16\n- cefazolin 1000 MG Injection, started on 2016-12-16, presumably until 2016-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 06:55:00, ended at 2017-01-18 10:10:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] in Venous blood: 61.7 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Prothrombin time (PT): 77.7 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Arterial blood: 9.9 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Body height: 5' 9.882\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Methemoglobin/Hemoglobin.total in Blood: <1.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Zinc [Mass/volume] in Blood: 86 (microgram per deciliter)\n\n### Procedure\n- Medical team conference with interdisciplinary team of health care professionals, patient and/or family not present, 30 minutes or more; participation by physician\n- Closure of median sternotomy separation with or without debridement (separate procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Repair Right Pulmonary Artery, Open Approach\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Repair Atrial Septum, Open Approach\n- Repair of pulmonary artery stenosis by reconstruction with patch or graft\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Unlisted pulmonary service or procedure\n- Splitting of blood or blood products, each unit\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hemodialysis procedure requiring repeated evaluation(s) with or without substantial revision of dialysis prescription\n- Controlled ventilation procedure and therapy, initiation and management\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Oxygen uptake, expired gas analysis; rest, indirect (separate procedure)\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial re\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Hemodialysis procedure with single evaluation by a physician or other qualified health care professional\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Supplement Right Femoral Artery with Nonautologous Tissue Substitute, Open Approach\n- Repair Chest Wall, Open Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed\n- Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach\n- Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch\n- Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach\n- Bypass Right Ventricle to Pulmonary Trunk with Zooplastic Tissue, Open Approach\n- Repair of complex cardiac anomaly other than pulmonary atresia with ventricular septal defect by construction or replacement of conduit from right or left ventricle to pulmonary artery\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)\n- Extirpation of Matter from Right Femoral Artery, Open Approach\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Release Right Lower Leg Muscle, Open Approach\n- Transfusion of Nonautologous Frozen Plasma into Peripheral Vein, Percutaneous Approach\n- Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Replacement of Thoracic Aorta, Ascending/Arch with Synthetic Substitute, Open Approach\n- Replacement of Aortic Valve with Synthetic Substitute, Open Approach\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Removal of Infusion Device from Upper Vein, External Approach\n- Introduction of Nutritional Substance into Central Vein, Percutaneous Approach\n- Performance of Cardiac Output, Continuous\n- Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures \n- Performance of Cardiac Pacing, Continuous\n- Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, Continuous Positive Airway Pressure\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Repair Left Pulmonary Artery, Open Approach\n- Hospital discharge day management; more than 30 minutes\n- Restoration of Cardiac Rhythm, Single\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Performance of Urinary Filtration, Multiple (Deprecated)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Drainage of Left Lower Lobe Bronchus, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Repair blood vessel, direct; lower extremity\n\n### Condition\n- Acute combined systolic and diastolic heart failure\n- Aortic incompetence, non-rheumatic\n- Finding of urine output\n- Iatrogenic hypotension\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n- Obstructive sleep apnea syndrome\n- Polyneuropathy\n- Seizure\n- Supraventricular tachycardia\n- Transplanted heart valve present\n- Acute tubular necrosis\n- Bleeding\n- Disorder of pulmonary circulation\n- Drug-induced anaphylaxis\n- Low blood pressure\n- Open wound of front wall of thorax\n- Tetralogy of Fallot\n- Ulcer\n- Cardiac insufficiency following cardiac surgery\n- Compartment syndrome of lower limb\n- Gangrenous disorder\n- Iatrogenic disorder\n- Iron deficiency anemia\n- Primary diagnosis: Postoperative state\n- Postprocedural respiratory failure\n- Stenosis due to any device, implant AND/OR graft\n- Thromboembolus of artery of lower limb\n- Type 2 diabetes mellitus without complication\n- Atherosclerosis of arteries of the extremities\n- Atrial septal defect\n- Cardiac arrhythmia\n- Cardiogenic shock\n- Chronic kidney disease stage 4\n- Combined disorders of mitral, aortic and tricuspid valves\n- Congestive heart failure\n- Disseminated intravascular coagulation\n- Insomnia\n- Postoperative renal failure\n- Thromboembolism of vein\n- Acute hypoxemic respiratory failure\n- Acute renal failure syndrome\n- Atherosclerosis of artery of lower limb\n- Disorder of cardiovascular system\n- Heparin-induced thrombocytopenia\n- Open wound of ankle\n- Perioperative hemorrhage\n- Persistent pain following procedure\n- Renal failure syndrome\n- Disorder of bilirubin metabolism\n- Hepatosplenomegaly\n- Hypokalemia\n- Obesity\n- Rhabdomyolysis\n- Tonsil and/or adenoid hypertrophy\n- Abnormal breathing\n- Acute on chronic combined systolic and diastolic heart failure\n- Anemia in chronic kidney disease\n- Atresia of pulmonary valve\n- Blood coagulation disorder\n- Congenital heart disease\n- Dependence on enabling machine or device\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Late effect of complications of procedure\n- Malaise\n- Open wound of lower leg\n- Stricture of artery\n- Type 2 diabetes mellitus\n- Ventricular tachycardia\n- Atelectasis\n- Atrial flutter\n- Electroencephalogram abnormal\n- Hypertensive heart failure\n- Hypo-osmolality and or hyponatremia\n- Hypocalcemia\n- Open wound of knee\n- Pulmonary stenosis, non-rheumatic\n- Sepsis\n- Thoracic aortic aneurysm without rupture\n- Ventricular fibrillation\n- Autoimmune hemolytic anemia\n- Disorder of phosphorus metabolism\n- Heart failure\n- Hypervolemia\n- Pain in right foot\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (500 mg total) by mouth 2 (two) times a day.\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth 3 (three) times a day with meals.\n- 50 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-20\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2017-01-06\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-18\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-01-07, presumably until 2017-01-17\n- 150 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-25, presumably until 2016-12-27\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-12-23, presumably until 2016-12-23\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-23, presumably until 2017-01-17\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 20 mg by mouth daily.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth nightly as needed for sleep.\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-17\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2016-12-24, presumably until 2016-12-27\n- melatonin 5 MG Oral Tablet, through Oral route, started on 2016-12-26, presumably until 2016-12-26\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2016-12-19, presumably until 2016-12-19\n- folic acid, through Oral route, started on 2017-01-01, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet by mouth daily.\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2016-12-17, presumably until 2016-12-23\n- 50 ML argatroban 1 MG/ML Injection, through Intravenous route, started on 2016-12-21, presumably until 2017-01-14\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2016-12-28, presumably until 2016-12-28\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (15 mg total) by mouth daily.\n- heparin sodium, porcine 10 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-12-31, presumably until 2017-01-09\n- iodixanol, through Intravenous route, started on 2016-12-20, presumably until 2016-12-20\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2016-12-20, presumably until 2016-12-20\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-04, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 capsule (250 mg total) by mouth 2 (two) times a day as needed for constipation.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-23\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-01-01, presumably until 2017-01-01\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 2 tablets (8 mg total) by mouth every evening.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 tablets by mouth 2 (two) times a day.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth daily.\n- ketamine 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-26, presumably until 2016-12-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-09, presumably until 2017-01-09\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2017-01-06\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-01-04, presumably until 2017-01-18\n- 100 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-27\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-17\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-02, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 capsules (1,334 mg total) by mouth 3 (three) times a day with meals.\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 81 mg by mouth daily.\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-07, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Inject 1 mL (4,000 Units total) into the skin Tuesday, Thursday and Saturday.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-20, presumably until 2016-12-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2016-12-24, presumably until 2016-12-24\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth 3 (three) times a day.\n- ketamine 100 MG/ML Injectable Solution, started on 2016-12-17, presumably until 2016-12-17\n- melatonin 1 MG/ML Oral Solution, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: 10 mLs (10 mg total) by NG-Tube route at bedtime.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2017-01-01, presumably until 2017-01-17\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-19\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2017-01-06\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth every 4 (four) hours as needed.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2016-12-19, presumably until 2016-12-29\n- midazolam 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2017-01-06\n- 50 ML glucose 500 MG/ML Injection, through Intravenous route, started on 2016-12-26, presumably until 2016-12-27\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-15, presumably until 2017-01-17\n- phenylephrine hydrochloride 5 MG/ML Nasal Spray, through Nasal route, started on 2016-12-24, presumably until 2016-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of artery of lower limb\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of artery of lower limb\n- Primary diagnosis: Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2016-12-20, presumably until 2016-12-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Compartment syndrome of upper limb\n- Pain in toe\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thromboembolus of artery of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Edema\n- Localized swelling, mass and lump, lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Thromboembolus of artery of upper limb\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compartment syndrome of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-24 09:09:00, ended at 2016-12-24 14:44:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Localized swelling, mass and lump, lower limb\n- Pain in right foot\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Pain in toe\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-02 00:00:00, ended at 2017-01-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-02 13:00:00, ended at 2017-01-02 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-09 00:00:00, ended at 2017-01-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-20 00:00:00, ended at 2017-01-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-24 13:29:49, ended at 2017-01-24 15:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-01-24 17:46:00, ended at 2017-02-13 14:30:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: -1.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.88 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.25 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Osmolality of Urine: 257 (milliosmole per kilogram)\n- Oxygen [Partial pressure] in Arterial blood: 231.0 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Prothrombin time (PT): 21.9 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 21.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.13 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 110 (millimeter per hour)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 17 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 9.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.5 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 7.92 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Base excess in Blood by calculation: 4 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.6 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 53.69 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.75 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 6.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.6 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Extraction of Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Excision of Right Tibia, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Excision of Right Lower Leg Muscle, Open Approach\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Detachment at Right Lower Leg, Mid, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Amputation, leg, through tibia and fibula; open, circular (guillotine)\n- Splitting of blood or blood products, each unit\n- Radiologic examination, chest; single view, frontal\n- Excision of Right Fibula, Open Approach\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Amputation, leg, through tibia and fibula; re-amputation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Bacterial infection due to Pseudomonas\n- Hypokalemia\n- Necrosis of amputation stump\n- Rhabdomyolysis\n- Absence of lower limb\n- Postoperative state\n- Right bundle branch block\n- Type 2 diabetes mellitus without complication\n- Acquired absence of organ\n- Complication following amputation of limb\n- Infection by methicillin sensitive Staphylococcus aureus\n- Phantom limb syndrome with pain\n- Tachycardia\n- Transplanted heart valve present\n- Complication of procedure\n- Gangrenous disorder\n- Hypo-osmolality and or hyponatremia\n- Obesity\n- Primary diagnosis: Compartment syndrome of lower limb\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n- Gangrene due to type 2 diabetes mellitus\n- Peripheral angiopathy due to diabetes mellitus\n- Cardiomegaly\n- Electrocardiogram abnormal\n- Persistent pain following procedure\n- Acute renal failure syndrome\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus\n- Anemia\n\n### Drug\n- 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 500 mg by mouth\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-01-28, presumably until 2017-02-06\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2017-02-06, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 325 mg by mouth\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-02-10, presumably until 2017-02-11\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-31\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-31, presumably until 2017-02-05\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-24, presumably until 2017-02-12\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-02-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2017-01-29, presumably until 2017-02-05\n- sodium hypochlorite 1.25 MG/ML Topical Solution, started on 2017-01-31, presumably until 2017-02-11\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours\n- folic acid, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2017-02-09, presumably until 2017-02-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-01-24, presumably until 2017-02-09\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 15 mg by mouth daily\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-01-25, presumably until 2017-02-13\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-04-29, with intended 0 refill(s). Instructions: take 1 Peaslee by mouth every bedtime\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 2 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-01-27\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2017-02-05\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2017-02-06, presumably until 2017-02-11\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-02-03, presumably until 2017-06-17, with intended 0 refill(s). Instructions: by Topical route 2 times a day\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 10 mg by mouth \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-01-25, presumably until 2017-01-28\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-02-13\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-02-07\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-02-08, presumably until 2017-02-17, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-24\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1,334 mg by mouth 2 times a day\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-18, presumably until 2017-02-13, with intended 0 refill(s). Instructions: inject 4,000 Units subcutaneous (under the skin)\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-25, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-01-25, presumably until 2017-02-07\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-01-30, presumably until 2017-01-30\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-02-03\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-01-31, presumably until 2017-02-06\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 80 mg by mouth\n- melatonin 1 MG/ML Oral Solution, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: 10 mg\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 6 Caps by mouth 3 times a day\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-06-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-12, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-01-27, presumably until 2017-02-13\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2017-01-25, presumably until 2017-01-25\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of upper leg\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n\n### Condition\n- Transplanted heart valve present\n- Gangrenous disorder\n- Compartment syndrome of lower limb\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-01-25\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- cefazolin 1000 MG Injection, started on 2017-01-25, presumably until 2017-01-25\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Heart failure\n- Gangrenous disorder\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- ketamine 100 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; brachial plexus\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- midazolam 1 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Compartment syndrome of lower limb\n- Peripheral vascular disease\n- Essential hypertension\n- Gangrenous disorder\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2017-02-05, presumably until 2017-02-05\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n- Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 14:52:51, ended at 2017-02-17 16:16:11\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Acute renal failure syndrome\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 16:22:24, ended at 2017-02-17 16:22:37\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Absence of lower limb\n- Acute renal failure syndrome\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-24 15:03:43, ended at 2017-02-24 16:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 14:00:00, ended at 2017-03-17 16:45:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 54.7 (percent)\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:00:31, ended at 2017-03-17 16:34:55\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:02:20, ended at 2017-03-17 16:35:29\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart valve present\n- Electrocardiogram abnormal\n- Right bundle branch block\n- Tetralogy of Fallot\n- Postoperative state\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-03-17, presumably until 2017-07-17, with intended 3 refill(s). Instructions: take 2 Caps by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 16:46:00, ended at 2017-03-17 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 336 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-28 00:00:00, ended at 2017-04-28 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2017-04-28, presumably until 2017-04-28, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-29 00:00:00, ended at 2017-04-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-29, presumably until 2018-06-04, with intended 6 refill(s). Instructions: take 1 Fleischner by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-17 15:04:14, ended at 2017-06-17 16:50:01\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Absence of lower limb\n- Transplanted heart valve present\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-14, with intended 3 refill(s). Instructions: Take 2 caps by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-12 00:00:00, ended at 2017-08-12 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Primary diagnosis: Right lower quadrant pain\n- Injury of femoral artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-13 13:43:00, ended at 2017-08-13 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Right lower quadrant pain\n- Tetralogy of Fallot\n- Injury of femoral artery\n- Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iothalamic acid, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-08-14, presumably until 2017-08-14\n- iothalamate, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for procedures on arteries of lower leg, including bypass graft; not otherwise specified\n\n### Condition\n- Cellulitis of groin\n- Tetralogy of Fallot\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-14, presumably until 2017-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-08-14 12:09:00, ended at 2017-08-20 11:28:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.70 (thousand per microliter)\n- Base excess in Arterial blood by calculation: -2.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 21.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 167 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 325 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 48 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Prothrombin time (PT): 25.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 206.0 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Repair blood vessel, direct; lower extremity\n- Insertion of Infusion Device into Upper Vein, Percutaneous Approach\n- Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft\n- Collection of venous blood by venipuncture\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquire\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Excision of infected graft; extremity\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Replacement of Right Femoral Artery with Autologous Tissue Substitute, Open Approach\n- Excision of Left Saphenous Vein, Open Approach\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Postoperative state\n- Tetralogy of Fallot\n- Traumatic or non-traumatic injury\n- Abscess of groin\n- Abscess of skin and/or subcutaneous tissue\n- Complication associated with device\n- Complication of surgical procedure\n- Infection by methicillin sensitive Staphylococcus aureus\n- Infection of amputation stump\n- Postprocedural infection\n- Absence of lower limb\n- Aneurysm of artery of lower extremity\n- Primary diagnosis: Cellulitis of groin\n- Complication following amputation of limb\n- Transplanted heart valve present\n- Acquired absence of organ\n- Localized infection of skin AND/OR subcutaneous tissue\n- Obesity\n- Obstructive sleep apnea syndrome\n- Sepsis\n- Secondary pulmonary hypertension\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-19\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2022-04-24, with intended 0 refill(s). Instructions: take 10 mg by mouth every Wednesday\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2022-04-24, with intended 1 refill(s). Instructions: take 5 mg by mouth every Monday\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-17\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-10-13, with intended 2 refill(s). Instructions: 2 g by Intravenous route every 8 hours\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-19\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-08-16, presumably until 2017-08-18\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-14, presumably until 2017-08-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2018-01-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day \n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2017-08-14, presumably until 2017-08-17\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-09-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-20, with intended 3 refill(s). Instructions: 100 mL by Intravenous route every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n\n### Condition\n- Tetralogy of Fallot\n- Cellulitis of groin\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2017-08-19, presumably until 2017-08-19\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-26 09:09:25, ended at 2017-08-26 10:59:39\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 500 mg by Swish & Swallow route\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2017-03-10, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1 Application by Topical route\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2017-08-26, with intended 0 refill(s). Instructions: 20 mg by Swish & Swallow route\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 81 mg by Swish & Swallow route\n- gabapentin 300 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-26, with intended 0 refill(s). Instructions: One qhs\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1,334 mg by Swish & Swallow route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-26 13:30:00, ended at 2017-08-26 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Laceration - injury\n- Cellulitis of groin\n- Transplanted heart valve present\n- Open wound of anterior abdominal wall\n- Injury to blood vessels of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-02 08:10:47, ended at 2017-09-02 09:04:28\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Open wound of inguinal region\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-05 00:00:00, ended at 2017-09-05 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 09:31:07, ended at 2017-09-09 10:26:49\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:19:51, ended at 2017-09-09 16:25:24\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Open wound of anterior abdominal wall\n- Tetralogy of Fallot\n- Right bundle branch block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:20:09, ended at 2017-09-09 16:25:32\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-10 09:06:39, ended at 2017-09-10 10:05:44\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abscess of groin\n- Infection by methicillin sensitive Staphylococcus aureus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-16 09:57:09, ended at 2017-09-16 11:04:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-23 09:52:28, ended at 2017-09-23 10:25:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-30 09:55:42, ended at 2017-09-30 10:51:41\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-01 10:51:35, ended at 2017-10-01 12:00:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-03 00:00:00, ended at 2017-10-03 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 10:57:00, ended at 2017-10-13 12:46:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Body height: 5' 10\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n\n### Procedure\n- Removal of Infusion Device from Great Vessel, External Approach\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2017-10-13, presumably until 2017-10-13\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6608c77a8df64af106484f8202d60c2955aca5e016266c3b6f3901d4f43c855d", "prompt_hash": "b4efb958070690612eb61477da47943e5cc6509a9d39762ba87b55909209c73c", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115969856, "visit_occurrence_id": 64072731, "death_date": null, "visit_concept_name": "Inpatient Visit", "visit_start_datetime": "2014-07-07 09:56:00", "visit_end_datetime": "2014-07-10 18:55:00", "visit_length_in_hours": 80.98333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 09:56:00, ended at 2014-07-10 18:55:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Blood by Automated count: 14.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n\n### Procedure\n- Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar\n- Medical induction of labor\n- Collection of venous blood by venipuncture\n- Other fetal monitoring\n- Induction of labor by artificial rupture of membranes\n- Vaginal delivery only (with or without episiotomy and/or forceps)\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Other manually assisted delivery\n\n### Condition\n- Abnormal fetal heart rate\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Nonspecific tuberculin test reaction\n- Obesity\n- Single live birth\n- Complication of pregnancy, childbirth and/or puerperium\n- Group B Streptococcus carrier\n- Mother delivered\n- Postpartum finding\n- Severe pre-eclampsia - delivered\n- Finding related to pregnancy\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ampicillin 2000 MG Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-20, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth every 6 (six) hours as needed for pain score, mild (1-3).for up to 10 days\n- etonogestrel 68 MG Drug Implant, through Transdermal route, started on 2014-07-10, presumably until 2014-07-10, with intended 0 refill(s). Instructions: Place 1 Device (68 mg total) onto the skin once.for 1 dose\n- 1 ML terbutaline sulfate 1 MG/ML Injection, through Intravenous route, started on 2014-07-08, presumably until 2014-07-08\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-07-10, presumably until 2014-08-24, with intended 4 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 4 ML labetalol hydrochloride 5 MG/ML Cartridge, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ampicillin 1000 MG Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-10, with intended 1 refill(s). Instructions: 1 tab / PO q6hr PRN pain\n- nitroglycerin 0.4 MG/ACTUAT Mucosal Spray, through Translingual, started on 2014-07-08, presumably until 2014-07-08\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-08-09, with intended 3 refill(s). Instructions: Take 1 tablet (200 mg total) by mouth 2 (two) times a day.for 30 days\n- 500 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-09\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-08\n\n", "approximate_token_count": 935, "patient_first_visit_date": "2009-07-07 13:44:00", "patient_last_visit_date": "2015-07-28 00:00:00", "end_obs_date": "2015-07-10", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 16, "cumulated_visit_num": 16, "cumulated_approximate_token_count": 4840, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-07-07 13:44:00, ended at 2009-07-07 22:26:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.59 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.38 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 26646 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Early stage of pregnancy\n- Hemorrhagic complication of pregnancy\n- Disorder of product of conception\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-07-12 18:54:00, ended at 2009-07-13 00:03:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.68 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 85.7 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 20318 (milli-international unit per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Miscarriage without complication\n- Noninflammatory disorder of the vagina\n\n### Drug\n- misoprostol 0.2 MG Oral Tablet, through Oral route, started on 2009-07-12, presumably until 2009-07-12\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2009-07-12, presumably until 2010-07-12, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed \n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2009-07-12, presumably until 2009-07-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-12, presumably until 2010-01-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-22 12:20:08, ended at 2014-04-22 15:15:59\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Complication occurring during pregnancy\n- Primary diagnosis: Finding related to pregnancy\n- Primary diagnosis: Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-03 14:09:02, ended at 2014-05-03 15:15:41\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Primary diagnosis: Nonspecific tuberculin test reaction\n- Complication occurring during pregnancy\n- Obesity\n- Suspected fetal abnormality affecting management of mother\n- Finding related to pregnancy\n- Genitourinary tract infection in pregnancy - not delivered\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-17 10:49:33, ended at 2014-05-17 12:02:45\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asymptomatic bacteriuria in pregnancy\n- Finding related to pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Group B Streptococcus carrier\n- Obesity\n- Nonspecific tuberculin test reaction\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Complication occurring during pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-28 14:11:00, ended at 2014-05-28 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Nonspecific tuberculin test reaction\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 10:55:03, ended at 2014-05-30 12:02:51\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Complication occurring during pregnancy\n- Genitourinary tract infection in pregnancy - not delivered\n- Obesity\n- Suspected fetal abnormality affecting management of mother\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Primary diagnosis: Nonspecific tuberculin test reaction\n- Finding related to pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 09:52:00, ended at 2014-06-02 09:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a prev\n\n### Condition\n- Complication occurring during pregnancy\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Finding related to pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Suspected fetal abnormality affecting management of mother\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 10:00:00, ended at 2014-06-02 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Fetal non-stress test\n\n### Condition\n- Finding related to pregnancy\n- Complication occurring during pregnancy\n- Suspected fetal abnormality affecting management of mother\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-13 16:45:25, ended at 2014-06-13 17:19:03\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Complication occurring during pregnancy\n- Asymptomatic bacteriuria in pregnancy\n- Finding related to pregnancy\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-27 16:43:34, ended at 2014-06-27 17:25:54\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Finding related to pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Obesity\n- Nonspecific tuberculin test reaction\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Complication occurring during pregnancy\n- Group B Streptococcus carrier\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-06-27 17:42:00, ended at 2014-07-01 12:50:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein/Creatinine [Mass Ratio] in Urine: 0.27 (milligram per milligram)\n- Leukocytes [#/volume] in Blood by Automated count: 9.9 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n\n### Procedure\n- Other fetal monitoring\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses\n- Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a prev\n\n### Condition\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Cervicitis and endocervicitis\n- Chlamydial infection of lower genitourinary tract\n- Finding related to pregnancy\n- Nonspecific tuberculin test reaction\n- Poor fetal growth affecting management\n- Genitourinary tract infection in pregnancy - not delivered\n- Group B Streptococcus carrier\n- Pre-eclampsia\n- Mental disorders during pregnancy, childbirth and the puerperium\n- Transient hypertension of pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Vaginitis associated with another disorder\n- Adult victim of abuse\n- Complication occurring during pregnancy\n- Obesity\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-06-29, presumably until 2014-06-29\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-06-27, presumably until 2014-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-04 15:02:00, ended at 2014-07-04 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses\n- Fetal non-stress test\n\n### Condition\n- Complication occurring during pregnancy\n- Pre-eclampsia\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Finding related to pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 00:00:00, ended at 2014-07-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor)\n\n### Condition\n- Postpartum finding\n- Severe pre-eclampsia - delivered\n- Finding related to pregnancy\n- Single live birth\n\n### Drug\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2014-07-08, presumably until 2014-07-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 00:00:00, ended at 2014-07-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Amniotic cavity infection - delivered\n- Placental condition affecting management of mother\n- Postpartum finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 09:56:00, ended at 2014-07-10 18:55:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Blood by Automated count: 14.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n\n### Procedure\n- Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar\n- Medical induction of labor\n- Collection of venous blood by venipuncture\n- Other fetal monitoring\n- Induction of labor by artificial rupture of membranes\n- Vaginal delivery only (with or without episiotomy and/or forceps)\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Other manually assisted delivery\n\n### Condition\n- Abnormal fetal heart rate\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Nonspecific tuberculin test reaction\n- Obesity\n- Single live birth\n- Complication of pregnancy, childbirth and/or puerperium\n- Group B Streptococcus carrier\n- Mother delivered\n- Postpartum finding\n- Severe pre-eclampsia - delivered\n- Finding related to pregnancy\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ampicillin 2000 MG Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-20, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth every 6 (six) hours as needed for pain score, mild (1-3).for up to 10 days\n- etonogestrel 68 MG Drug Implant, through Transdermal route, started on 2014-07-10, presumably until 2014-07-10, with intended 0 refill(s). Instructions: Place 1 Device (68 mg total) onto the skin once.for 1 dose\n- 1 ML terbutaline sulfate 1 MG/ML Injection, through Intravenous route, started on 2014-07-08, presumably until 2014-07-08\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-07-10, presumably until 2014-08-24, with intended 4 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 4 ML labetalol hydrochloride 5 MG/ML Cartridge, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ampicillin 1000 MG Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-10, with intended 1 refill(s). Instructions: 1 tab / PO q6hr PRN pain\n- nitroglycerin 0.4 MG/ACTUAT Mucosal Spray, through Translingual, started on 2014-07-08, presumably until 2014-07-08\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-08-09, with intended 3 refill(s). Instructions: Take 1 tablet (200 mg total) by mouth 2 (two) times a day.for 30 days\n- 500 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-09\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-08\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-07-07 13:44:00, ended at 2009-07-07 22:26:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.59 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.38 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 26646 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Early stage of pregnancy\n- Hemorrhagic complication of pregnancy\n- Disorder of product of conception\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-07-12 18:54:00, ended at 2009-07-13 00:03:00\nThe patient in this visit was 35 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.68 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 85.7 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 20318 (milli-international unit per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Miscarriage without complication\n- Noninflammatory disorder of the vagina\n\n### Drug\n- misoprostol 0.2 MG Oral Tablet, through Oral route, started on 2009-07-12, presumably until 2009-07-12\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2009-07-12, presumably until 2010-07-12, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed \n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2009-07-12, presumably until 2009-07-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-12, presumably until 2010-01-08, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-22 12:20:08, ended at 2014-04-22 15:15:59\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Complication occurring during pregnancy\n- Primary diagnosis: Finding related to pregnancy\n- Primary diagnosis: Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-03 14:09:02, ended at 2014-05-03 15:15:41\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Primary diagnosis: Nonspecific tuberculin test reaction\n- Complication occurring during pregnancy\n- Obesity\n- Suspected fetal abnormality affecting management of mother\n- Finding related to pregnancy\n- Genitourinary tract infection in pregnancy - not delivered\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-17 10:49:33, ended at 2014-05-17 12:02:45\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asymptomatic bacteriuria in pregnancy\n- Finding related to pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Group B Streptococcus carrier\n- Obesity\n- Nonspecific tuberculin test reaction\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Complication occurring during pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-28 14:11:00, ended at 2014-05-28 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Nonspecific tuberculin test reaction\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-30 10:55:03, ended at 2014-05-30 12:02:51\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Complication occurring during pregnancy\n- Genitourinary tract infection in pregnancy - not delivered\n- Obesity\n- Suspected fetal abnormality affecting management of mother\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Primary diagnosis: Nonspecific tuberculin test reaction\n- Finding related to pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 09:52:00, ended at 2014-06-02 09:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a prev\n\n### Condition\n- Complication occurring during pregnancy\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Finding related to pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Suspected fetal abnormality affecting management of mother\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 10:00:00, ended at 2014-06-02 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Fetal non-stress test\n\n### Condition\n- Finding related to pregnancy\n- Complication occurring during pregnancy\n- Suspected fetal abnormality affecting management of mother\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-13 16:45:25, ended at 2014-06-13 17:19:03\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Complication occurring during pregnancy\n- Asymptomatic bacteriuria in pregnancy\n- Finding related to pregnancy\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-27 16:43:34, ended at 2014-06-27 17:25:54\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Finding related to pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Obesity\n- Nonspecific tuberculin test reaction\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Complication occurring during pregnancy\n- Group B Streptococcus carrier\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-06-27 17:42:00, ended at 2014-07-01 12:50:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Protein/Creatinine [Mass Ratio] in Urine: 0.27 (milligram per milligram)\n- Leukocytes [#/volume] in Blood by Automated count: 9.9 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n\n### Procedure\n- Other fetal monitoring\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordinat\n- Collection of venous blood by venipuncture\n- Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses\n- Ultrasound, pregnant uterus, real time with image documentation, follow-up (eg, re-evaluation of fetal size by measuring standard growth parameters and amniotic fluid volume, re-evaluation of organ system(s) suspected or confirmed to be abnormal on a prev\n\n### Condition\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Cervicitis and endocervicitis\n- Chlamydial infection of lower genitourinary tract\n- Finding related to pregnancy\n- Nonspecific tuberculin test reaction\n- Poor fetal growth affecting management\n- Genitourinary tract infection in pregnancy - not delivered\n- Group B Streptococcus carrier\n- Pre-eclampsia\n- Mental disorders during pregnancy, childbirth and the puerperium\n- Transient hypertension of pregnancy\n- Maternal obesity complicating pregnancy, childbirth and the puerperium, antepartum\n- Vaginitis associated with another disorder\n- Adult victim of abuse\n- Complication occurring during pregnancy\n- Obesity\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-06-29, presumably until 2014-06-29\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-06-27, presumably until 2014-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-07-04 15:02:00, ended at 2014-07-04 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses\n- Fetal non-stress test\n\n### Condition\n- Complication occurring during pregnancy\n- Pre-eclampsia\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Finding related to pregnancy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 00:00:00, ended at 2014-07-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor)\n\n### Condition\n- Postpartum finding\n- Severe pre-eclampsia - delivered\n- Finding related to pregnancy\n- Single live birth\n\n### Drug\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2014-07-08, presumably until 2014-07-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 00:00:00, ended at 2014-07-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Amniotic cavity infection - delivered\n- Placental condition affecting management of mother\n- Postpartum finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-07-07 09:56:00, ended at 2014-07-10 18:55:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Blood by Automated count: 14.0 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n\n### Procedure\n- Injection(s), including indwelling catheter placement, continuous infusion or intermittent bolus, of diagnostic or therapeutic substance(s) (eg, anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, interlaminar\n- Medical induction of labor\n- Collection of venous blood by venipuncture\n- Other fetal monitoring\n- Induction of labor by artificial rupture of membranes\n- Vaginal delivery only (with or without episiotomy and/or forceps)\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Other manually assisted delivery\n\n### Condition\n- Abnormal fetal heart rate\n- Abnormal glucose tolerance in mother complicating pregnancy, childbirth AND/OR puerperium\n- Nonspecific tuberculin test reaction\n- Obesity\n- Single live birth\n- Complication of pregnancy, childbirth and/or puerperium\n- Group B Streptococcus carrier\n- Mother delivered\n- Postpartum finding\n- Severe pre-eclampsia - delivered\n- Finding related to pregnancy\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ampicillin 2000 MG Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-20, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth every 6 (six) hours as needed for pain score, mild (1-3).for up to 10 days\n- etonogestrel 68 MG Drug Implant, through Transdermal route, started on 2014-07-10, presumably until 2014-07-10, with intended 0 refill(s). Instructions: Place 1 Device (68 mg total) onto the skin once.for 1 dose\n- 1 ML terbutaline sulfate 1 MG/ML Injection, through Intravenous route, started on 2014-07-08, presumably until 2014-07-08\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2014-07-10, presumably until 2014-08-24, with intended 4 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 4 ML labetalol hydrochloride 5 MG/ML Cartridge, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ampicillin 1000 MG Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-07\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-10, with intended 1 refill(s). Instructions: 1 tab / PO q6hr PRN pain\n- nitroglycerin 0.4 MG/ACTUAT Mucosal Spray, through Translingual, started on 2014-07-08, presumably until 2014-07-08\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-08-09, with intended 3 refill(s). Instructions: Take 1 tablet (200 mg total) by mouth 2 (two) times a day.for 30 days\n- 500 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2014-07-07, presumably until 2014-07-09\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-07-08, presumably until 2014-07-08\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "7b3e7dcef5d0a111e9a1832d264c2dce964cbf4daab18962e587cb27a0a2d883", "prompt_hash": "a7992432e3003a5f2db46f930df40756e7e773db3abaf096cd877599c77b526b", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115970382, "visit_occurrence_id": 165756686, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2020-10-04 14:28:37", "visit_end_datetime": "2020-10-04 14:57:19", "visit_length_in_hours": 0.47833333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2020-10-04 14:28:37, ended at 2020-10-04 14:57:19\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver function tests abnormal\n- Portal hypertension\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 102, "patient_first_visit_date": "2012-01-01 15:59:00", "patient_last_visit_date": "2023-02-06 00:00:00", "end_obs_date": "2021-10-04", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "recurrent", "liver_cancer_one_year_diagnosis": 1, "visit_sequence_number": 345, "cumulated_visit_num": 345, "cumulated_approximate_token_count": 87351, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-01-01 15:59:00, ended at 2012-01-06 14:05:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- Prothrombin time (PT): 18.1 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 549 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.65 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.35 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.9 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n\n### Procedure\n- Abdominal paracentesis\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Ultrasound, abdominal, real time with image documentation; complete\n- Physical therapy evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis without obstruction\n- Dehydration\n- Abdominal pain\n- Cirrhosis - non-alcoholic\n- Deficiency anemias\n- Generalized abdominal pain\n- Hepatic encephalopathy\n- Splenomegaly\n- Tachycardia\n- Alcoholic cirrhosis\n- Loss of appetite\n- Acute renal failure syndrome\n- Chronic kidney disease\n- Depressive disorder\n- Chronic congestive splenomegaly\n- Intestinal infectious disease\n- Jaundice\n- Acidosis\n- Ascites\n- Portal hypertension\n- Retention of urine\n- Nausea and vomiting\n- Renal failure syndrome\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06. Instructions: take 1 mg by mouth daily.\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06. Instructions: take 100 mg by mouth daily.\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2012-01-02, presumably until 2012-01-06\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-01-01, presumably until 2012-01-01\n- amitriptyline hydrochloride 25 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-04-05. Instructions: take 25 mg by mouth every bedtime.\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-01-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-02\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-02\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-05\n- propranolol hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06. Instructions: take 10 mg by mouth 3 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-01-02, presumably until 2012-01-02\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-01-04, presumably until 2012-01-04\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-01-01, presumably until 2012-01-01\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2012-01-01, presumably until 2012-01-01\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-04\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2012-03-25. Instructions: take  by mouth Every Day.\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2012-01-03, presumably until 2012-01-06\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2012-01-02, presumably until 2012-01-02\n- ciprofloxacin 750 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-03-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 7 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-08 15:47:00, ended at 2012-01-08 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 127 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 18.9 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.9 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 428 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.98 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-15 12:59:34, ended at 2012-01-15 13:39:12\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-15 14:48:00, ended at 2012-01-15 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 128 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 390 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.31 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.7 (percent)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-16 00:00:00, ended at 2012-01-16 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-16 00:00:00, ended at 2012-01-16 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-01-16, presumably until 2012-03-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2012-01-16, presumably until 2012-03-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-20 14:25:00, ended at 2012-01-20 17:03:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Abdominal paracentesis\n\n### Condition\n- Ascites\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-01-20, presumably until 2012-01-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 09:45:00, ended at 2012-01-21 09:45:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 428 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.44 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 77 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 124 (microgram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.69 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 62 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.68 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 524 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Prothrombin time (PT): 18.8 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 119 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 09:46:00, ended at 2012-01-21 12:04:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 12:05:00, ended at 2012-01-21 12:34:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 14:29:00, ended at 2012-01-21 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; group (2 or more individual(s)), each 30 minutes\n\n### Condition\n- Alcoholic cirrhosis\n- Jaundice\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-22 10:55:00, ended at 2012-01-22 11:23:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-22 11:24:00, ended at 2012-01-22 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Alcoholic cirrhosis\n- Cirrhosis - non-alcoholic\n- Splenomegaly\n- Ascites\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-27 09:30:00, ended at 2012-01-27 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-12 13:45:00, ended at 2012-02-12 16:40:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Abdominal paracentesis\n\n### Condition\n- Ascites\n- Alcoholic cirrhosis\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-02-12, presumably until 2012-02-12\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2012-02-12, presumably until 2012-02-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-02-13 16:10:00, ended at 2012-02-14 14:45:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 530 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Base excess in Blood by calculation: 0.0 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.09 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 139 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Abdominal pain\n- Alcohol dependence\n- Portal hypertension\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Ascites\n- Chronic kidney disease\n- Alcoholic cirrhosis\n- Generalized abdominal pain\n- Leukocytosis\n- Nausea and vomiting\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-02-14, presumably until 2012-02-14\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-02-13, presumably until 2012-02-14\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2012-02-13, presumably until 2012-02-13\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-02-14, presumably until 2012-02-14\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2012-02-13, presumably until 2012-02-14\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-17 00:00:00, ended at 2012-02-17 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 21:39:00, ended at 2012-02-17 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 643 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.94 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.0 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 19.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.0 (percent)\n- Prothrombin time (PT): 18.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-14 22:43:00, ended at 2012-03-25 14:55:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.33 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 1.93 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Prothrombin time (PT): N/A (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 650 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 34 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 135 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 59.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Other endovascular procedures on other vessels\n- Transfusion, blood or blood components\n- Irrigation of stomach\n- Radiologic examination, abdomen; single anteroposterior view\n- Insertion of two vascular stents\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Counseling\n- Transcatheter occlusion or embolization (eg, for tumor destruction, to achieve hemostasis, to occlude a vascular malformation), percutaneous, any method, non-central nervous system, non-head or neck\n- Angioplasty of other non-coronary vessel(s)\n- Phlebography of the portal venous system using contrast material\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Arterial puncture, withdrawal of blood for diagnosis\n- Insertion of other (naso-)gastric tube\n- Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s)\n- Abdominal paracentesis\n- Respiratory flow volume loop\n- Selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Transfusion of other serum\n- Phlebography of other Intra-Abdominal veins using contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Ultrasound, abdominal, real time with image documentation; complete\n- Packed blood cell transfusion\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Collection of venous blood by venipuncture\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Other endoscopy of small intestine\n- Transcatheter therapy, embolization, any method, radiological supervision and interpretation\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Gastric intubation and aspiration(s) therapeutic, necessitating physician's skill (eg, for gastrointestinal hemorrhage), including lavage if performed\n- Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recannulization/dilatation, stent placement and all associated\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Angiography through existing catheter for follow-up study for transcatheter therapy, embolization or infusion, other than for thrombolysis\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Radiologic examination, chest; single view, frontal\n- Procedure on three vessels\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n\n### Condition\n- Hypokalemia\n- Hypovolemia\n- Loss of appetite\n- Portal hypertension\n- Atelectasis\n- Complication associated with device\n- Esophageal varices associated with another disorder\n- Gastric ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Hepatorenal syndrome\n- Splenomegaly\n- Tachycardia\n- Chronic kidney disease\n- Gastrointestinal hemorrhage\n- Lung field abnormal\n- Vascular complication of medical care\n- Venous varices\n- Cough\n- Low blood pressure\n- Ascites\n- Hematemesis\n- Depressive disorder\n- Paralytic ileus\n- Alcoholic cirrhosis\n- Cirrhosis - non-alcoholic\n- Hematochezia\n- Intestinal obstruction\n- Pleural effusion\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-03-20, presumably until 2012-03-24\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-03-25\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2012-03-14, presumably until 2012-03-25\n- benzocaine 200 MG/ML Mucosal Spray, through Submucosal route, started on 2012-03-15, presumably until 2012-03-15\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-03-25\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2012-03-20, presumably until 2012-03-21\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-03-18, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-20\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-03-18, presumably until 2012-03-20\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2012-03-15, presumably until 2012-03-15\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-03-14, presumably until 2012-03-23\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2012-03-24, presumably until 2012-03-24\n- amitriptyline hydrochloride 25 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-03-24\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-03-25, presumably until 2012-04-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-03-20, presumably until 2012-03-20\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-03-18, presumably until 2012-03-20\n- ropinirole 0.25 MG Oral Tablet, through Oral route, started on 2012-03-25, presumably until 2012-03-25\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-03-18, presumably until 2012-03-18\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-03-17, presumably until 2012-03-25\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2012-03-24, presumably until 2012-12-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q48H. Take one tablet on Saturday, 03/26/2012, and your second and last dose on Monday, 03/28/2012.\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-17\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-03-16, presumably until 2012-03-25\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2012-03-14, presumably until 2012-03-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-03-14, presumably until 2012-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2012-03-15, presumably until 2012-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-15\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2012-03-24, presumably until 2012-03-24\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-21\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2012-03-16, presumably until 2013-03-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2012-03-20, presumably until 2012-03-23\n- midazolam 1 MG/ML Injectable Solution, started on 2012-03-15, presumably until 2012-03-15\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-03-14, presumably until 2012-03-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-05 00:00:00, ended at 2012-04-05 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-11-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-07-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-05 15:26:20, ended at 2012-04-05 15:55:26\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Alcoholic cirrhosis\n- Hypervolemia\n- Primary bacterial peritonitis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-26 00:00:00, ended at 2012-04-26 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n- Gastrointestinal hemorrhage\n- Low blood pressure\n\n### Drug\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-04-26, presumably until 2012-07-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-26 13:50:00, ended at 2012-05-26 17:16:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 146 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 19.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n\n### Procedure\n- Abdominal paracentesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n- Ascites\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-05-26, presumably until 2012-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-05 15:32:33, ended at 2012-07-05 16:14:54\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Alcoholic cirrhosis\n- Portal hypertension\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-07-13 00:00:00, ended at 2012-07-13 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcohol abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-20 00:00:00, ended at 2012-07-20 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure\n- Gastrointestinal hemorrhage\n- Alcoholic cirrhosis\n\n### Drug\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-07-20, presumably until 2012-07-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-21 00:00:00, ended at 2012-07-21 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-07-21, presumably until 2012-10-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-21 10:00:00, ended at 2012-07-21 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n\n### Condition\n- Alcoholic cirrhosis\n- Alcohol dependence\n- Alcohol abuse\n- Cholelithiasis without obstruction\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-17 00:00:00, ended at 2012-08-17 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-08-17, presumably until 2012-10-20, with intended 5 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-08-26 00:00:00, ended at 2012-08-26 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-26 00:00:00, ended at 2012-08-26 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2012-08-26, presumably until 2013-03-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-26 08:57:30, ended at 2012-08-26 11:27:19\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-26 11:06:00, ended at 2012-08-26 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Prothrombin time (PT): 18.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 124 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-14 00:00:00, ended at 2012-09-14 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2012-09-14, presumably until 2012-09-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n- midodrine hydrochloride 10 MG Oral Tablet, started on 2012-09-14, presumably until 2012-09-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-28 00:00:00, ended at 2012-09-28 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2012-09-28, presumably until 2012-09-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-04 00:00:00, ended at 2012-10-04 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-04, presumably until 2012-11-09, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2012-10-19, presumably until 2012-10-19, with intended 4 refill(s). Instructions: TAKE 30 ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-20 00:00:00, ended at 2012-10-20 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hepatic encephalopathy\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-10-20, presumably until 2012-12-09, with intended 5 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-31 00:00:00, ended at 2012-10-31 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2012-10-31, presumably until 2012-10-31, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n- midodrine hydrochloride 10 MG Oral Tablet, started on 2012-10-31, presumably until 2012-10-31, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-09 00:00:00, ended at 2012-11-09 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-11-09, presumably until 2013-11-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-11-09, presumably until 2013-03-13, with intended 5 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-15 00:00:00, ended at 2012-11-15 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-11-15, presumably until 2013-03-13, with intended 5 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-15 00:00:00, ended at 2012-11-15 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2012-11-15, presumably until 2012-11-15, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-01 00:00:00, ended at 2012-12-01 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2012-12-01, presumably until 2012-12-01, with intended 4 refill(s). Instructions: TAKE 30ML BY MOUTH TWICE DAILY AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-06 00:00:00, ended at 2012-12-06 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-12-06, presumably until 2012-12-07, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-07 00:00:00, ended at 2012-12-07 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-12-07, presumably until 2013-01-07, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-09 15:29:01, ended at 2012-12-09 16:20:38\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Hepatic encephalopathy\n- Primary diagnosis: Alcoholic cirrhosis\n- Hypervolemia\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2013-03-16. Instructions: take 20 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-14 00:00:00, ended at 2012-12-14 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-07 00:00:00, ended at 2013-01-07 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-01-07, presumably until 2013-03-16, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-26 14:10:00, ended at 2013-01-26 14:54:10\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions\n\n### Condition\n- Primary diagnosis: Inflamed seborrheic keratosis\n- Disorder of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-09 00:00:00, ended at 2013-02-09 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-02-09, presumably until 2013-02-09, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-09 00:00:00, ended at 2013-02-09 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-02-09, presumably until 2013-08-11, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-02-13 19:34:00, ended at 2013-02-13 21:50:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Prothrombin time (PT): 15.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n\n### Procedure\n- Renewal of prescription\n\n### Condition\n- Altered mental status\n- Disorder of the urea cycle metabolism\n- Sequela of chronic liver disease\n\n### Drug\n- lactulose 20000 MG Powder for Oral Solution, through Oral route, started on 2013-02-13, presumably until 2013-03-13, with intended 0 refill(s). Instructions: take 30 g by mouth 2 times a day.\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-02-13, presumably until 2013-02-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-03-13 06:37:00, ended at 2013-03-16 20:15:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.4 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Body height: 5' 7.008\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Prothrombin time (PT): N/A (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.04 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 44.1 (second)\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ascites\n- Nausea and vomiting\n- Psychostimulant dependence\n- Abdominal pain\n- Alcoholic cirrhosis\n- Drug abuse in remission\n- Chronic kidney disease\n- Hepatic encephalopathy\n- Insomnia\n- Portal hypertension\n- Acute renal failure syndrome\n- Cholelithiasis without obstruction\n- Diverticular disease of colon\n- Alcohol abuse\n- Venous varices\n- Clostridioides difficile infection\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2013-03-16, presumably until 2014-03-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-03-16, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-03-13, presumably until 2013-03-16\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-03-13, presumably until 2013-03-13\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-03-16, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2013-03-15, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours.\n- camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion, through Topical route, started on 2013-03-14, presumably until 2013-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-03-13, presumably until 2013-03-14\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-03-13, presumably until 2013-03-13\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2013-03-13, presumably until 2013-03-15\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-03-13, presumably until 2013-03-13\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-03-13, presumably until 2013-03-16\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2013-03-13, presumably until 2013-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-25 13:20:13, ended at 2013-04-25 13:57:31\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Hepatic encephalopathy\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-28 00:00:00, ended at 2013-06-28 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-28, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 2 tabs at 12 noon\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, started on 2013-06-28, presumably until 2013-07-18, with intended 0 refill(s). Instructions: As directed in preparation for colonoscopy.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-18 09:56:00, ended at 2013-07-18 13:18:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Colonoscopy\n- Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n\n### Condition\n- Portal hypertension\n- Alcoholic cirrhosis\n- Diverticular disease of colon\n- Essential hypertension\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-07-18, presumably until 2013-07-18\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-04-06. Instructions: take 20 mg by mouth 2 times a day.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-07-18, presumably until 2013-07-18\n- midazolam 1 MG/ML Injectable Solution, started on 2013-07-18, presumably until 2013-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-20 00:00:00, ended at 2013-07-20 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-08 00:00:00, ended at 2013-08-08 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-11 00:00:00, ended at 2013-08-11 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-08-11, presumably until 2014-08-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:24:00, ended at 2013-09-05 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Alcoholic cirrhosis\n- Cirrhosis - non-alcoholic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-04 00:00:00, ended at 2013-11-04 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-04, presumably until 2013-11-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-08 00:00:00, ended at 2013-11-08 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2013-11-15, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-10 10:52:13, ended at 2013-11-10 11:53:19\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Alcoholic cirrhosis\n- Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-15 00:00:00, ended at 2013-11-15 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-15, presumably until 2014-11-06, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-04 02:48:00, ended at 2013-12-04 06:01:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.92 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 190 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- Prothrombin time (PT): 16.3 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- Anoscopy; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n\n### Condition\n- Feces contents abnormal\n- Disease of liver\n- Primary diagnosis: Hematochezia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-17 00:00:00, ended at 2013-12-17 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2013-12-17, presumably until 2014-07-26, with intended 11 refill(s). Instructions: TAKE 30 ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-30 00:00:00, ended at 2014-03-30 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-31 00:00:00, ended at 2014-03-31 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-06 00:00:00, ended at 2014-04-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-06 13:29:08, ended at 2014-04-06 15:07:37\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.772\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hepatic encephalopathy\n- Alcoholic cirrhosis\n- Periapical abscess with sinus tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 09:10:00, ended at 2014-05-08 23:59:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-11 13:49:23, ended at 2014-05-11 14:40:24\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.535\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Dental caries\n- Exostosis of jaw\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-29 00:00:00, ended at 2014-05-29 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraoral procedures, including biopsy; not otherwise specified\n\n### Condition\n- Periapical abscess\n- Portal hypertension\n- Alcoholic cirrhosis\n\n### Drug\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-29, presumably until 2014-05-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-29 00:00:00, ended at 2014-05-29 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-29, presumably until 2014-05-29\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2014-05-29, presumably until 2014-05-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-29 08:28:00, ended at 2014-05-29 16:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Dental alveoplasty\n- Unlisted procedure, dentoalveolar structures\n- Other surgical extraction of tooth\n- Alveoloplasty, each quadrant (specify)\n\n### Condition\n- Alcoholic cirrhosis\n- Portal hypertension\n- Primary diagnosis: Dental caries\n- Low back pain\n- Periapical abscess\n- Gastroesophageal reflux disease\n- Hepatic encephalopathy\n- Chronic kidney disease\n- Exostosis of jaw\n- Alcohol dependence\n- Chronic pain\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n- hydrocodone bitartrate 7.5 MG / ibuprofen 200 MG Oral Tablet, through Oral route, started on 2014-05-29, presumably until 2014-10-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2014-05-29, presumably until 2014-06-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-05-29, presumably until 2014-05-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-15 11:58:37, ended at 2014-06-15 12:24:32\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Periapical abscess with sinus tract\n\n### Drug\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, started on 2014-06-15, presumably until 2014-10-02, with intended 2 refill(s). Instructions: Paroex (0.12% chlorhexidine mouth rinse WITHOUT alcohol). Swish 15mL 2x per day for 2 weeks. Please call Dr. Rahall 999-999-9999 if you do not have the formulation without alcohol.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-26 00:00:00, ended at 2014-07-26 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2014-07-26, presumably until 2015-09-08, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-16 00:00:00, ended at 2014-08-16 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2014-08-16, presumably until 2015-09-03, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-02 00:00:00, ended at 2014-10-02 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-02 13:21:58, ended at 2014-10-02 14:01:12\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Primary diagnosis: Alcoholic cirrhosis\n- Inguinal hernia\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 14:05:00, ended at 2014-10-02 23:59:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Prothrombin time (PT): 14.8 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 4 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-06 00:00:00, ended at 2014-10-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2014-11-06, presumably until 2014-11-06, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2014-11-06, presumably until 2015-08-02, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-27 00:00:00, ended at 2014-11-27 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-28 17:05:23, ended at 2014-11-28 18:29:20\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tics of organic origin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-02 00:00:00, ended at 2015-04-02 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-02 14:00:42, ended at 2015-04-02 14:38:45\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Portal hypertension\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-19 18:56:00, ended at 2015-04-19 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Primary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2015-06-17 09:45:00, ended at 2015-06-17 12:50:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.76 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Prothrombin time (PT): 16.0 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 40.2 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Alcoholic cirrhosis\n- Cough\n- Dyspnea\n- Low back pain\n- Portal hypertension\n- Chest pain\n- Esophageal varices associated with another disorder\n- Primary diagnosis: Infective pneumonia\n- Alcohol dependence\n- Backache\n- Cirrhosis - non-alcoholic\n- Hepatic encephalopathy\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-06-17, presumably until 2015-06-17\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-06-17, presumably until 2015-06-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, through Intravenous route, started on 2015-06-17, presumably until 2015-06-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-03 10:05:46, ended at 2015-07-03 12:11:44\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Tics of organic origin\n- Disorder of the peripheral nervous system\n- Parkinson's disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-03 12:34:00, ended at 2015-07-03 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.6 (percent)\n- Thiamine [Moles/volume] in Serum or Plasma: 11 (nanomole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.41 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of the peripheral nervous system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2015-08-08, presumably until 2015-08-12, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-18 14:25:31, ended at 2015-07-18 16:26:40\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Inguinal hernia\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2015-07-18, presumably until 2015-07-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2015-07-18, presumably until 2015-07-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-18 15:57:50, ended at 2015-07-18 16:27:35\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Acquired keratoderma\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Discoloration of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-26 08:02:00, ended at 2015-07-26 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n- Nerve conduction studies; 5-6 studies\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal lev\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n- Electromyogram abnormal\n- Disorder of the peripheral nervous system\n- Abnormal results function studies peripheral nervous system special senses\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 11:21:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Peripheral neuritis\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-30 00:00:00, ended at 2015-07-30 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-02 00:00:00, ended at 2015-08-02 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2015-08-08, presumably until 2015-08-08, with intended 11 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2015-08-17, presumably until 2016-09-03, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-12 00:00:00, ended at 2015-08-12 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2015-08-17, presumably until 2015-08-22, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-22 13:29:49, ended at 2015-08-22 14:32:30\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Hepatic encephalopathy\n- Essential hypertension\n- Inguinal hernia\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2015-08-22, presumably until 2016-01-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-27 00:00:00, ended at 2015-08-27 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-03 00:00:00, ended at 2015-09-03 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2015-09-05, presumably until 2015-10-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-08 00:00:00, ended at 2015-09-08 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2015-09-12, presumably until 2017-04-30, with intended 11 refill(s). Instructions: TAKE 30 ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-19 13:21:43, ended at 2015-09-19 14:27:03\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- General examination of patient\n\n### Condition\n- Inguinal hernia\n- Postprocedural state finding\n- Low back pain\n- Essential hypertension\n- Alcoholic cirrhosis\n- Hepatic encephalopathy\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2015-09-19, presumably until 2015-09-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2015-09-19, presumably until 2015-09-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-27 13:42:14, ended at 2015-09-27 14:14:05\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Inguinal hernia\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-10-04 00:00:00, ended at 2015-10-04 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- methylprednisolone acetate 80 MG/ML Injectable Suspension, started on 2015-10-04, presumably until 2015-10-04\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- iohexol, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- midazolam 1 MG/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-04 11:51:00, ended at 2015-10-04 14:18:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the pre\n- Introduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n- Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach\n\n### Condition\n- Lumbar radiculopathy\n- Primary diagnosis: Spinal stenosis of lumbar region\n- Portal hypertension\n- Hepatic coma due to alcoholic liver failure\n- Alcohol abuse\n- Alcohol-induced mood disorder\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-11 00:00:00, ended at 2015-10-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2015-10-17, presumably until 2015-11-30, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-01 08:51:16, ended at 2015-11-01 10:01:50\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbago with sciatica\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-02 00:00:00, ended at 2015-11-02 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Prothrombin time (PT): 11.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1853 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3061 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 547 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per liter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-21 12:54:15, ended at 2015-11-21 14:56:13\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-30 00:00:00, ended at 2015-11-30 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2015-11-30, presumably until 2016-12-05, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-05 00:00:00, ended at 2015-12-05 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2158 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3601 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 165 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 169 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 533 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.2 (femtoliter)\n- Prothrombin time (PT): 11.5 (second)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-05 00:00:00, ended at 2015-12-05 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2015-12-05, presumably until 2015-12-05, with intended 12 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-05 13:00:55, ended at 2015-12-05 14:21:26\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Myopia\n- Primary diagnosis: Alcoholic cirrhosis\n- Disorder of skin and/or subcutaneous tissue\n- Inguinal hernia\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2016-11-05, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2016-01-27, with intended 1 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, started on 2015-12-28, presumably until 2016-11-05, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, through Oral route, started on 2015-12-25, presumably until 2015-12-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-04 00:00:00, ended at 2016-01-04 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 462 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Prothrombin time (PT): 11.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 145 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1773 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils [#/volume] in Blood by Automated count: 18 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2002 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-16 14:35:16, ended at 2016-01-16 15:34:20\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Lumbosacral radiculopathy\n- Finding of frequency of urination\n- Hyperlipidemia\n- Inguinal hernia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-01-26 13:18:00, ended at 2016-01-26 16:09:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.92 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.88 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 406 (microgram of fibrinogen equivalent unit per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Alcoholic cirrhosis\n- Backache\n- Inguinal hernia\n- Lumbosacral radiculopathy\n- Primary diagnosis: Pain in thoracic spine\n- Tics of organic origin\n- Dyspnea\n- Chest pain on breathing\n- Epigastric pain\n- Disorder of soft tissue\n- Chest pain\n- Essential hypertension\n\n### Drug\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2016-01-26, presumably until 2016-01-26\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2016-01-26, presumably until 2016-01-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-27 00:00:00, ended at 2016-01-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2016-01-30, presumably until 2016-01-30, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2016-01-30, presumably until 2016-01-30, with intended 12 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-28 14:05:36, ended at 2016-01-28 17:05:55\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral radiculopathy\n- Inguinal hernia\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-30 00:00:00, ended at 2016-01-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2016-01-30, presumably until 2017-02-13, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2016-01-30, presumably until 2016-11-05, with intended 12 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in lower abdomen; not otherwise specified\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2016-02-19, presumably until 2016-02-19\n- clindamycin 150 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-19, presumably until 2016-02-19\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-02-19, presumably until 2016-02-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-02-19, presumably until 2016-02-19\n- ketamine 100 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2016-02-19, presumably until 2016-02-19\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-19, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 05:35:00, ended at 2016-02-19 14:20:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Repair initial inguinal hernia, age 5 years or older; reducible\n- Supplement Left Inguinal Region with Synthetic Substitute, Open Approach\n\n### Condition\n- Chronic pain\n- Essential hypertension\n- Gastroesophageal reflux disease without esophagitis\n- Alcoholic hepatic failure\n- Alcoholic cirrhosis\n- Low back pain\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2016-02-19, presumably until 2017-02-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-19, presumably until 2016-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-22 00:00:00, ended at 2016-02-22 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-25, presumably until 2016-07-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-25 13:00:25, ended at 2016-02-25 14:27:49\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- Determination of refractive state\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; optic nerve\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-02-27 00:00:00, ended at 2016-02-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2016-02-27, presumably until 2016-02-27\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-02-27, presumably until 2016-02-27\n- iohexol, through Intravenous route, started on 2016-02-27, presumably until 2016-02-27\n- 10 ML clonidine hydrochloride 0.1 MG/ML Injection, through Epidural route, started on 2016-02-27, presumably until 2016-02-27\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2016-02-27, presumably until 2016-02-27\n- midazolam 1 MG/ML Injectable Solution, started on 2016-02-27, presumably until 2016-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-27 07:23:00, ended at 2016-02-27 13:25:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Introduction of Anti-inflammatory into Epidural Space, Percutaneous Approach\n- Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the pre\n- Introduction of Anesthetic Agent into Epidural Space, Percutaneous Approach\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Essential hypertension\n- Tear film insufficiency\n- Hepatic failure\n- Tics of organic origin\n- Alcoholic cirrhosis\n- Inguinal hernia\n- Portal hypertension\n- Lumbar radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-05 14:22:25, ended at 2016-03-05 15:01:54\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-27 14:10:23, ended at 2016-03-27 14:33:20\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-15 00:00:00, ended at 2016-04-15 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 166 (cells per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 614 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 91.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3405 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2182 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.6 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Prothrombin time (PT): 11.5 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-18 00:00:00, ended at 2016-04-18 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 28 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2457 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.6 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.9 (femtoliter)\n- Prothrombin time (PT): 11.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.41 (million per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3593 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Monocytes [#/volume] in Blood by Automated count: 760 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 263 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 193 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-25 00:00:00, ended at 2016-04-25 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-28 00:00:00, ended at 2016-04-28 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-02 00:00:00, ended at 2016-05-02 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-09 00:00:00, ended at 2016-05-09 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-16 00:00:00, ended at 2016-05-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-23 00:00:00, ended at 2016-05-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 208 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.1 (femtoliter)\n- Prothrombin time (PT): 11.4 (second)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1827 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3560 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 674 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-30 00:00:00, ended at 2016-05-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 238 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.98 (million per liter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.9 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2019 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 622 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3172 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Prothrombin time (PT): 11.5 (second)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-30 00:00:00, ended at 2016-05-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-06 00:00:00, ended at 2016-06-06 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 632 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3422 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1804 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.29 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 50 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 16.2 (gram per deciliter)\n- Prothrombin time (PT): 11.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 291 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-13 00:00:00, ended at 2016-06-13 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.8 (femtoliter)\n- Prothrombin time (PT): 11.2 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3434 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 50 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2060 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 158 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.7 (percent)\n- MCV [Entitic volume] by Automated count: 87.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 599 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-20 00:00:00, ended at 2016-06-20 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 205 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3019 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.9 (percent)\n- Prothrombin time (PT): 11.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 405 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 179 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1733 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-27 00:00:00, ended at 2016-06-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-27 00:00:00, ended at 2016-06-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2373 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 657 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 248 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Prothrombin time (PT): 11.2 (second)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per liter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3993 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.0 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 29 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 221 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-27 00:00:00, ended at 2016-06-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1829 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 161 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 707 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.9 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3466 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 37 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-11 00:00:00, ended at 2016-07-11 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-22 13:03:00, ended at 2016-07-22 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Alcoholic cirrhosis\n- Ascites due to alcoholic cirrhosis\n- Cholelithiasis without obstruction\n- Cirrhosis of liver\n- Gallstone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-22 00:00:00, ended at 2016-08-22 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-03 00:00:00, ended at 2016-09-03 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2016-09-30, presumably until 2017-01-20, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-05 00:00:00, ended at 2016-09-05 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 243 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 608 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Prothrombin time (PT): 11.2 (second)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3571 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1946 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.13 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-09-09 00:00:00, ended at 2016-09-09 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-09-09, presumably until 2016-09-09\n- iohexol, through Intravenous route, started on 2016-09-09, presumably until 2016-09-09\n- methylprednisolone acetate 40 MG/ML Injectable Suspension, started on 2016-09-09, presumably until 2016-09-09\n- midazolam 1 MG/ML Injectable Solution, started on 2016-09-09, presumably until 2016-09-09\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2016-09-09, presumably until 2016-09-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-09 11:09:00, ended at 2016-09-09 15:52:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach\n- Injection(s), of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, includes contrast for localization when performed,\n- Introduction of Regional Anesthetic into Spinal Canal, Percutaneous Approach (Deprecated)\n\n### Condition\n- Low back pain\n- Lumbar radiculopathy\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-09-09, presumably until 2016-09-09\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-09-09, presumably until 2016-09-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-09-28 19:55:00, ended at 2016-09-28 21:11:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neck pain\n- Motor vehicle accident, driver\n- Wrist joint pain\n- Backache\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-09-28, presumably until 2016-09-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-30 00:00:00, ended at 2016-09-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2016-09-30, presumably until 2017-01-20, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-02 12:55:57, ended at 2016-10-02 13:15:27\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-03 00:00:00, ended at 2016-10-03 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-16 08:46:41, ended at 2016-10-16 11:14:31\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neck pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule, started on 2016-11-07, presumably until 2019-09-15, with intended 1 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-05 13:22:09, ended at 2016-11-05 14:27:49\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n- Essential hypertension\n- Finding of frequency of urination\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule, through Oral route, started on 2016-11-05, presumably until 2016-11-07, with intended 1 refill(s). Instructions: take 1 Murray by mouth every morning\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2016-11-05, presumably until 2017-11-05, with intended 3 refill(s). Instructions: take 2 Caps by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-07 00:00:00, ended at 2016-11-07 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2016-11-12, presumably until 2016-11-12, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-12 12:52:00, ended at 2016-11-12 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material\n\n### Condition\n- Neck pain\n- Spinal stenosis in cervical region\n- Cervical spondylosis without myelopathy\n- Displacement of cervical intervertebral disc\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-14 00:00:00, ended at 2016-11-14 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.5 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-28 00:00:00, ended at 2016-11-28 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, started on 2016-11-28, presumably until 2016-11-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-03 13:27:13, ended at 2016-12-03 14:21:15\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Alcoholic cirrhosis\n- Finding of frequency of urination\n- Familial hyperchylomicronemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2016-12-05, presumably until 2017-11-30, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-26 00:00:00, ended at 2016-12-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-07 14:15:43, ended at 2017-01-07 16:11:58\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nummular eczema\n\n### Drug\n- mometasone furoate 0.001 MG/MG Topical Ointment, started on 2017-01-07, presumably until 2019-09-15, with intended 0 refill(s). Instructions: Apply to affected area twice per day for 3 weeks.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-12 00:00:00, ended at 2017-01-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2017-01-12, presumably until 2017-01-12, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-20 00:00:00, ended at 2017-01-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2017-01-20, presumably until 2018-03-21, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-06 00:00:00, ended at 2017-02-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.4 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-12 00:00:00, ended at 2017-02-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-02-13, presumably until 2017-03-23, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-04 13:25:58, ended at 2017-03-04 14:21:33\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Melanocytic nevus\n- Primary diagnosis: Alcoholic cirrhosis\n- Essential hypertension\n\n### Drug\n- triamterene 50 MG Oral Capsule, through Oral route, started on 2017-03-04, presumably until 2018-03-04, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- triamcinolone acetonide 1 MG/ML Topical Lotion, through Topical route, started on 2017-03-04, presumably until 2018-03-04, with intended 0 refill(s). Instructions: by Topical route 3 times a day use thin layer\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-11 00:00:00, ended at 2017-03-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nummular eczema\n\n### Drug\n- mometasone furoate 0.001 MG/MG Topical Ointment, started on 2017-03-11, presumably until 2017-03-11, with intended 0 refill(s). Instructions: Apply to affected area twice per day for 3 weeks.\n- triamcinolone acetonide 1 MG/ML Topical Lotion, through Topical route, started on 2017-03-11, presumably until 2018-03-11, with intended 0 refill(s). Instructions: by Topical route 3 times a day use thin layer\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-11 00:00:00, ended at 2017-03-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2017-03-11, presumably until 2017-03-11, with intended 0 refill(s). Instructions: TAKE 30ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-12 15:18:57, ended at 2017-03-12 16:07:26\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n- Hypertrophic condition of skin\n- Neoplasm of uncertain behavior of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-20 00:00:00, ended at 2017-03-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-21 00:00:00, ended at 2017-03-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-03-23, presumably until 2018-04-05, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-06 00:00:00, ended at 2017-04-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2017-04-06, presumably until 2018-04-13, with intended 12 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-10 00:00:00, ended at 2017-04-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-30 00:00:00, ended at 2017-04-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.81 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3046 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 227 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 589 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1501 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.8 (percent)\n- Prothrombin time (PT): 11.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 14:34:15, ended at 2017-04-30 15:07:26\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n- Portal hypertension\n- Primary diagnosis: Pain in right foot\n- Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2017-04-30, presumably until 2017-05-04, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-04 00:00:00, ended at 2017-05-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2017-05-04, presumably until 2019-01-12, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-08 00:00:00, ended at 2017-05-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-08 08:39:00, ended at 2017-05-08 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Portal hypertension\n- Cirrhosis of liver\n- Hepatic failure\n- Alcoholic cirrhosis\n- Lumbar radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-05 00:00:00, ended at 2017-06-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2.8 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.8 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Prothrombin time (PT): 11.8 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2041 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 477 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2602 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.75 (million per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 148 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-17 13:20:52, ended at 2017-06-17 13:50:02\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-19 00:00:00, ended at 2017-06-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-03 00:00:00, ended at 2017-07-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1840 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 221 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3566 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.3 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 11.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 636 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-24 00:00:00, ended at 2017-07-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-31 00:00:00, ended at 2017-07-31 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-17 09:00:00, ended at 2017-08-17 09:04:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Mononeuropathy of lower limb\n- Arthralgia of the ankle and/or foot\n- Acquired hallux valgus\n- Pain in left foot\n- Pain in right foot\n- Metatarsus primus varus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-17 09:05:00, ended at 2017-08-17 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Metatarsus primus varus\n- Acquired hallux valgus\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-17 09:13:19, ended at 2017-08-17 10:26:49\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuropathy of lower limb\n- Pain in right foot\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-18 00:00:00, ended at 2017-08-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Pain in left foot\n- Primary diagnosis: Polyneuropathy\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-08-18, presumably until 2018-08-18, with intended 2 refill(s). Instructions: take 1 Cap by mouth every day 1 tab at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-21 10:15:44, ended at 2017-08-21 11:14:31\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lichen simplex chronicus\n- Asteatosis cutis\n- Post-inflammatory hyperpigmentation\n- Primary diagnosis: Nummular eczema\n\n### Drug\n- clobetasol propionate 0.0005 MG/MG Topical Ointment, through Topical route, started on 2017-08-21, presumably until 2018-08-21, with intended 0 refill(s). Instructions: by Topical route 2 times a day To itchy raised bump on shin until it is flat OR no longer itchy\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-26 00:00:00, ended at 2017-08-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.9 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 52 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1934 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2371 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Prothrombin time (PT): 11.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 218 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 624 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.18 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nummular eczema\n\n### Drug\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2017-08-28, presumably until 2020-03-21, with intended 3 refill(s). Instructions: Apply 2 times a day to itchy raised bump on shin until it is flat OR no longer itchy\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Eosinophils [#/volume] in Blood by Automated count: 162 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1836 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.01 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Prothrombin time (PT): 11.7 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2840 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 513 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.4 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Prothrombin time (PT): 11.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 605 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2020 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.23 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 243 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2484 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-19 00:00:00, ended at 2017-10-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 632 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.9 (percent)\n- Prothrombin time (PT): 11.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2533 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.07 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.0 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 162 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2025 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-30 00:00:00, ended at 2017-11-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2017-12-10, presumably until 2019-01-20, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-25 00:00:00, ended at 2017-12-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 578 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.13 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Prothrombin time (PT): 11.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1882 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 85.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2210 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.9 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 191 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-31 14:22:55, ended at 2017-12-31 14:56:57\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-02 00:00:00, ended at 2018-02-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-11 12:20:00, ended at 2018-02-11 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-02-27 20:39:00, ended at 2018-02-27 23:16:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.97 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.3 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.39 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.90 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Leukocytosis\n- Primary diagnosis: Lobar pneumonia\n- Alcoholic cirrhosis\n- Abnormal findings on diagnostic imaging of lung\n- Essential hypertension\n- Fever\n- Cough\n- Hypokalemia\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-27, presumably until 2018-02-27\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2018-02-27, presumably until 2018-03-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-02-27, presumably until 2018-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-05 00:00:00, ended at 2018-03-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2625 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 1535 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 600 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.2 (femtoliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 4.2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Prothrombin time (PT): 11.0 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.14 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-09 00:00:00, ended at 2018-03-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Gastric varices\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2018-03-21, presumably until 2018-07-28, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-04 00:00:00, ended at 2018-04-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2018-04-05, presumably until 2019-04-19, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-13 00:00:00, ended at 2018-04-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2018-04-14, presumably until 2019-01-18, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-14 00:00:00, ended at 2018-05-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Prothrombin time (PT): 11.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2580 (cells per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 288 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2220 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 870 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 42 (cells per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-11 00:00:00, ended at 2018-07-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-23 00:00:00, ended at 2018-07-23 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2035 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per liter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.3 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Prothrombin time (PT): 11.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 158 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 674 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3396 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-28 00:00:00, ended at 2018-07-28 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Gastric varices\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2018-07-28, presumably until 2019-08-01, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 10:14:00, ended at 2018-08-11 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Portal hypertension\n- Cirrhosis of liver\n- Ascites due to alcoholic cirrhosis\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 275 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2007 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3123 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 43 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 653 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-22 00:00:00, ended at 2018-09-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Prothrombin time (PT): 11.1 (second)\n- Monocytes [#/volume] in Blood by Automated count: 763 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 31 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2922 (cells per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 232 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2153 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-29 00:00:00, ended at 2018-10-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:43:33, ended at 2018-11-24 11:21:23\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30, or quantitative, automated threshold perim\n\n### Condition\n- Primary diagnosis: Glaucoma suspect\n- Pinguecula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:43:47, ended at 2018-11-24 11:21:31\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 11 (millimeter mercury column)\n- Intraocular pressure of right eye: 10 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pinguecula\n- Primary diagnosis: Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-10 00:00:00, ended at 2018-12-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3036 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 280 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2490 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- MCHC [Mass/volume] by Automated count: 36.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 657 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Prothrombin time (PT): 11.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Hepatic failure\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-24 00:00:00, ended at 2018-12-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-07 00:00:00, ended at 2019-01-07 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2019-01-12, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-13 00:00:00, ended at 2019-01-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2019-01-19, presumably until 2019-04-19, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-20 00:00:00, ended at 2019-01-20 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-21 00:00:00, ended at 2019-01-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2117 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.7 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 524 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 227 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2500 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-27 15:50:51, ended at 2019-01-27 16:46:43\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-04 17:35:00, ended at 2019-02-04 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2019-02-17, presumably until 2020-03-15, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2019-02-17, presumably until 2020-03-15, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2019-02-17, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2019-02-17, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-17 08:57:20, ended at 2019-02-17 09:10:23\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-18 00:00:00, ended at 2019-02-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 20:47:00, ended at 2019-02-24 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Lumbosacral radiculopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 14:11:23, ended at 2019-03-03 15:14:40\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions\n\n### Condition\n- Primary diagnosis: Inflamed seborrheic keratosis\n- Melanocytic nevus of trunk\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-04 00:00:00, ended at 2019-03-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 726 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2720 (cells per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.93 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 201 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- MCV [Entitic volume] by Automated count: 87.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2213 (cells per microliter)\n- Prothrombin time (PT): 11.1 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-18 00:00:00, ended at 2019-03-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-01 00:00:00, ended at 2019-04-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Hepatic failure\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-14 00:00:00, ended at 2019-04-14 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2.9 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Prothrombin time (PT): 11.2 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 53 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 785 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 363 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3293 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2105 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.85 (million per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-04-22, presumably until 2019-04-22, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2019-04-22, presumably until 2019-04-22, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-18 00:00:00, ended at 2019-04-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2019-04-18, presumably until 2019-05-15, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-19 00:00:00, ended at 2019-04-19 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-04-22, presumably until 2019-10-04, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2019-04-22, presumably until 2019-10-04, with intended 0 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-23 00:00:00, ended at 2019-04-23 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-04-27, presumably until 2019-04-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-28 13:11:30, ended at 2019-04-28 14:53:17\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30, or quantitative, automated threshold perim\n\n### Condition\n- Glaucoma suspect\n- Primary diagnosis: Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-28 13:11:30, ended at 2019-04-28 14:53:17\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Glaucoma suspect\n- Primary diagnosis: Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-02 13:01:00, ended at 2019-05-02 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-10 00:00:00, ended at 2019-05-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1495 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Prothrombin time (PT): 11.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 48 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2915 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 281 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 562 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-15 00:00:00, ended at 2019-05-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2019-05-16, presumably until 2019-09-15, with intended 5 refill(s). Instructions: TAKE 1 CAPSULE(100 MG) BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.38 (million per liter)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.15 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 30 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 159 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.9 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1646 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 614 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3452 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.5 (percent)\n- Prothrombin time (PT): 11.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-01 21:10:00, ended at 2019-06-02 00:01:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.22 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 48.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Body height: 5' 7\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Tachycardia\n- Alcoholic cirrhosis\n- Chronic pain\n- Essential hypertension\n- Dyspnea\n- Gastric varices\n- Esophageal varices without bleeding\n- Inguinal hernia\n- Portal hypertension\n- Alcohol dependence\n- Chest pain\n- Cough\n- Abnormal findings on diagnostic imaging of lung\n- Hepatic failure\n- Low back pain\n- Primary diagnosis: Pneumonia\n\n### Drug\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2019-06-01, presumably until 2019-06-05, with intended 0 refill(s). Instructions: take 1 Tab (750 mg total) by mouth daily for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.8 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Eosinophils [#/volume] in Blood by Automated count: 222 (cells per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.15 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 42 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1938 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3288 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Prothrombin time (PT): 11.1 (second)\n- Monocytes [#/volume] in Blood by Automated count: 510 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-24 00:00:00, ended at 2019-06-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-18 09:00:00, ended at 2019-07-18 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-28 00:00:00, ended at 2019-07-28 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Gastric varices\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2021-12-23, presumably until 2021-12-23, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-01 00:00:00, ended at 2019-08-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Gastric varices\n- Portal hypertension\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-08-01, presumably until 2020-03-15, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-22 00:00:00, ended at 2019-08-22 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-15 00:00:00, ended at 2019-09-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-15 13:44:00, ended at 2019-09-15 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-21 00:00:00, ended at 2019-09-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-30 00:00:00, ended at 2019-09-30 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1528 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 578 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Prothrombin time (PT): 11.0 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.6 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3056 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.05 (million per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-03 00:00:00, ended at 2019-10-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disease of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2019-10-12, presumably until 2019-11-02, with intended 12 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-06 00:00:00, ended at 2019-10-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-11-04, presumably until 2019-11-04, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2019-11-04, presumably until 2019-11-04, with intended 0 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-28 00:00:00, ended at 2019-10-28 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-02 00:00:00, ended at 2019-11-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2019-11-03, presumably until 2019-11-03, with intended 1 refill(s). Instructions: TAKE 1 TABLET(5 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-02 13:32:04, ended at 2019-11-02 15:01:08\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Nocturia\n- Benign prostatic hyperplasia with outflow obstruction\n- Lumbosacral radiculopathy\n\n### Drug\n- finasteride 5 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2020-03-15, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-12-09, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2019-11-02, presumably until 2020-03-15, with intended 2 refill(s). Instructions: take 3 Caps (300 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-03 00:00:00, ended at 2019-11-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign prostatic hyperplasia with outflow obstruction\n- Primary diagnosis: Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2019-11-08, presumably until 2020-02-13, with intended 2 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, started on 2019-11-15, presumably until 2019-11-15, with intended 12 refill(s). Instructions: TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-11 00:00:00, ended at 2019-11-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-09 00:00:00, ended at 2019-12-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-09 14:22:33, ended at 2019-12-09 15:48:03\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Asymptomatic microscopic hematuria\n- Hyperlipidemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2019-12-09, presumably until 2020-03-15, with intended 2 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-12 00:00:00, ended at 2019-12-12 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Asymptomatic microscopic hematuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-15 11:11:00, ended at 2019-12-15 11:34:01\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nocturia\n- Benign prostatic hyperplasia with outflow obstruction\n- Microscopic hematuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-23 00:00:00, ended at 2019-12-23 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-27 14:09:00, ended at 2019-12-27 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Asymptomatic microscopic hematuria\n- Microscopic hematuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-05 12:11:00, ended at 2020-01-05 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-06 00:00:00, ended at 2020-01-06 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 189 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1716 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.88 (million per liter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.0 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 580 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2084 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-20 00:00:00, ended at 2020-01-20 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-03 00:00:00, ended at 2020-02-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 498 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Basophils [#/volume] in Blood by Automated count: 28 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 268 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2040 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.90 (million per liter)\n- Prothrombin time (PT): 11.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.4 (percent)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1866 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.7 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-08 10:12:46, ended at 2020-02-08 12:39:23\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy (separate procedure)\n\n### Condition\n- Primary diagnosis: Microscopic hematuria\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2020-02-08, presumably until 2020-02-08\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2020-02-08, presumably until 2020-02-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, started on 2020-02-13, presumably until 2020-02-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, started on 2020-02-13, presumably until 2020-03-15, with intended 2 refill(s). Instructions: TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-17 00:00:00, ended at 2020-02-17 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-24 00:00:00, ended at 2020-02-24 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Psychoactive substance use disorder\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Psychoactive substance use disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2020-02-29, presumably until 2020-02-29, with intended 1 refill(s). Instructions: TAKE 1 TABLET(5 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.23 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1840 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 425 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Prothrombin time (PT): 11.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2505 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 190 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.1 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Gastric varices\n- Hepatic failure\n- Benign prostatic hyperplasia with outflow obstruction\n- Lumbosacral radiculopathy\n- Hyperlipidemia\n- Nocturia\n- Portal hypertension\n\n### Drug\n- finasteride 5 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-21, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-15, with intended 4 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 4 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2020-03-15, presumably until 2020-04-02, with intended 11 refill(s). Instructions: take 3 Caps (300 mg total) by mouth 3 times a day\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 4 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nocturia\n- Benign prostatic hyperplasia with outflow obstruction\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hyperlipidemia\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-15, with intended 4 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-15, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-26, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-15 09:04:00, ended at 2020-03-15 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n- Alcoholic cirrhosis\n- Ascites due to alcoholic cirrhosis\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-22 14:04:48, ended at 2020-03-22 14:29:01\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-28 00:00:00, ended at 2020-03-28 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-30 00:00:00, ended at 2020-03-30 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1711 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 597 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 162 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3300 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 29 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.5 (percent)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Prothrombin time (PT): 11.4 (second)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-02 10:35:52, ended at 2020-04-02 11:08:43\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Benign prostatic hyperplasia\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Inguinal hernia\n- Gastric varices\n- Hepatic failure\n- Hyperlipidemia\n- Lumbosacral radiculopathy\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with sphincterotomy/papillotomy\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal of calculi/debris from biliary/pancreatic duct(s)\n- Endoscopic retrograde cholangiopancreatography (ERCP); with biopsy, single or multiple\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Hyperlipidemia\n- Calculus of bile duct without obstruction\n- Essential hypertension\n\n### Drug\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-04-03, presumably until 2020-04-03\n- midazolam 1 MG/ML Injectable Solution, started on 2020-04-03, presumably until 2020-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-03 07:32:00, ended at 2020-04-03 10:37:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation\n- Endoscopic retrograde cholangiopancreatography (ERCP); with biopsy, single or multiple\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal of calculi/debris from biliary/pancreatic duct(s)\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Essential hypertension\n- Hepatic failure\n- Liver cell carcinoma\n- Disorder of biliary tract\n- Hyperlipidemia\n- Primary diagnosis: Obstruction of bile duct\n- Obesity\n- Calculus of bile duct without obstruction\n- Alcoholic cirrhosis\n\n### Drug\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-04-03, presumably until 2020-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Gastric varices\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2020-04-08, presumably until 2020-04-08, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-09 00:00:00, ended at 2020-05-09 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Primary diagnosis: Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n- Primary diagnosis: Gastric varices\n- Nocturia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-08 14:05:08, ended at 2020-06-08 14:14:48\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tremor\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-21 00:00:00, ended at 2020-06-21 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-13 08:51:00, ended at 2020-07-13 12:07:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-19 07:40:00, ended at 2020-07-19 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-19 07:40:00, ended at 2020-07-19 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-24 00:00:00, ended at 2020-07-24 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-04 14:28:37, ended at 2020-10-04 14:57:19\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver function tests abnormal\n- Portal hypertension\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-01-01 15:59:00, ended at 2012-01-06 14:05:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- Prothrombin time (PT): 18.1 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 549 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- MCV [Entitic volume] by Automated count: 98.3 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.65 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.35 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.9 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n\n### Procedure\n- Abdominal paracentesis\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Ultrasound, abdominal, real time with image documentation; complete\n- Physical therapy evaluation\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Cholelithiasis without obstruction\n- Dehydration\n- Abdominal pain\n- Cirrhosis - non-alcoholic\n- Deficiency anemias\n- Generalized abdominal pain\n- Hepatic encephalopathy\n- Splenomegaly\n- Tachycardia\n- Alcoholic cirrhosis\n- Loss of appetite\n- Acute renal failure syndrome\n- Chronic kidney disease\n- Depressive disorder\n- Chronic congestive splenomegaly\n- Intestinal infectious disease\n- Jaundice\n- Acidosis\n- Ascites\n- Portal hypertension\n- Retention of urine\n- Nausea and vomiting\n- Renal failure syndrome\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06. Instructions: take 1 mg by mouth daily.\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06. Instructions: take 100 mg by mouth daily.\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2012-01-02, presumably until 2012-01-06\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-01-01, presumably until 2012-01-01\n- amitriptyline hydrochloride 25 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-04-05. Instructions: take 25 mg by mouth every bedtime.\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-01-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- ciprofloxacin 250 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-02\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-02\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-05\n- propranolol hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-01-02, presumably until 2012-01-06. Instructions: take 10 mg by mouth 3 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-01-02, presumably until 2012-01-02\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-01-04, presumably until 2012-01-04\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2012-01-04, presumably until 2012-01-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-01-01, presumably until 2012-01-01\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2012-01-01, presumably until 2012-01-01\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-01-01, presumably until 2012-01-04\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2012-03-25. Instructions: take  by mouth Every Day.\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2012-01-03, presumably until 2012-01-06\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2012-01-02, presumably until 2012-01-02\n- ciprofloxacin 750 MG Oral Tablet, through Oral route, started on 2012-01-06, presumably until 2012-03-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 7 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-08 15:47:00, ended at 2012-01-08 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 127 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 18.9 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.9 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 428 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.98 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-15 12:59:34, ended at 2012-01-15 13:39:12\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-15 14:48:00, ended at 2012-01-15 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 128 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 390 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.31 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.7 (percent)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-16 00:00:00, ended at 2012-01-16 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-16 00:00:00, ended at 2012-01-16 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-01-16, presumably until 2012-03-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2012-01-16, presumably until 2012-03-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-20 14:25:00, ended at 2012-01-20 17:03:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Abdominal paracentesis\n\n### Condition\n- Ascites\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-01-20, presumably until 2012-01-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 09:45:00, ended at 2012-01-21 09:45:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 428 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.44 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 77 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 124 (microgram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.69 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- MCV [Entitic volume] by Automated count: 99.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 62 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 4 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.68 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 524 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Prothrombin time (PT): 18.8 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 119 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 09:46:00, ended at 2012-01-21 12:04:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 12:05:00, ended at 2012-01-21 12:34:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-21 14:29:00, ended at 2012-01-21 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; group (2 or more individual(s)), each 30 minutes\n\n### Condition\n- Alcoholic cirrhosis\n- Jaundice\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-22 10:55:00, ended at 2012-01-22 11:23:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-22 11:24:00, ended at 2012-01-22 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Alcoholic cirrhosis\n- Cirrhosis - non-alcoholic\n- Splenomegaly\n- Ascites\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-27 09:30:00, ended at 2012-01-27 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-12 13:45:00, ended at 2012-02-12 16:40:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Abdominal paracentesis\n\n### Condition\n- Ascites\n- Alcoholic cirrhosis\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-02-12, presumably until 2012-02-12\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2012-02-12, presumably until 2012-02-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-02-13 16:10:00, ended at 2012-02-14 14:45:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 530 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Base excess in Blood by calculation: 0.0 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.3 (percent)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.09 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 139 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Abdominal pain\n- Alcohol dependence\n- Portal hypertension\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Ascites\n- Chronic kidney disease\n- Alcoholic cirrhosis\n- Generalized abdominal pain\n- Leukocytosis\n- Nausea and vomiting\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-02-14, presumably until 2012-02-14\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-02-13, presumably until 2012-02-14\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2012-02-13, presumably until 2012-02-13\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-02-14, presumably until 2012-02-14\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2012-02-13, presumably until 2012-02-14\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2012-02-14, presumably until 2012-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-17 00:00:00, ended at 2012-02-17 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 21:39:00, ended at 2012-02-17 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 643 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 133 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.94 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99.0 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 19.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.0 (percent)\n- Prothrombin time (PT): 18.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-14 22:43:00, ended at 2012-03-25 14:55:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.33 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 1.93 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Prothrombin time (PT): N/A (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 650 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 34 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 2.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 135 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 59.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Other endovascular procedures on other vessels\n- Transfusion, blood or blood components\n- Irrigation of stomach\n- Radiologic examination, abdomen; single anteroposterior view\n- Insertion of two vascular stents\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Counseling\n- Transcatheter occlusion or embolization (eg, for tumor destruction, to achieve hemostasis, to occlude a vascular malformation), percutaneous, any method, non-central nervous system, non-head or neck\n- Angioplasty of other non-coronary vessel(s)\n- Phlebography of the portal venous system using contrast material\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Arterial puncture, withdrawal of blood for diagnosis\n- Insertion of other (naso-)gastric tube\n- Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s)\n- Abdominal paracentesis\n- Respiratory flow volume loop\n- Selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Transfusion of other serum\n- Phlebography of other Intra-Abdominal veins using contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Ultrasound, abdominal, real time with image documentation; complete\n- Packed blood cell transfusion\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Collection of venous blood by venipuncture\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Other endoscopy of small intestine\n- Transcatheter therapy, embolization, any method, radiological supervision and interpretation\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Gastric intubation and aspiration(s) therapeutic, necessitating physician's skill (eg, for gastrointestinal hemorrhage), including lavage if performed\n- Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recannulization/dilatation, stent placement and all associated\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Angiography through existing catheter for follow-up study for transcatheter therapy, embolization or infusion, other than for thrombolysis\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Radiologic examination, chest; single view, frontal\n- Procedure on three vessels\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n\n### Condition\n- Hypokalemia\n- Hypovolemia\n- Loss of appetite\n- Portal hypertension\n- Atelectasis\n- Complication associated with device\n- Esophageal varices associated with another disorder\n- Gastric ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Hepatorenal syndrome\n- Splenomegaly\n- Tachycardia\n- Chronic kidney disease\n- Gastrointestinal hemorrhage\n- Lung field abnormal\n- Vascular complication of medical care\n- Venous varices\n- Cough\n- Low blood pressure\n- Ascites\n- Hematemesis\n- Depressive disorder\n- Paralytic ileus\n- Alcoholic cirrhosis\n- Cirrhosis - non-alcoholic\n- Hematochezia\n- Intestinal obstruction\n- Pleural effusion\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-03-20, presumably until 2012-03-24\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-03-25\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2012-03-14, presumably until 2012-03-25\n- benzocaine 200 MG/ML Mucosal Spray, through Submucosal route, started on 2012-03-15, presumably until 2012-03-15\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-03-25\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2012-03-20, presumably until 2012-03-21\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-03-18, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-20\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-03-18, presumably until 2012-03-20\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2012-03-15, presumably until 2012-03-15\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-03-14, presumably until 2012-03-23\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2012-03-24, presumably until 2012-03-24\n- amitriptyline hydrochloride 25 MG Oral Tablet, through Oral route, started on 2012-03-15, presumably until 2012-03-24\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-03-25, presumably until 2012-04-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-03-20, presumably until 2012-03-20\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2012-03-18, presumably until 2012-03-20\n- ropinirole 0.25 MG Oral Tablet, through Oral route, started on 2012-03-25, presumably until 2012-03-25\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-03-18, presumably until 2012-03-18\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-03-17, presumably until 2012-03-25\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2012-03-24, presumably until 2012-12-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q48H. Take one tablet on Saturday, 03/26/2012, and your second and last dose on Monday, 03/28/2012.\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-17\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-03-16, presumably until 2012-03-25\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2012-03-14, presumably until 2012-03-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-03-14, presumably until 2012-03-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2012-03-15, presumably until 2012-03-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-15\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2012-03-24, presumably until 2012-03-24\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2012-03-15, presumably until 2012-03-21\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2012-03-16, presumably until 2013-03-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2012-03-20, presumably until 2012-03-23\n- midazolam 1 MG/ML Injectable Solution, started on 2012-03-15, presumably until 2012-03-15\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2012-03-14, presumably until 2012-03-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-05 00:00:00, ended at 2012-04-05 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-11-15, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-07-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-05 15:26:20, ended at 2012-04-05 15:55:26\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Alcoholic cirrhosis\n- Hypervolemia\n- Primary bacterial peritonitis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-26 00:00:00, ended at 2012-04-26 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n- Gastrointestinal hemorrhage\n- Low blood pressure\n\n### Drug\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-04-26, presumably until 2012-07-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-26 13:50:00, ended at 2012-05-26 17:16:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 146 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 19.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n\n### Procedure\n- Abdominal paracentesis\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n- Ascites\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2012-05-26, presumably until 2012-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-05 15:32:33, ended at 2012-07-05 16:14:54\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Alcoholic cirrhosis\n- Portal hypertension\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-07-13 00:00:00, ended at 2012-07-13 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcohol abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-20 00:00:00, ended at 2012-07-20 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure\n- Gastrointestinal hemorrhage\n- Alcoholic cirrhosis\n\n### Drug\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-07-20, presumably until 2012-07-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-07-21 00:00:00, ended at 2012-07-21 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-07-21, presumably until 2012-10-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-21 10:00:00, ended at 2012-07-21 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n\n### Condition\n- Alcoholic cirrhosis\n- Alcohol dependence\n- Alcohol abuse\n- Cholelithiasis without obstruction\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-17 00:00:00, ended at 2012-08-17 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-08-17, presumably until 2012-10-20, with intended 5 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-08-26 00:00:00, ended at 2012-08-26 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-08-26 00:00:00, ended at 2012-08-26 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2012-08-26, presumably until 2013-03-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-26 08:57:30, ended at 2012-08-26 11:27:19\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-26 11:06:00, ended at 2012-08-26 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Prothrombin time (PT): 18.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 124 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-14 00:00:00, ended at 2012-09-14 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2012-09-14, presumably until 2012-09-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n- midodrine hydrochloride 10 MG Oral Tablet, started on 2012-09-14, presumably until 2012-09-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-09-28 00:00:00, ended at 2012-09-28 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2012-09-28, presumably until 2012-09-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-04 00:00:00, ended at 2012-10-04 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-04, presumably until 2012-11-09, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2012-10-19, presumably until 2012-10-19, with intended 4 refill(s). Instructions: TAKE 30 ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-20 00:00:00, ended at 2012-10-20 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hepatic encephalopathy\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-10-20, presumably until 2012-12-09, with intended 5 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-10-31 00:00:00, ended at 2012-10-31 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2012-10-31, presumably until 2012-10-31, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n- midodrine hydrochloride 10 MG Oral Tablet, started on 2012-10-31, presumably until 2012-10-31, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-09 00:00:00, ended at 2012-11-09 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-11-09, presumably until 2013-11-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-11-09, presumably until 2013-03-13, with intended 5 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-15 00:00:00, ended at 2012-11-15 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-11-15, presumably until 2013-03-13, with intended 5 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-15 00:00:00, ended at 2012-11-15 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2012-11-15, presumably until 2012-11-15, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-01 00:00:00, ended at 2012-12-01 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2012-12-01, presumably until 2012-12-01, with intended 4 refill(s). Instructions: TAKE 30ML BY MOUTH TWICE DAILY AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-06 00:00:00, ended at 2012-12-06 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-12-06, presumably until 2012-12-07, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-07 00:00:00, ended at 2012-12-07 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2012-12-07, presumably until 2013-01-07, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-09 15:29:01, ended at 2012-12-09 16:20:38\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Hepatic encephalopathy\n- Primary diagnosis: Alcoholic cirrhosis\n- Hypervolemia\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2013-03-16. Instructions: take 20 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-14 00:00:00, ended at 2012-12-14 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-07 00:00:00, ended at 2013-01-07 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-01-07, presumably until 2013-03-16, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-26 14:10:00, ended at 2013-01-26 14:54:10\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions\n\n### Condition\n- Primary diagnosis: Inflamed seborrheic keratosis\n- Disorder of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-09 00:00:00, ended at 2013-02-09 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-02-09, presumably until 2013-02-09, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-09 00:00:00, ended at 2013-02-09 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-02-09, presumably until 2013-08-11, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-02-13 19:34:00, ended at 2013-02-13 21:50:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Prothrombin time (PT): 15.2 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n\n### Procedure\n- Renewal of prescription\n\n### Condition\n- Altered mental status\n- Disorder of the urea cycle metabolism\n- Sequela of chronic liver disease\n\n### Drug\n- lactulose 20000 MG Powder for Oral Solution, through Oral route, started on 2013-02-13, presumably until 2013-03-13, with intended 0 refill(s). Instructions: take 30 g by mouth 2 times a day.\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-02-13, presumably until 2013-02-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-03-13 06:37:00, ended at 2013-03-16 20:15:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.4 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Body height: 5' 7.008\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Prothrombin time (PT): N/A (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.04 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 44.1 (second)\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n\n### Condition\n- Ascites\n- Nausea and vomiting\n- Psychostimulant dependence\n- Abdominal pain\n- Alcoholic cirrhosis\n- Drug abuse in remission\n- Chronic kidney disease\n- Hepatic encephalopathy\n- Insomnia\n- Portal hypertension\n- Acute renal failure syndrome\n- Cholelithiasis without obstruction\n- Diverticular disease of colon\n- Alcohol abuse\n- Venous varices\n- Clostridioides difficile infection\n- Primary diagnosis: Epigastric pain\n\n### Drug\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2013-03-16, presumably until 2014-03-16, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-03-16, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-03-13, presumably until 2013-03-16\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-03-13, presumably until 2013-03-13\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-03-16, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2013-03-15, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours.\n- camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion, through Topical route, started on 2013-03-14, presumably until 2013-03-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-03-13, presumably until 2013-03-14\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2013-03-13, presumably until 2013-03-13\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2013-03-13, presumably until 2013-03-15\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-03-13, presumably until 2013-03-13\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-03-13, presumably until 2013-03-16\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2013-03-13, presumably until 2013-03-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-25 13:20:13, ended at 2013-04-25 13:57:31\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Hepatic encephalopathy\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-28 00:00:00, ended at 2013-06-28 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-28, presumably until 2013-07-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth as directed. Take 2 tabs at 12 noon\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, started on 2013-06-28, presumably until 2013-07-18, with intended 0 refill(s). Instructions: As directed in preparation for colonoscopy.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-18 09:56:00, ended at 2013-07-18 13:18:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Colonoscopy\n- Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n\n### Condition\n- Portal hypertension\n- Alcoholic cirrhosis\n- Diverticular disease of colon\n- Essential hypertension\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-07-18, presumably until 2013-07-18\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-04-06. Instructions: take 20 mg by mouth 2 times a day.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-07-18, presumably until 2013-07-18\n- midazolam 1 MG/ML Injectable Solution, started on 2013-07-18, presumably until 2013-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-20 00:00:00, ended at 2013-07-20 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-08 00:00:00, ended at 2013-08-08 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-11 00:00:00, ended at 2013-08-11 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-08-11, presumably until 2014-08-16, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:24:00, ended at 2013-09-05 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Alcoholic cirrhosis\n- Cirrhosis - non-alcoholic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-04 00:00:00, ended at 2013-11-04 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-04, presumably until 2013-11-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-08 00:00:00, ended at 2013-11-08 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2013-11-15, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-10 10:52:13, ended at 2013-11-10 11:53:19\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Alcoholic cirrhosis\n- Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-15 00:00:00, ended at 2013-11-15 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastrointestinal hemorrhage\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-15, presumably until 2014-11-06, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2013-12-04 02:48:00, ended at 2013-12-04 06:01:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.92 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 190 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- Prothrombin time (PT): 16.3 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- Anoscopy; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n\n### Condition\n- Feces contents abnormal\n- Disease of liver\n- Primary diagnosis: Hematochezia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-17 00:00:00, ended at 2013-12-17 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2013-12-17, presumably until 2014-07-26, with intended 11 refill(s). Instructions: TAKE 30 ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-30 00:00:00, ended at 2014-03-30 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-31 00:00:00, ended at 2014-03-31 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-06 00:00:00, ended at 2014-04-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-06 13:29:08, ended at 2014-04-06 15:07:37\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.772\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hepatic encephalopathy\n- Alcoholic cirrhosis\n- Periapical abscess with sinus tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-08 09:10:00, ended at 2014-05-08 23:59:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-11 13:49:23, ended at 2014-05-11 14:40:24\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6.535\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Dental caries\n- Exostosis of jaw\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-29 00:00:00, ended at 2014-05-29 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraoral procedures, including biopsy; not otherwise specified\n\n### Condition\n- Periapical abscess\n- Portal hypertension\n- Alcoholic cirrhosis\n\n### Drug\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2014-05-29, presumably until 2014-05-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-05-29 00:00:00, ended at 2014-05-29 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2014-05-29, presumably until 2014-05-29\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2014-05-29, presumably until 2014-05-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-29 08:28:00, ended at 2014-05-29 16:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Dental alveoplasty\n- Unlisted procedure, dentoalveolar structures\n- Other surgical extraction of tooth\n- Alveoloplasty, each quadrant (specify)\n\n### Condition\n- Alcoholic cirrhosis\n- Portal hypertension\n- Primary diagnosis: Dental caries\n- Low back pain\n- Periapical abscess\n- Gastroesophageal reflux disease\n- Hepatic encephalopathy\n- Chronic kidney disease\n- Exostosis of jaw\n- Alcohol dependence\n- Chronic pain\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2014-05-29, presumably until 2014-05-29\n- hydrocodone bitartrate 7.5 MG / ibuprofen 200 MG Oral Tablet, through Oral route, started on 2014-05-29, presumably until 2014-10-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed.\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2014-05-29, presumably until 2014-06-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2014-05-29, presumably until 2014-05-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-15 11:58:37, ended at 2014-06-15 12:24:32\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Periapical abscess with sinus tract\n\n### Drug\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, started on 2014-06-15, presumably until 2014-10-02, with intended 2 refill(s). Instructions: Paroex (0.12% chlorhexidine mouth rinse WITHOUT alcohol). Swish 15mL 2x per day for 2 weeks. Please call Dr. Rahall 999-999-9999 if you do not have the formulation without alcohol.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-26 00:00:00, ended at 2014-07-26 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2014-07-26, presumably until 2015-09-08, with intended 11 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-16 00:00:00, ended at 2014-08-16 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2014-08-16, presumably until 2015-09-03, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-02 00:00:00, ended at 2014-10-02 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-02 13:21:58, ended at 2014-10-02 14:01:12\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Primary diagnosis: Alcoholic cirrhosis\n- Inguinal hernia\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 14:05:00, ended at 2014-10-02 23:59:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Prothrombin time (PT): 14.8 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 4 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-10-06 00:00:00, ended at 2014-10-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2014-11-06, presumably until 2014-11-06, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2014-11-06, presumably until 2015-08-02, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-27 00:00:00, ended at 2014-11-27 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-11-28 17:05:23, ended at 2014-11-28 18:29:20\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tics of organic origin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-04-02 00:00:00, ended at 2015-04-02 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-02 14:00:42, ended at 2015-04-02 14:38:45\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic encephalopathy\n- Portal hypertension\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-04-19 18:56:00, ended at 2015-04-19 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Primary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2015-06-17 09:45:00, ended at 2015-06-17 12:50:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.76 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Prothrombin time (PT): 16.0 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 40.2 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Alcoholic cirrhosis\n- Cough\n- Dyspnea\n- Low back pain\n- Portal hypertension\n- Chest pain\n- Esophageal varices associated with another disorder\n- Primary diagnosis: Infective pneumonia\n- Alcohol dependence\n- Backache\n- Cirrhosis - non-alcoholic\n- Hepatic encephalopathy\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-06-17, presumably until 2015-06-17\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-06-17, presumably until 2015-06-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, through Intravenous route, started on 2015-06-17, presumably until 2015-06-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-03 10:05:46, ended at 2015-07-03 12:11:44\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Tics of organic origin\n- Disorder of the peripheral nervous system\n- Parkinson's disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-03 12:34:00, ended at 2015-07-03 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.6 (percent)\n- Thiamine [Moles/volume] in Serum or Plasma: 11 (nanomole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.41 (micro-international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of the peripheral nervous system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2015-08-08, presumably until 2015-08-12, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-18 14:25:31, ended at 2015-07-18 16:26:40\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Inguinal hernia\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2015-07-18, presumably until 2015-07-18, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2015-07-18, presumably until 2015-07-18, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-18 15:57:50, ended at 2015-07-18 16:27:35\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Acquired keratoderma\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Discoloration of skin\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-26 08:02:00, ended at 2015-07-26 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; limited (List separately in addition to code for primary procedure)\n- Nerve conduction studies; 5-6 studies\n- Needle electromyography, each extremity, with related paraspinal areas, when performed, done with nerve conduction, amplitude and latency/velocity study; complete, five or more muscles studied, innervated by three or more nerves or four or more spinal lev\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n- Electromyogram abnormal\n- Disorder of the peripheral nervous system\n- Abnormal results function studies peripheral nervous system special senses\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 11:21:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Peripheral neuritis\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-30 00:00:00, ended at 2015-07-30 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-02 00:00:00, ended at 2015-08-02 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2015-08-08, presumably until 2015-08-08, with intended 11 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2015-08-17, presumably until 2016-09-03, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-12 00:00:00, ended at 2015-08-12 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2015-08-17, presumably until 2015-08-22, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-22 13:29:49, ended at 2015-08-22 14:32:30\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Hepatic encephalopathy\n- Essential hypertension\n- Inguinal hernia\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2015-08-22, presumably until 2016-01-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-27 00:00:00, ended at 2015-08-27 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-03 00:00:00, ended at 2015-09-03 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2015-09-05, presumably until 2015-10-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-08 00:00:00, ended at 2015-09-08 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2015-09-12, presumably until 2017-04-30, with intended 11 refill(s). Instructions: TAKE 30 ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-19 13:21:43, ended at 2015-09-19 14:27:03\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- General examination of patient\n\n### Condition\n- Inguinal hernia\n- Postprocedural state finding\n- Low back pain\n- Essential hypertension\n- Alcoholic cirrhosis\n- Hepatic encephalopathy\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2015-09-19, presumably until 2015-09-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2015-09-19, presumably until 2015-09-19, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-27 13:42:14, ended at 2015-09-27 14:14:05\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Inguinal hernia\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-10-04 00:00:00, ended at 2015-10-04 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- methylprednisolone acetate 80 MG/ML Injectable Suspension, started on 2015-10-04, presumably until 2015-10-04\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- iohexol, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- midazolam 1 MG/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-04 11:51:00, ended at 2015-10-04 14:18:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the pre\n- Introduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n- Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach\n\n### Condition\n- Lumbar radiculopathy\n- Primary diagnosis: Spinal stenosis of lumbar region\n- Portal hypertension\n- Hepatic coma due to alcoholic liver failure\n- Alcohol abuse\n- Alcohol-induced mood disorder\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-11 00:00:00, ended at 2015-10-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2015-10-17, presumably until 2015-11-30, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-01 08:51:16, ended at 2015-11-01 10:01:50\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbago with sciatica\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-02 00:00:00, ended at 2015-11-02 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Prothrombin time (PT): 11.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.87 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1853 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 157 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3061 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 547 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.70 (million per liter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-21 12:54:15, ended at 2015-11-21 14:56:13\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-11-30 00:00:00, ended at 2015-11-30 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, started on 2015-11-30, presumably until 2016-12-05, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-05 00:00:00, ended at 2015-12-05 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2158 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3601 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 165 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 169 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 533 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.2 (femtoliter)\n- Prothrombin time (PT): 11.5 (second)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-05 00:00:00, ended at 2015-12-05 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2015-12-05, presumably until 2015-12-05, with intended 12 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-05 13:00:55, ended at 2015-12-05 14:21:26\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Myopia\n- Primary diagnosis: Alcoholic cirrhosis\n- Disorder of skin and/or subcutaneous tissue\n- Inguinal hernia\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2016-11-05, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2015-12-05, presumably until 2016-01-27, with intended 1 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, started on 2015-12-28, presumably until 2016-11-05, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, through Oral route, started on 2015-12-25, presumably until 2015-12-25, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-01-04 00:00:00, ended at 2016-01-04 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 462 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Prothrombin time (PT): 11.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 145 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1773 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils [#/volume] in Blood by Automated count: 18 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2002 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-16 14:35:16, ended at 2016-01-16 15:34:20\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Lumbosacral radiculopathy\n- Finding of frequency of urination\n- Hyperlipidemia\n- Inguinal hernia\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-01-26 13:18:00, ended at 2016-01-26 16:09:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.92 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.88 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 406 (microgram of fibrinogen equivalent unit per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Alcoholic cirrhosis\n- Backache\n- Inguinal hernia\n- Lumbosacral radiculopathy\n- Primary diagnosis: Pain in thoracic spine\n- Tics of organic origin\n- Dyspnea\n- Chest pain on breathing\n- Epigastric pain\n- Disorder of soft tissue\n- Chest pain\n- Essential hypertension\n\n### Drug\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2016-01-26, presumably until 2016-01-26\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2016-01-26, presumably until 2016-01-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-27 00:00:00, ended at 2016-01-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2016-01-30, presumably until 2016-01-30, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2016-01-30, presumably until 2016-01-30, with intended 12 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-28 14:05:36, ended at 2016-01-28 17:05:55\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral radiculopathy\n- Inguinal hernia\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-30 00:00:00, ended at 2016-01-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2016-01-30, presumably until 2017-02-13, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2016-01-30, presumably until 2016-11-05, with intended 12 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in lower abdomen; not otherwise specified\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2016-02-19, presumably until 2016-02-19\n- clindamycin 150 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-02-19, presumably until 2016-02-19\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-02-19, presumably until 2016-02-19\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-02-19, presumably until 2016-02-19\n- ketamine 100 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2016-02-19, presumably until 2016-02-19\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2016-02-19, presumably until 2016-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-19 00:00:00, ended at 2016-02-19 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-19, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 05:35:00, ended at 2016-02-19 14:20:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Repair initial inguinal hernia, age 5 years or older; reducible\n- Supplement Left Inguinal Region with Synthetic Substitute, Open Approach\n\n### Condition\n- Chronic pain\n- Essential hypertension\n- Gastroesophageal reflux disease without esophagitis\n- Alcoholic hepatic failure\n- Alcoholic cirrhosis\n- Low back pain\n- Primary diagnosis: Inguinal hernia\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2016-02-19, presumably until 2017-02-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-19, presumably until 2016-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-22 00:00:00, ended at 2016-02-22 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inguinal hernia\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-02-25, presumably until 2016-07-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-25 13:00:25, ended at 2016-02-25 14:27:49\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- Determination of refractive state\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; optic nerve\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-02-27 00:00:00, ended at 2016-02-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2016-02-27, presumably until 2016-02-27\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-02-27, presumably until 2016-02-27\n- iohexol, through Intravenous route, started on 2016-02-27, presumably until 2016-02-27\n- 10 ML clonidine hydrochloride 0.1 MG/ML Injection, through Epidural route, started on 2016-02-27, presumably until 2016-02-27\n- triamcinolone acetonide 40 MG/ML Injectable Suspension, started on 2016-02-27, presumably until 2016-02-27\n- midazolam 1 MG/ML Injectable Solution, started on 2016-02-27, presumably until 2016-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-27 07:23:00, ended at 2016-02-27 13:25:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- Introduction of Anti-inflammatory into Epidural Space, Percutaneous Approach\n- Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the pre\n- Introduction of Anesthetic Agent into Epidural Space, Percutaneous Approach\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Essential hypertension\n- Tear film insufficiency\n- Hepatic failure\n- Tics of organic origin\n- Alcoholic cirrhosis\n- Inguinal hernia\n- Portal hypertension\n- Lumbar radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-05 14:22:25, ended at 2016-03-05 15:01:54\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Postoperative state\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-27 14:10:23, ended at 2016-03-27 14:33:20\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-15 00:00:00, ended at 2016-04-15 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 166 (cells per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 614 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 91.5 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3405 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.68 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2182 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.6 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Prothrombin time (PT): 11.5 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.88 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-18 00:00:00, ended at 2016-04-18 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 28 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2457 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.6 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.9 (femtoliter)\n- Prothrombin time (PT): 11.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.41 (million per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3593 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Monocytes [#/volume] in Blood by Automated count: 760 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 263 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 193 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-21 00:00:00, ended at 2016-04-21 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-25 00:00:00, ended at 2016-04-25 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-28 00:00:00, ended at 2016-04-28 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-02 00:00:00, ended at 2016-05-02 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-09 00:00:00, ended at 2016-05-09 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-16 00:00:00, ended at 2016-05-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-23 00:00:00, ended at 2016-05-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 208 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.1 (femtoliter)\n- Prothrombin time (PT): 11.4 (second)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1827 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3560 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 674 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-30 00:00:00, ended at 2016-05-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 238 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.98 (million per liter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.9 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- MCV [Entitic volume] by Automated count: 88.0 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2019 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 622 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3172 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Prothrombin time (PT): 11.5 (second)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-30 00:00:00, ended at 2016-05-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-06 00:00:00, ended at 2016-06-06 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 632 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3422 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1804 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.29 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 50 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 16.2 (gram per deciliter)\n- Prothrombin time (PT): 11.0 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 291 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-13 00:00:00, ended at 2016-06-13 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.8 (femtoliter)\n- Prothrombin time (PT): 11.2 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3434 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 50 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2060 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 158 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.7 (percent)\n- MCV [Entitic volume] by Automated count: 87.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 599 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-20 00:00:00, ended at 2016-06-20 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 205 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.0 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3019 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.9 (percent)\n- Prothrombin time (PT): 11.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 405 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 179 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1733 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-27 00:00:00, ended at 2016-06-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-27 00:00:00, ended at 2016-06-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2373 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 657 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 248 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Prothrombin time (PT): 11.2 (second)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per liter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3993 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.0 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.5 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 29 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 221 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-27 00:00:00, ended at 2016-06-27 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1829 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 161 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 707 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.9 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3466 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 37 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-11 00:00:00, ended at 2016-07-11 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-22 13:03:00, ended at 2016-07-22 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Alcoholic cirrhosis\n- Ascites due to alcoholic cirrhosis\n- Cholelithiasis without obstruction\n- Cirrhosis of liver\n- Gallstone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-22 00:00:00, ended at 2016-08-22 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-03 00:00:00, ended at 2016-09-03 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2016-09-30, presumably until 2017-01-20, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-05 00:00:00, ended at 2016-09-05 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 243 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 608 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Prothrombin time (PT): 11.2 (second)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3571 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1946 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.13 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-09-09 00:00:00, ended at 2016-09-09 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-09-09, presumably until 2016-09-09\n- iohexol, through Intravenous route, started on 2016-09-09, presumably until 2016-09-09\n- methylprednisolone acetate 40 MG/ML Injectable Suspension, started on 2016-09-09, presumably until 2016-09-09\n- midazolam 1 MG/ML Injectable Solution, started on 2016-09-09, presumably until 2016-09-09\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2016-09-09, presumably until 2016-09-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-09 11:09:00, ended at 2016-09-09 15:52:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach\n- Injection(s), of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, includes contrast for localization when performed,\n- Introduction of Regional Anesthetic into Spinal Canal, Percutaneous Approach (Deprecated)\n\n### Condition\n- Low back pain\n- Lumbar radiculopathy\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-09-09, presumably until 2016-09-09\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-09-09, presumably until 2016-09-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-09-28 19:55:00, ended at 2016-09-28 21:11:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neck pain\n- Motor vehicle accident, driver\n- Wrist joint pain\n- Backache\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-09-28, presumably until 2016-09-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-30 00:00:00, ended at 2016-09-30 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2016-09-30, presumably until 2017-01-20, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-02 12:55:57, ended at 2016-10-02 13:15:27\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-03 00:00:00, ended at 2016-10-03 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-16 08:46:41, ended at 2016-10-16 11:14:31\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neck pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule, started on 2016-11-07, presumably until 2019-09-15, with intended 1 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY MORNING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-05 13:22:09, ended at 2016-11-05 14:27:49\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Alcoholic cirrhosis\n- Essential hypertension\n- Finding of frequency of urination\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule, through Oral route, started on 2016-11-05, presumably until 2016-11-07, with intended 1 refill(s). Instructions: take 1 Murray by mouth every morning\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2016-11-05, presumably until 2017-11-05, with intended 3 refill(s). Instructions: take 2 Caps by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-07 00:00:00, ended at 2016-11-07 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, started on 2016-11-12, presumably until 2016-11-12, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-12 12:52:00, ended at 2016-11-12 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, cervical; without contrast material\n\n### Condition\n- Neck pain\n- Spinal stenosis in cervical region\n- Cervical spondylosis without myelopathy\n- Displacement of cervical intervertebral disc\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-14 00:00:00, ended at 2016-11-14 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.5 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-11-28 00:00:00, ended at 2016-11-28 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- doxazosin 4 MG Oral Tablet, started on 2016-11-28, presumably until 2016-11-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-03 13:27:13, ended at 2016-12-03 14:21:15\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Alcoholic cirrhosis\n- Finding of frequency of urination\n- Familial hyperchylomicronemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2016-12-05, presumably until 2017-11-30, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-26 00:00:00, ended at 2016-12-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-07 14:15:43, ended at 2017-01-07 16:11:58\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nummular eczema\n\n### Drug\n- mometasone furoate 0.001 MG/MG Topical Ointment, started on 2017-01-07, presumably until 2019-09-15, with intended 0 refill(s). Instructions: Apply to affected area twice per day for 3 weeks.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-12 00:00:00, ended at 2017-01-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2017-01-12, presumably until 2017-01-12, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-20 00:00:00, ended at 2017-01-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2017-01-20, presumably until 2018-03-21, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-06 00:00:00, ended at 2017-02-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.4 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-12 00:00:00, ended at 2017-02-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-02-13, presumably until 2017-03-23, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-04 13:25:58, ended at 2017-03-04 14:21:33\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Melanocytic nevus\n- Primary diagnosis: Alcoholic cirrhosis\n- Essential hypertension\n\n### Drug\n- triamterene 50 MG Oral Capsule, through Oral route, started on 2017-03-04, presumably until 2018-03-04, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- triamcinolone acetonide 1 MG/ML Topical Lotion, through Topical route, started on 2017-03-04, presumably until 2018-03-04, with intended 0 refill(s). Instructions: by Topical route 3 times a day use thin layer\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-11 00:00:00, ended at 2017-03-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nummular eczema\n\n### Drug\n- mometasone furoate 0.001 MG/MG Topical Ointment, started on 2017-03-11, presumably until 2017-03-11, with intended 0 refill(s). Instructions: Apply to affected area twice per day for 3 weeks.\n- triamcinolone acetonide 1 MG/ML Topical Lotion, through Topical route, started on 2017-03-11, presumably until 2018-03-11, with intended 0 refill(s). Instructions: by Topical route 3 times a day use thin layer\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-11 00:00:00, ended at 2017-03-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, started on 2017-03-11, presumably until 2017-03-11, with intended 0 refill(s). Instructions: TAKE 30ML BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-12 15:18:57, ended at 2017-03-12 16:07:26\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Senile hyperkeratosis\n- Hypertrophic condition of skin\n- Neoplasm of uncertain behavior of soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-20 00:00:00, ended at 2017-03-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-21 00:00:00, ended at 2017-03-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-03-23, presumably until 2018-04-05, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-06 00:00:00, ended at 2017-04-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2017-04-06, presumably until 2018-04-13, with intended 12 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-10 00:00:00, ended at 2017-04-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-30 00:00:00, ended at 2017-04-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.81 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3046 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 227 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 589 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.4 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 227 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1501 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.8 (percent)\n- Prothrombin time (PT): 11.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 14:34:15, ended at 2017-04-30 15:07:26\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n- Portal hypertension\n- Primary diagnosis: Pain in right foot\n- Alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2017-04-30, presumably until 2017-05-04, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-05-04 00:00:00, ended at 2017-05-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2017-05-04, presumably until 2019-01-12, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-08 00:00:00, ended at 2017-05-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-08 08:39:00, ended at 2017-05-08 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Portal hypertension\n- Cirrhosis of liver\n- Hepatic failure\n- Alcoholic cirrhosis\n- Lumbar radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-05 00:00:00, ended at 2017-06-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2.8 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.8 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Prothrombin time (PT): 11.8 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2041 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 477 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2602 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.75 (million per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 148 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-17 13:20:52, ended at 2017-06-17 13:50:02\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-19 00:00:00, ended at 2017-06-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-03 00:00:00, ended at 2017-07-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1840 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 221 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3566 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.3 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 11.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 636 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-24 00:00:00, ended at 2017-07-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-31 00:00:00, ended at 2017-07-31 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-17 09:00:00, ended at 2017-08-17 09:04:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Mononeuropathy of lower limb\n- Arthralgia of the ankle and/or foot\n- Acquired hallux valgus\n- Pain in left foot\n- Pain in right foot\n- Metatarsus primus varus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-17 09:05:00, ended at 2017-08-17 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Metatarsus primus varus\n- Acquired hallux valgus\n- Arthralgia of the ankle and/or foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-17 09:13:19, ended at 2017-08-17 10:26:49\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuropathy of lower limb\n- Pain in right foot\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-18 00:00:00, ended at 2017-08-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain in right foot\n- Pain in left foot\n- Primary diagnosis: Polyneuropathy\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-08-18, presumably until 2018-08-18, with intended 2 refill(s). Instructions: take 1 Cap by mouth every day 1 tab at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-21 10:15:44, ended at 2017-08-21 11:14:31\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Lichen simplex chronicus\n- Asteatosis cutis\n- Post-inflammatory hyperpigmentation\n- Primary diagnosis: Nummular eczema\n\n### Drug\n- clobetasol propionate 0.0005 MG/MG Topical Ointment, through Topical route, started on 2017-08-21, presumably until 2018-08-21, with intended 0 refill(s). Instructions: by Topical route 2 times a day To itchy raised bump on shin until it is flat OR no longer itchy\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-26 00:00:00, ended at 2017-08-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.9 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 52 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1934 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2371 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Prothrombin time (PT): 11.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 218 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 624 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.18 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nummular eczema\n\n### Drug\n- fluocinonide 0.0005 MG/MG Topical Ointment, started on 2017-08-28, presumably until 2020-03-21, with intended 3 refill(s). Instructions: Apply 2 times a day to itchy raised bump on shin until it is flat OR no longer itchy\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Eosinophils [#/volume] in Blood by Automated count: 162 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1836 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.01 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Prothrombin time (PT): 11.7 (second)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2840 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 230 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 513 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.4 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Prothrombin time (PT): 11.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 605 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2020 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.23 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 243 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2484 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-07 00:00:00, ended at 2017-10-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-19 00:00:00, ended at 2017-10-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 632 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.9 (percent)\n- Prothrombin time (PT): 11.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2533 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.07 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.0 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 162 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2025 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-11-30 00:00:00, ended at 2017-11-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2017-12-10, presumably until 2019-01-20, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-25 00:00:00, ended at 2017-12-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 578 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.13 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.04 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Prothrombin time (PT): 11.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1882 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 85.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2210 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.9 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 191 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-31 14:22:55, ended at 2017-12-31 14:56:57\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-02 00:00:00, ended at 2018-02-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-02-11 12:20:00, ended at 2018-02-11 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2018-02-27 20:39:00, ended at 2018-02-27 23:16:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.97 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.3 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.39 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.90 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Leukocytosis\n- Primary diagnosis: Lobar pneumonia\n- Alcoholic cirrhosis\n- Abnormal findings on diagnostic imaging of lung\n- Essential hypertension\n- Fever\n- Cough\n- Hypokalemia\n\n### Drug\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-02-27, presumably until 2018-02-27\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2018-02-27, presumably until 2018-03-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 7 days\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-02-27, presumably until 2018-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-05 00:00:00, ended at 2018-03-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2625 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 1535 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 600 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.2 (femtoliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 4.2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Prothrombin time (PT): 11.0 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.14 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-09 00:00:00, ended at 2018-03-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Gastric varices\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2018-03-21, presumably until 2018-07-28, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-04 00:00:00, ended at 2018-04-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2018-04-05, presumably until 2019-04-19, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-13 00:00:00, ended at 2018-04-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2018-04-14, presumably until 2019-01-18, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-14 00:00:00, ended at 2018-05-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Prothrombin time (PT): 11.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.98 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2580 (cells per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 288 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2220 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.0 (percent)\n- MCV [Entitic volume] by Automated count: 86.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 870 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 42 (cells per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-11 00:00:00, ended at 2018-07-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-23 00:00:00, ended at 2018-07-23 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2035 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per liter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.3 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Prothrombin time (PT): 11.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 158 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 674 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3396 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-28 00:00:00, ended at 2018-07-28 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Gastric varices\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2018-07-28, presumably until 2019-08-01, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-11 10:14:00, ended at 2018-08-11 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Portal hypertension\n- Cirrhosis of liver\n- Ascites due to alcoholic cirrhosis\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.3 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 275 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2007 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3123 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 43 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 653 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-22 00:00:00, ended at 2018-09-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Prothrombin time (PT): 11.1 (second)\n- Monocytes [#/volume] in Blood by Automated count: 763 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 31 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2922 (cells per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 232 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2153 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-29 00:00:00, ended at 2018-10-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:43:33, ended at 2018-11-24 11:21:23\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30, or quantitative, automated threshold perim\n\n### Condition\n- Primary diagnosis: Glaucoma suspect\n- Pinguecula\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-24 09:43:47, ended at 2018-11-24 11:21:31\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 11 (millimeter mercury column)\n- Intraocular pressure of right eye: 10 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pinguecula\n- Primary diagnosis: Glaucoma suspect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-10 00:00:00, ended at 2018-12-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3036 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 85.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 217 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 280 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2490 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 38.3 (percent)\n- MCHC [Mass/volume] by Automated count: 36.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 657 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Prothrombin time (PT): 11.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Hepatic failure\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-24 00:00:00, ended at 2018-12-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-07 00:00:00, ended at 2019-01-07 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2019-01-12, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-13 00:00:00, ended at 2019-01-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2019-01-19, presumably until 2019-04-19, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-20 00:00:00, ended at 2019-01-20 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-21 00:00:00, ended at 2019-01-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2117 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.7 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 524 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 227 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2500 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-27 15:50:51, ended at 2019-01-27 16:46:43\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-04 17:35:00, ended at 2019-02-04 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2019-02-17, presumably until 2020-03-15, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2019-02-17, presumably until 2020-03-15, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-17 00:00:00, ended at 2019-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2019-02-17, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2019-02-17, presumably until 2019-02-17, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-17 08:57:20, ended at 2019-02-17 09:10:23\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-18 00:00:00, ended at 2019-02-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 20:47:00, ended at 2019-02-24 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Lumbosacral radiculopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 14:11:23, ended at 2019-03-03 15:14:40\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions\n\n### Condition\n- Primary diagnosis: Inflamed seborrheic keratosis\n- Melanocytic nevus of trunk\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-04 00:00:00, ended at 2019-03-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 726 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2720 (cells per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.93 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 201 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- MCV [Entitic volume] by Automated count: 87.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.5 (percent)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2213 (cells per microliter)\n- Prothrombin time (PT): 11.1 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-18 00:00:00, ended at 2019-03-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-01 00:00:00, ended at 2019-04-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Hepatic failure\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-14 00:00:00, ended at 2019-04-14 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbosacral radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2.9 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Prothrombin time (PT): 11.2 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 53 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 785 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 200 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 363 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3293 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2105 (cells per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.85 (million per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-17 00:00:00, ended at 2019-04-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-04-22, presumably until 2019-04-22, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n- hydrochlorothiazide 12.5 MG Oral Capsule, started on 2019-04-22, presumably until 2019-04-22, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-18 00:00:00, ended at 2019-04-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2019-04-18, presumably until 2019-05-15, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-19 00:00:00, ended at 2019-04-19 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-04-22, presumably until 2019-10-04, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2019-04-22, presumably until 2019-10-04, with intended 0 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-23 00:00:00, ended at 2019-04-23 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-04-27, presumably until 2019-04-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-28 13:11:30, ended at 2019-04-28 14:53:17\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30, or quantitative, automated threshold perim\n\n### Condition\n- Glaucoma suspect\n- Primary diagnosis: Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-28 13:11:30, ended at 2019-04-28 14:53:17\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Glaucoma suspect\n- Primary diagnosis: Visual field defect\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-02 13:01:00, ended at 2019-05-02 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-10 00:00:00, ended at 2019-05-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1495 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Prothrombin time (PT): 11.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 48 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.86 (million per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2915 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 281 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 562 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-15 00:00:00, ended at 2019-05-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2019-05-16, presumably until 2019-09-15, with intended 5 refill(s). Instructions: TAKE 1 CAPSULE(100 MG) BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.38 (million per liter)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.15 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 30 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 159 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.9 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1646 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 614 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 16.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.4 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.7 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3452 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.5 (percent)\n- Prothrombin time (PT): 11.4 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-06-01 21:10:00, ended at 2019-06-02 00:01:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.22 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 48.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Body height: 5' 7\" (inch (US))\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Tachycardia\n- Alcoholic cirrhosis\n- Chronic pain\n- Essential hypertension\n- Dyspnea\n- Gastric varices\n- Esophageal varices without bleeding\n- Inguinal hernia\n- Portal hypertension\n- Alcohol dependence\n- Chest pain\n- Cough\n- Abnormal findings on diagnostic imaging of lung\n- Hepatic failure\n- Low back pain\n- Primary diagnosis: Pneumonia\n\n### Drug\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2019-06-01, presumably until 2019-06-05, with intended 0 refill(s). Instructions: take 1 Tab (750 mg total) by mouth daily for 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54.8 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Eosinophils [#/volume] in Blood by Automated count: 222 (cells per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.15 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 42 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1938 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.89 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3288 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Prothrombin time (PT): 11.1 (second)\n- Monocytes [#/volume] in Blood by Automated count: 510 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Esophageal varices without bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-24 00:00:00, ended at 2019-06-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n- Esophageal varices without bleeding\n- Hepatic failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-18 09:00:00, ended at 2019-07-18 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-28 00:00:00, ended at 2019-07-28 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Portal hypertension\n- Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Gastric varices\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, started on 2021-12-23, presumably until 2021-12-23, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-01 00:00:00, ended at 2019-08-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Gastric varices\n- Portal hypertension\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-08-01, presumably until 2020-03-15, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-22 00:00:00, ended at 2019-08-22 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Esophageal varices without bleeding\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-09-15 00:00:00, ended at 2019-09-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-15 13:44:00, ended at 2019-09-15 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-21 00:00:00, ended at 2019-09-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-30 00:00:00, ended at 2019-09-30 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1528 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 578 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Prothrombin time (PT): 11.0 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 3.6 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 38 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3056 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.05 (million per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-03 00:00:00, ended at 2019-10-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disease of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-10-12, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2019-10-12, presumably until 2019-11-02, with intended 12 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-06 00:00:00, ended at 2019-10-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2019-11-04, presumably until 2019-11-04, with intended 0 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG Oral Capsule, through Oral route, started on 2019-11-04, presumably until 2019-11-04, with intended 0 refill(s). Instructions: take 12.5 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-28 00:00:00, ended at 2019-10-28 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-02 00:00:00, ended at 2019-11-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2019-11-03, presumably until 2019-11-03, with intended 1 refill(s). Instructions: TAKE 1 TABLET(5 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-02 13:32:04, ended at 2019-11-02 15:01:08\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Nocturia\n- Benign prostatic hyperplasia with outflow obstruction\n- Lumbosacral radiculopathy\n\n### Drug\n- finasteride 5 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2020-03-15, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2019-11-02, presumably until 2019-12-09, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2019-11-02, presumably until 2020-03-15, with intended 2 refill(s). Instructions: take 3 Caps (300 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-03 00:00:00, ended at 2019-11-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign prostatic hyperplasia with outflow obstruction\n- Primary diagnosis: Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2019-11-08, presumably until 2020-02-13, with intended 2 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, started on 2019-11-15, presumably until 2019-11-15, with intended 12 refill(s). Instructions: TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-11 00:00:00, ended at 2019-11-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-25 00:00:00, ended at 2019-11-25 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-09 00:00:00, ended at 2019-12-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-09 14:22:33, ended at 2019-12-09 15:48:03\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Asymptomatic microscopic hematuria\n- Hyperlipidemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2019-12-09, presumably until 2020-03-15, with intended 2 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-12 00:00:00, ended at 2019-12-12 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Asymptomatic microscopic hematuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-15 11:11:00, ended at 2019-12-15 11:34:01\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nocturia\n- Benign prostatic hyperplasia with outflow obstruction\n- Microscopic hematuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-23 00:00:00, ended at 2019-12-23 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-27 14:09:00, ended at 2019-12-27 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Asymptomatic microscopic hematuria\n- Microscopic hematuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-05 12:11:00, ended at 2020-01-05 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-06 00:00:00, ended at 2020-01-06 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Hemoglobin [Mass/volume] in Blood: 15.4 (gram per deciliter)\n- Prothrombin time (PT): 11.4 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 189 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1716 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.88 (million per liter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.0 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.95 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 580 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 32 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2084 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-11 00:00:00, ended at 2020-01-11 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-20 00:00:00, ended at 2020-01-20 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-03 00:00:00, ended at 2020-02-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 498 (cells per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Basophils [#/volume] in Blood by Automated count: 28 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 268 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2040 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.90 (million per liter)\n- Prothrombin time (PT): 11.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 43.4 (percent)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1866 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.7 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-08 10:12:46, ended at 2020-02-08 12:39:23\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy (separate procedure)\n\n### Condition\n- Primary diagnosis: Microscopic hematuria\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2020-02-08, presumably until 2020-02-08\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2020-02-08, presumably until 2020-02-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, started on 2020-02-13, presumably until 2020-02-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-13 00:00:00, ended at 2020-02-13 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Nocturia\n\n### Drug\n- doxazosin 2 MG Oral Tablet, started on 2020-02-13, presumably until 2020-03-15, with intended 2 refill(s). Instructions: TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-17 00:00:00, ended at 2020-02-17 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-24 00:00:00, ended at 2020-02-24 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Psychoactive substance use disorder\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-27 00:00:00, ended at 2020-02-27 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Psychoactive substance use disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- lisinopril 5 MG Oral Tablet, started on 2020-02-29, presumably until 2020-02-29, with intended 1 refill(s). Instructions: TAKE 1 TABLET(5 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.23 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1840 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 425 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 195 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Prothrombin time (PT): 11.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2505 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 190 (cells per microliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.1 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hepatic failure\n- Portal hypertension\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Gastric varices\n- Hepatic failure\n- Benign prostatic hyperplasia with outflow obstruction\n- Lumbosacral radiculopathy\n- Hyperlipidemia\n- Nocturia\n- Portal hypertension\n\n### Drug\n- finasteride 5 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-21, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-15, with intended 4 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 4 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 11 refill(s). Instructions: take 30 mL by mouth every day\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2020-03-15, presumably until 2020-04-02, with intended 11 refill(s). Instructions: take 3 Caps (300 mg total) by mouth 3 times a day\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-05-10, with intended 4 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nocturia\n- Benign prostatic hyperplasia with outflow obstruction\n\n### Drug\n- doxazosin 2 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily TAKE 1 TABLET(2 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hyperlipidemia\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-15, with intended 4 refill(s). Instructions: take 1 Tab (10 mg total) by mouth every bedtime\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-15, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2020-03-15, with intended 12 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-15 00:00:00, ended at 2020-03-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Hepatic failure\n- Portal hypertension\n\n### Drug\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2020-03-15, presumably until 2021-03-26, with intended 11 refill(s). Instructions: take 550 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-15 09:04:00, ended at 2020-03-15 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n- Alcoholic cirrhosis\n- Ascites due to alcoholic cirrhosis\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-22 14:04:48, ended at 2020-03-22 14:29:01\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-28 00:00:00, ended at 2020-03-28 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-30 00:00:00, ended at 2020-03-30 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1711 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 597 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.06 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 162 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3300 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 29 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.5 (percent)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Prothrombin time (PT): 11.4 (second)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-02 10:35:52, ended at 2020-04-02 11:08:43\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Benign prostatic hyperplasia\n- Liver cell carcinoma\n- Ascites due to alcoholic cirrhosis\n- Esophageal varices without bleeding\n- Inguinal hernia\n- Gastric varices\n- Hepatic failure\n- Hyperlipidemia\n- Lumbosacral radiculopathy\n- Portal hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endoscopic retrograde cholangiopancreatography (ERCP); with sphincterotomy/papillotomy\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal of calculi/debris from biliary/pancreatic duct(s)\n- Endoscopic retrograde cholangiopancreatography (ERCP); with biopsy, single or multiple\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; endoscopic retrograde cholangiopancreatography (ERCP)\n\n### Condition\n- Hyperlipidemia\n- Calculus of bile duct without obstruction\n- Essential hypertension\n\n### Drug\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-04-03, presumably until 2020-04-03\n- midazolam 1 MG/ML Injectable Solution, started on 2020-04-03, presumably until 2020-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Obstruction of bile duct\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-03 07:32:00, ended at 2020-04-03 10:37:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Endoscopic catheterization of the biliary ductal system, radiological supervision and interpretation\n- Endoscopic retrograde cholangiopancreatography (ERCP); with biopsy, single or multiple\n- Endoscopic retrograde cholangiopancreatography (ERCP); with removal of calculi/debris from biliary/pancreatic duct(s)\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Essential hypertension\n- Hepatic failure\n- Liver cell carcinoma\n- Disorder of biliary tract\n- Hyperlipidemia\n- Primary diagnosis: Obstruction of bile duct\n- Obesity\n- Calculus of bile duct without obstruction\n- Alcoholic cirrhosis\n\n### Drug\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-04-03, presumably until 2020-04-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-08 00:00:00, ended at 2020-04-08 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophageal varices without bleeding\n- Gastric varices\n- Ascites due to alcoholic cirrhosis\n- Portal hypertension\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2020-04-08, presumably until 2020-04-08, with intended 4 refill(s). Instructions: take 40 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-09 00:00:00, ended at 2020-05-09 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Primary diagnosis: Esophageal varices without bleeding\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n- Primary diagnosis: Gastric varices\n- Nocturia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-06-08 14:05:08, ended at 2020-06-08 14:14:48\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tremor\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-21 00:00:00, ended at 2020-06-21 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-13 08:51:00, ended at 2020-07-13 12:07:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-19 07:40:00, ended at 2020-07-19 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-07-19 07:40:00, ended at 2020-07-19 23:59:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-24 00:00:00, ended at 2020-07-24 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites due to alcoholic cirrhosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 00:00:00, ended at 2020-08-15 00:00:00\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ascites due to alcoholic cirrhosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-04 14:28:37, ended at 2020-10-04 14:57:19\nThe patient in this visit was 58 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver function tests abnormal\n- Portal hypertension\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "ad0d7aab2dab01189cf84428d0ab04e16ea67be12360f72aa527860914ddddde", "prompt_hash": "6f26dadd7af71f549915f73a63478ced417eff5a6f143778d033eb1c4e949a8f", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115970542, "visit_occurrence_id": 114142409, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2018-01-06 00:00:00", "visit_end_datetime": "2018-01-06 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2018-01-07, presumably until 2019-01-03, with intended 3 refill(s). Instructions: 2 caps twice a day\n\n", "approximate_token_count": 117, "patient_first_visit_date": "2014-11-20 00:00:00", "patient_last_visit_date": "2022-10-23 15:51:46", "end_obs_date": "2019-01-06", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 27, "cumulated_visit_num": 27, "cumulated_approximate_token_count": 5915, "visit_cumulated": "## Visit\nThis visit record, was from Telehealth, started at 2014-11-20 00:00:00, ended at 2014-11-20 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-11-20, presumably until 2015-11-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take for 5 days if travelers diarrhea\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, through Oral route, started on 2014-11-20, presumably until 2015-11-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. Start 1-2 days before exposure and finish 7 days after end of exposure to malaria  Note to pharm: was given inadequate # pills with previous rx written on 10/23/2014 by Dr Celia Peter\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-05 00:00:00, ended at 2014-12-05 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, through Oral route, started on 2014-10-12, presumably until 2014-12-31, with intended 3 refill(s). Instructions: take 200 mg by mouth 2 times a day.\n- budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray, started on 2014-10-12, presumably until 2015-04-30, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2014-12-31, presumably until 2016-01-17, with intended 4 refill(s). Instructions: 2 caps twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-03 13:33:13, ended at 2015-01-03 14:19:02\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2015-01-03, presumably until 2016-03-31, with intended 0 refill(s). Instructions: take 5-10 mL by mouth every 6 hours as needed for Cough. Please use only at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-30 00:00:00, ended at 2015-01-30 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olopatadine 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-01-30, presumably until 2015-02-08, with intended 3 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-02-06 00:00:00, ended at 2015-02-06 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olopatadine 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-02-08, presumably until 2016-03-31, with intended 12 refill(s). Instructions: instill 1 Drop to both eyes daily as needed. For eye allergies\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 120 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- carBAMazepine [Mass/volume] in Serum or Plasma: 7.7 (milligram per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 207 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Epilepsy\n- Impaired glucose tolerance test\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-29 10:05:46, ended at 2015-03-29 12:25:47\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.5\" (inch (US))\n\n### Procedure\n- General examination of patient\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Epilepsy\n- Impaired glucose tolerance test\n- Obesity\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-30 00:00:00, ended at 2015-04-30 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2015-04-30, presumably until 2016-04-08, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n- budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray, started on 2015-04-30, presumably until 2016-04-08, with intended 4 refill(s). Instructions: Use 2 sprays in each nostril every am as needed for allergy symptoms\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-02 15:36:19, ended at 2016-01-02 16:43:15\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 111 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 199 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.59 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 52 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- carBAMazepine [Mass/volume] in Serum or Plasma: 7.6 (microgram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n- Hyperlipidemia\n- Epilepsy\n- Impaired glucose tolerance\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (severe pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-17 00:00:00, ended at 2016-01-17 00:00:00\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2016-01-17, presumably until 2016-12-14, with intended 3 refill(s). Instructions: 2 caps twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-31 07:14:39, ended at 2016-03-31 08:04:09\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Epilepsy\n- Impaired glucose tolerance\n- Allergic rhinitis due to pollen\n- Hyperlipidemia\n- Skin finding\n\n### Drug\n- olopatadine 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-03-31, presumably until 2017-04-01, with intended 12 refill(s). Instructions: instill 1 Drop to both eyes daily as needed For eye allergies\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-08 00:00:00, ended at 2016-04-08 00:00:00\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2016-04-10, presumably until 2016-12-14, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n- budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-04-10, presumably until 2016-04-10, with intended 4 refill(s). Instructions: Use 2 sprays in each nostril every am as needed for allergy symptoms\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-19 11:30:43, ended at 2016-10-19 14:50:15\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n- Hip pain\n- Primary diagnosis: Dizziness and giddiness\n- Metatarsalgia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2016-12-14, presumably until 2017-01-06, with intended 3 refill(s). Instructions: 2 caps twice a day\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2016-12-14, presumably until 2017-01-06, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-06 00:00:00, ended at 2017-01-06 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2017-01-06, presumably until 2018-01-07, with intended 3 refill(s). Instructions: 2 caps twice a day\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2017-01-06, presumably until 2018-03-22, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-22 00:00:00, ended at 2017-01-22 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 14 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.6 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 191 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- carBAMazepine [Mass/volume] in Serum or Plasma: 7.7 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 100 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 218 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCV [Entitic volume] by Automated count: 68 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heterozygous thalassemia\n- Epilepsy\n- Impaired glucose tolerance\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-01 16:02:50, ended at 2017-04-01 17:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n- Cough\n- Allergic rhinitis due to pollen\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2017-04-01, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 5-10 mL by mouth every 6 hours as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-01, presumably until 2017-05-20, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2017-04-01, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- olopatadine 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2017-04-01, presumably until 2019-03-18, with intended 12 refill(s). Instructions: instill 1 Drop to both eyes daily as needed For eye allergies\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-21 10:51:33, ended at 2017-05-21 13:35:39\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Chondromalacia of patella\n- Hyperlipidemia\n- Impaired glucose tolerance\n- Allergic rhinitis due to pollen\n- Epilepsy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-04 09:50:21, ended at 2017-08-04 10:42:13\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Eustachian tube disorder\n\n### Drug\n- pseudoephedrine hydrochloride 30 MG Oral Tablet, through Oral route, started on 2017-08-04, presumably until 2018-08-02, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-08-04, presumably until 2018-08-04, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day Use in each nostril as directed\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2017-08-04, presumably until 2018-08-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-18 00:00:00, ended at 2017-08-18 00:00:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Eustachian tube disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-13 14:19:24, ended at 2017-09-13 15:16:11\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Posterior rhinorrhea\n- Xerostomia\n- Deviated nasal septum\n- Primary diagnosis: Eustachian tube disorder\n- Chronic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-27 09:39:00, ended at 2017-09-27 23:59:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material\n\n### Condition\n- Disorder of both middle ear and mastoid\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-14 10:19:17, ended at 2017-10-14 11:16:18\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n- Posterior rhinorrhea\n- Deviated nasal septum\n- Eustachian tube disorder\n- Xerostomia\n- Primary diagnosis: Chronic mastoiditis\n\n### Drug\n- methylprednisolone 4 MG Oral Tablet, started on 2017-11-02, presumably until 2018-01-20, with intended 0 refill(s). Instructions: Use As Directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-17 13:27:19, ended at 2017-12-17 13:44:10\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Posterior rhinorrhea\n- Primary diagnosis: Chronic mastoiditis\n- Deviated nasal septum\n- Eustachian tube disorder\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-12-17, presumably until 2017-12-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 20 MG Oral Tablet, started on 2017-12-17, presumably until 2018-08-02, with intended 0 refill(s). Instructions: 3 tablets QAM PO x 3 days, then 2 tablets QAM PO x 3 days, then 1 tablet QAM PO x 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2018-01-07, presumably until 2019-01-03, with intended 3 refill(s). Instructions: 2 caps twice a day\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-20 00:00:00, ended at 2014-11-20 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-11-20, presumably until 2015-11-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take for 5 days if travelers diarrhea\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, through Oral route, started on 2014-11-20, presumably until 2015-11-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. Start 1-2 days before exposure and finish 7 days after end of exposure to malaria  Note to pharm: was given inadequate # pills with previous rx written on 10/23/2014 by Dr Celia Peter\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-05 00:00:00, ended at 2014-12-05 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, through Oral route, started on 2014-10-12, presumably until 2014-12-31, with intended 3 refill(s). Instructions: take 200 mg by mouth 2 times a day.\n- budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray, started on 2014-10-12, presumably until 2015-04-30, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-31 00:00:00, ended at 2014-12-31 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2014-12-31, presumably until 2016-01-17, with intended 4 refill(s). Instructions: 2 caps twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-01-03 13:33:13, ended at 2015-01-03 14:19:02\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2015-01-03, presumably until 2016-03-31, with intended 0 refill(s). Instructions: take 5-10 mL by mouth every 6 hours as needed for Cough. Please use only at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-30 00:00:00, ended at 2015-01-30 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olopatadine 1 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-01-30, presumably until 2015-02-08, with intended 3 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-02-06 00:00:00, ended at 2015-02-06 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- olopatadine 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-02-08, presumably until 2016-03-31, with intended 12 refill(s). Instructions: instill 1 Drop to both eyes daily as needed. For eye allergies\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-03-13 00:00:00, ended at 2015-03-13 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 120 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- carBAMazepine [Mass/volume] in Serum or Plasma: 7.7 (milligram per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 207 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Epilepsy\n- Impaired glucose tolerance test\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-03-29 10:05:46, ended at 2015-03-29 12:25:47\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.5\" (inch (US))\n\n### Procedure\n- General examination of patient\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Epilepsy\n- Impaired glucose tolerance test\n- Obesity\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-30 00:00:00, ended at 2015-04-30 00:00:00\nThe patient in this visit was 48 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2015-04-30, presumably until 2016-04-08, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n- budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray, started on 2015-04-30, presumably until 2016-04-08, with intended 4 refill(s). Instructions: Use 2 sprays in each nostril every am as needed for allergy symptoms\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-02 15:36:19, ended at 2016-01-02 16:43:15\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 111 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 199 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.59 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 52 (international unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- carBAMazepine [Mass/volume] in Serum or Plasma: 7.6 (microgram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n- Hyperlipidemia\n- Epilepsy\n- Impaired glucose tolerance\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (severe pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-17 00:00:00, ended at 2016-01-17 00:00:00\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2016-01-17, presumably until 2016-12-14, with intended 3 refill(s). Instructions: 2 caps twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-31 07:14:39, ended at 2016-03-31 08:04:09\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Epilepsy\n- Impaired glucose tolerance\n- Allergic rhinitis due to pollen\n- Hyperlipidemia\n- Skin finding\n\n### Drug\n- olopatadine 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2016-03-31, presumably until 2017-04-01, with intended 12 refill(s). Instructions: instill 1 Drop to both eyes daily as needed For eye allergies\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-04-08 00:00:00, ended at 2016-04-08 00:00:00\nThe patient in this visit was 49 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2016-04-10, presumably until 2016-12-14, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n- budesonide 0.032 MG/ACTUAT Metered Dose Nasal Spray, started on 2016-04-10, presumably until 2016-04-10, with intended 4 refill(s). Instructions: Use 2 sprays in each nostril every am as needed for allergy symptoms\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-19 11:30:43, ended at 2016-10-19 14:50:15\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n- Hip pain\n- Primary diagnosis: Dizziness and giddiness\n- Metatarsalgia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2016-12-14, presumably until 2017-01-06, with intended 3 refill(s). Instructions: 2 caps twice a day\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2016-12-14, presumably until 2017-01-06, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-14 00:00:00, ended at 2016-12-14 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-01-06 00:00:00, ended at 2017-01-06 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2017-01-06, presumably until 2018-01-07, with intended 3 refill(s). Instructions: 2 caps twice a day\n- fluocinolone acetonide 0.1 MG/ML Topical Oil, started on 2017-01-06, presumably until 2018-03-22, with intended 4 refill(s). Instructions: Sparingly once daily, at bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-01-22 00:00:00, ended at 2017-01-22 00:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 14 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 21.6 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 191 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- carBAMazepine [Mass/volume] in Serum or Plasma: 7.7 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 100 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 218 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.46 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCV [Entitic volume] by Automated count: 68 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heterozygous thalassemia\n- Epilepsy\n- Impaired glucose tolerance\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-01 16:02:50, ended at 2017-04-01 17:00:00\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute upper respiratory infection\n- Cough\n- Allergic rhinitis due to pollen\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2017-04-01, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 5-10 mL by mouth every 6 hours as needed\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-01, presumably until 2017-05-20, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 6 hours as needed\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2017-04-01, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day\n- olopatadine 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2017-04-01, presumably until 2019-03-18, with intended 12 refill(s). Instructions: instill 1 Drop to both eyes daily as needed For eye allergies\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-21 10:51:33, ended at 2017-05-21 13:35:39\nThe patient in this visit was 50 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Chondromalacia of patella\n- Hyperlipidemia\n- Impaired glucose tolerance\n- Allergic rhinitis due to pollen\n- Epilepsy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-04 09:50:21, ended at 2017-08-04 10:42:13\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Eustachian tube disorder\n\n### Drug\n- pseudoephedrine hydrochloride 30 MG Oral Tablet, through Oral route, started on 2017-08-04, presumably until 2018-08-02, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed\n- azelastine hydrochloride 0.137 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2017-08-04, presumably until 2018-08-04, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route 2 times a day Use in each nostril as directed\n- loratadine 10 MG Oral Tablet, through Oral route, started on 2017-08-04, presumably until 2018-08-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-18 00:00:00, ended at 2017-08-18 00:00:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis due to pollen\n- Primary diagnosis: Eustachian tube disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-13 14:19:24, ended at 2017-09-13 15:16:11\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Posterior rhinorrhea\n- Xerostomia\n- Deviated nasal septum\n- Primary diagnosis: Eustachian tube disorder\n- Chronic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-27 09:39:00, ended at 2017-09-27 23:59:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, orbit, sella, or posterior fossa or outer, middle, or inner ear; without contrast material\n\n### Condition\n- Disorder of both middle ear and mastoid\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-14 10:19:17, ended at 2017-10-14 11:16:18\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic rhinitis\n- Posterior rhinorrhea\n- Deviated nasal septum\n- Eustachian tube disorder\n- Xerostomia\n- Primary diagnosis: Chronic mastoiditis\n\n### Drug\n- methylprednisolone 4 MG Oral Tablet, started on 2017-11-02, presumably until 2018-01-20, with intended 0 refill(s). Instructions: Use As Directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-12-17 13:27:19, ended at 2017-12-17 13:44:10\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Posterior rhinorrhea\n- Primary diagnosis: Chronic mastoiditis\n- Deviated nasal septum\n- Eustachian tube disorder\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-12-17, presumably until 2017-12-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 20 MG Oral Tablet, started on 2017-12-17, presumably until 2018-08-02, with intended 0 refill(s). Instructions: 3 tablets QAM PO x 3 days, then 2 tablets QAM PO x 3 days, then 1 tablet QAM PO x 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-01-06 00:00:00, ended at 2018-01-06 00:00:00\nThe patient in this visit was 51 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Epilepsy\n\n### Drug\n- 12 HR carbamazepine 200 MG Extended Release Oral Capsule, started on 2018-01-07, presumably until 2019-01-03, with intended 3 refill(s). Instructions: 2 caps twice a day\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "b942701aece8b2c265cc37ebba2349a27ad3c2aa1def634eb020fd52fdcc00a5", "prompt_hash": "48471a1e3e0adb44a956df56a1fdeccb62c147bc8359a6fddfecdfcd54ac3ec0", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115971026, "visit_occurrence_id": 150656420, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2020-02-06 00:00:00", "visit_end_datetime": "2020-02-06 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2020-02-06, presumably until 2020-02-06, with intended 8 refill(s). Instructions: TAKE 1 TABLET DAILY OFFICE VISIT NECESSARY FOR ANY FUTURE REFILLS. DR. J\n\n", "approximate_token_count": 126, "patient_first_visit_date": "2014-09-17 16:18:45", "patient_last_visit_date": "2021-10-06 00:00:00", "end_obs_date": "2021-02-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 75, "cumulated_visit_num": 75, "cumulated_approximate_token_count": 9792, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2014-09-17 16:18:45, ended at 2014-09-17 17:08:56\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnos\n- General examination of patient\n\n### Condition\n- Primary diagnosis: Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-22 14:35:16, ended at 2015-09-22 15:54:11\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Thrombosed external hemorrhoids\n- Primary diagnosis: Abnormal glucose level\n- Essential hypertension\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2015-09-13, presumably until 2016-06-27, with intended 2 refill(s). Instructions: take 10 mg by mouth daily\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2015-09-22, presumably until 2016-05-06, with intended 6 refill(s). Instructions: Take two tabs in am and one tab in pm\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2016-06-27, with intended 4 refill(s). Instructions: take 100 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-30 10:05:22, ended at 2015-09-30 11:42:02\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet, started on 2015-09-23, presumably until 2015-09-23, with intended 6 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-12 00:00:00, ended at 2016-04-12 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-13 14:48:52, ended at 2016-04-13 16:18:04\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of lung\n\n### Drug\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-04-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-25 12:07:00, ended at 2016-04-25 23:59:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Steatosis of liver\n- Disorder of lung\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-27 00:00:00, ended at 2016-04-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-27 11:52:46, ended at 2016-04-27 14:23:36\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-06 00:00:00, ended at 2016-05-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Hyperglycemia\n- Thrombosed external hemorrhoids\n- Essential hypertension\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-05-09, presumably until 2017-08-10, with intended 6 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-27 13:53:39, ended at 2016-06-27 15:26:48\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Primary diagnosis: Dyspnea\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Type 2 diabetes mellitus without complication\n- Blood chemistry abnormal\n- Hyperglycemia\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2016-06-27, presumably until 2016-06-28, with intended 6 refill(s). Instructions: take 2 Tabs by mouth daily\n- valsartan 320 MG Oral Tablet, through Oral route, started on 2016-06-27, presumably until 2017-02-05, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-28 00:00:00, ended at 2016-06-28 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2016-06-29, presumably until 2016-10-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-30 00:00:00, ended at 2016-06-30 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2016-06-30, presumably until 2016-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Essential hypertension\n- Thrombosed external hemorrhoids\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-07-25, presumably until 2016-10-18, with intended 6 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-13 00:00:00, ended at 2016-09-13 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 5 MG Oral Tablet, started on 2016-09-14, presumably until 2018-09-26, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-18 16:20:31, ended at 2016-10-18 16:45:02\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-31 00:00:00, ended at 2016-10-31 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2016-10-31, presumably until 2017-03-02, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-04 08:54:36, ended at 2016-12-04 09:34:17\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Melanocytic nevus\n- Primary diagnosis: Senile hyperkeratosis\n- Hypertrophic condition of skin\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2016-11-24, presumably until 2018-09-26, with intended 0 refill(s). Instructions: TAKE 1-2 TAB EVERY 8 HOURS AS NEEDED ANXIETY\n- 60 ACTUAT testosterone 20.25 MG/ACTUAT Topical Gel, started on 2016-11-24, presumably until 2018-09-26, with intended 3 refill(s). Instructions: APPLT 2 PUMPS DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-02-06, presumably until 2017-07-15, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-02 00:00:00, ended at 2017-03-02 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-03-02, presumably until 2017-08-28, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-09 10:18:32, ended at 2017-04-09 11:09:35\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of skin\n- Trichilemmal cyst\n- Benign lipomatous tumor\n- Acne\n- Primary diagnosis: Rosacea\n- Seborrheic dermatitis\n\n### Drug\n- clindamycin 10 MG/ML Topical Lotion, through Topical route, started on 2017-04-09, presumably until 2018-09-26, with intended 2 refill(s). Instructions: 1 Applicator by Topical route every day\n- desonide 0.5 MG/ML Topical Cream, through Topical route, started on 2017-04-09, presumably until 2018-04-09, with intended 0 refill(s). Instructions: by Topical route 2 times a day Apply to affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-18 11:03:53, ended at 2017-04-18 12:44:52\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized swelling, mass and lump, lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-30 09:07:03, ended at 2017-05-30 15:37:24\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-11 10:00:00, ended at 2017-06-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-14 14:39:20, ended at 2017-06-14 15:58:59\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Steatosis of liver\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2017-06-14, presumably until 2017-09-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-06-14, presumably until 2018-06-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-15 00:00:00, ended at 2017-07-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-07-16, presumably until 2017-09-14, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-09 00:00:00, ended at 2017-08-09 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thrombosed external hemorrhoids\n- Hyperglycemia\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2017-08-10, presumably until 2018-02-25, with intended 6 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-08-28, presumably until 2017-09-25, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-13 00:00:00, ended at 2017-09-13 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2017-09-13, presumably until 2018-04-28, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-14 00:00:00, ended at 2017-09-14 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-09-17, presumably until 2018-11-21, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-09-25, presumably until 2017-12-27, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-09-25, presumably until 2018-01-27, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-27 00:00:00, ended at 2017-12-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-12-27, presumably until 2018-02-10, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-27 00:00:00, ended at 2018-01-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-01-28, presumably until 2018-04-07, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-10 00:00:00, ended at 2018-02-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-02-11, presumably until 2018-03-16, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-25 00:00:00, ended at 2018-02-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thrombosed external hemorrhoids\n- Hyperglycemia\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-02-26, presumably until 2018-11-21, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-16 00:00:00, ended at 2018-03-16 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-03-18, presumably until 2018-04-16, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-18 00:00:00, ended at 2018-03-18 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Thrombosed external hemorrhoids\n- Hyperglycemia\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-03-19, presumably until 2018-09-26, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-24 00:00:00, ended at 2018-03-24 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Essential hypertension\n- Hyperlipidemia\n- Thrombosed external hemorrhoids\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-03-25, presumably until 2018-03-25, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-07 00:00:00, ended at 2018-04-07 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-04-08, presumably until 2018-04-22, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-04-09, presumably until 2018-04-09, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-16 00:00:00, ended at 2018-04-16 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-04-17, presumably until 2018-05-10, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-22 00:00:00, ended at 2018-04-22 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-04-22, presumably until 2018-11-21, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-28 00:00:00, ended at 2018-04-28 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2018-04-29, presumably until 2018-05-28, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-10 00:00:00, ended at 2018-05-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-05-10, presumably until 2018-06-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2018-05-28, presumably until 2018-07-06, with intended 0 refill(s). Instructions: TAKE 1 TAB (TABLET) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-14 00:00:00, ended at 2018-06-14 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-06-14, presumably until 2018-09-04, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-06 00:00:00, ended at 2018-07-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2018-07-08, presumably until 2018-09-04, with intended 0 refill(s). Instructions: TAKE 1 TAB (TABLET) BY MOUTH DAILY. PATIENT MUST CONTACT DOCTOR'S OFFICE FOR MORE REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2018-09-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY. PATIENT MUST CONTACT DOCTOR'S OFFICE FOR MORE REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-09-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-06 00:00:00, ended at 2018-09-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-09-06, presumably until 2018-11-20, with intended 1 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n- amlodipine 2.5 MG Oral Tablet, started on 2018-09-06, presumably until 2018-09-06, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY. PATIENT MUST CONTACT DOCTOR'S OFFICE FOR MORE REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-25 00:00:00, ended at 2018-09-25 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:07:28, ended at 2018-09-26 14:55:34\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Essential hypertension\n- Hyperglycemia\n- Thrombosed external hemorrhoids\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-11-21, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-26 00:00:00, ended at 2018-10-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Thrombosed external hemorrhoids\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-10-28, presumably until 2018-10-28, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-30 00:00:00, ended at 2018-10-30 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Hyperlipidemia\n- Thrombosed external hemorrhoids\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-10-30, presumably until 2018-11-26, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-10-30, presumably until 2019-02-11, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-11-20, presumably until 2019-02-03, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-21 14:17:45, ended at 2018-11-21 15:27:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Hyperlipidemia\n- Liver function tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-11-26, presumably until 2018-12-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-29 00:00:00, ended at 2018-12-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-12-30, presumably until 2019-02-05, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-03 00:00:00, ended at 2019-02-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-02-03, presumably until 2019-03-03, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-05 00:00:00, ended at 2019-02-05 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-02-05, presumably until 2019-11-07, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-11 11:35:57, ended at 2019-02-11 13:59:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral disease\n- Primary diagnosis: Acute upper respiratory infection\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 0.4 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-17 14:12:23, ended at 2019-02-17 15:00:28\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bullous myringitis\n\n### Drug\n- ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension, through Otic route, started on 2019-02-17, presumably until 2019-02-17, with intended 0 refill(s). Instructions: 3 Drops by Otic route 2 times a day Attn Pharmacist. Please run code. RxBIN [000000] RxPCN Loyalty RxGRP [000000] ISSUER 80840 ID [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-03 00:00:00, ended at 2019-03-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-03-03, presumably until 2019-07-02, with intended 9 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Complication due to diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-12 00:00:00, ended at 2019-06-12 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-24 00:00:00, ended at 2019-06-24 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-02 00:00:00, ended at 2019-07-02 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-07-02, presumably until 2019-12-29, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-07 00:00:00, ended at 2019-11-07 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-11-07, presumably until 2020-08-02, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-07 09:47:28, ended at 2019-11-07 10:34:32\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Obstructive sleep apnea syndrome\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-11-07, presumably until 2020-01-05, with intended 6 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-11-07, presumably until 2019-12-16, with intended 6 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-16 00:00:00, ended at 2019-12-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-05-17, with intended 0 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-16 00:00:00, ended at 2019-12-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-12-15, with intended 0 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-12-22, presumably until 2019-12-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-12-29, presumably until 2020-02-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY Office visit necessary for any future refills. Dr. Loewen\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2020-01-06, presumably until 2021-01-24, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2020-02-06, presumably until 2020-02-06, with intended 8 refill(s). Instructions: TAKE 1 TABLET DAILY OFFICE VISIT NECESSARY FOR ANY FUTURE REFILLS. DR. J\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-17 16:18:45, ended at 2014-09-17 17:08:56\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnos\n- General examination of patient\n\n### Condition\n- Primary diagnosis: Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-22 14:35:16, ended at 2015-09-22 15:54:11\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Thrombosed external hemorrhoids\n- Primary diagnosis: Abnormal glucose level\n- Essential hypertension\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2015-09-13, presumably until 2016-06-27, with intended 2 refill(s). Instructions: take 10 mg by mouth daily\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2015-09-22, presumably until 2016-05-06, with intended 6 refill(s). Instructions: Take two tabs in am and one tab in pm\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2016-06-27, with intended 4 refill(s). Instructions: take 100 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-30 10:05:22, ended at 2015-09-30 11:42:02\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR alfuzosin hydrochloride 10 MG Extended Release Oral Tablet, started on 2015-09-23, presumably until 2015-09-23, with intended 6 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-12 00:00:00, ended at 2016-04-12 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-13 14:48:52, ended at 2016-04-13 16:18:04\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of lung\n\n### Drug\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2016-04-13, presumably until 2016-04-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-25 12:07:00, ended at 2016-04-25 23:59:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Steatosis of liver\n- Disorder of lung\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-04-27 00:00:00, ended at 2016-04-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-27 11:52:46, ended at 2016-04-27 14:23:36\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-06 00:00:00, ended at 2016-05-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Hyperglycemia\n- Thrombosed external hemorrhoids\n- Essential hypertension\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-05-09, presumably until 2017-08-10, with intended 6 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-27 13:53:39, ended at 2016-06-27 15:26:48\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Essential hypertension\n- Primary diagnosis: Dyspnea\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Type 2 diabetes mellitus without complication\n- Blood chemistry abnormal\n- Hyperglycemia\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2016-06-27, presumably until 2016-06-28, with intended 6 refill(s). Instructions: take 2 Tabs by mouth daily\n- valsartan 320 MG Oral Tablet, through Oral route, started on 2016-06-27, presumably until 2017-02-05, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-28 00:00:00, ended at 2016-06-28 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2016-06-29, presumably until 2016-10-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-30 00:00:00, ended at 2016-06-30 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2016-06-30, presumably until 2016-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Essential hypertension\n- Thrombosed external hemorrhoids\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2016-07-25, presumably until 2016-10-18, with intended 6 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-13 00:00:00, ended at 2016-09-13 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- zolpidem tartrate 5 MG Oral Tablet, started on 2016-09-14, presumably until 2018-09-26, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-18 16:20:31, ended at 2016-10-18 16:45:02\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-10-31 00:00:00, ended at 2016-10-31 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2016-10-31, presumably until 2017-03-02, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-04 08:54:36, ended at 2016-12-04 09:34:17\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Melanocytic nevus\n- Primary diagnosis: Senile hyperkeratosis\n- Hypertrophic condition of skin\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2016-11-24, presumably until 2018-09-26, with intended 0 refill(s). Instructions: TAKE 1-2 TAB EVERY 8 HOURS AS NEEDED ANXIETY\n- 60 ACTUAT testosterone 20.25 MG/ACTUAT Topical Gel, started on 2016-11-24, presumably until 2018-09-26, with intended 3 refill(s). Instructions: APPLT 2 PUMPS DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-02-06, presumably until 2017-07-15, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-02 00:00:00, ended at 2017-03-02 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-03-02, presumably until 2017-08-28, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-09 10:18:32, ended at 2017-04-09 11:09:35\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign neoplasm of skin\n- Trichilemmal cyst\n- Benign lipomatous tumor\n- Acne\n- Primary diagnosis: Rosacea\n- Seborrheic dermatitis\n\n### Drug\n- clindamycin 10 MG/ML Topical Lotion, through Topical route, started on 2017-04-09, presumably until 2018-09-26, with intended 2 refill(s). Instructions: 1 Applicator by Topical route every day\n- desonide 0.5 MG/ML Topical Cream, through Topical route, started on 2017-04-09, presumably until 2018-04-09, with intended 0 refill(s). Instructions: by Topical route 2 times a day Apply to affected area\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-18 11:03:53, ended at 2017-04-18 12:44:52\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Localized swelling, mass and lump, lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-30 09:07:03, ended at 2017-05-30 15:37:24\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-11 10:00:00, ended at 2017-06-11 23:59:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-14 14:39:20, ended at 2017-06-14 15:58:59\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Benign prostatic hyperplasia with outflow obstruction\n- Steatosis of liver\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2017-06-14, presumably until 2017-09-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2017-06-14, presumably until 2018-06-14, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-15 00:00:00, ended at 2017-07-15 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-07-16, presumably until 2017-09-14, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-09 00:00:00, ended at 2017-08-09 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thrombosed external hemorrhoids\n- Hyperglycemia\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2017-08-10, presumably until 2018-02-25, with intended 6 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-08-28, presumably until 2017-09-25, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-13 00:00:00, ended at 2017-09-13 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2017-09-13, presumably until 2018-04-28, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-14 00:00:00, ended at 2017-09-14 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-09-17, presumably until 2018-11-21, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-09-25, presumably until 2017-12-27, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2017-09-25, presumably until 2018-01-27, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-27 00:00:00, ended at 2017-12-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2017-12-27, presumably until 2018-02-10, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-27 00:00:00, ended at 2018-01-27 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-01-28, presumably until 2018-04-07, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-10 00:00:00, ended at 2018-02-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-02-11, presumably until 2018-03-16, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-25 00:00:00, ended at 2018-02-25 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thrombosed external hemorrhoids\n- Hyperglycemia\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-02-26, presumably until 2018-11-21, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-16 00:00:00, ended at 2018-03-16 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-03-18, presumably until 2018-04-16, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-18 00:00:00, ended at 2018-03-18 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Thrombosed external hemorrhoids\n- Hyperglycemia\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-03-19, presumably until 2018-09-26, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-24 00:00:00, ended at 2018-03-24 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Essential hypertension\n- Hyperlipidemia\n- Thrombosed external hemorrhoids\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-03-25, presumably until 2018-03-25, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-07 00:00:00, ended at 2018-04-07 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-04-08, presumably until 2018-04-22, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-04-09, presumably until 2018-04-09, with intended 1 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-16 00:00:00, ended at 2018-04-16 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-04-17, presumably until 2018-05-10, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-22 00:00:00, ended at 2018-04-22 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valsartan 320 MG Oral Tablet, started on 2018-04-22, presumably until 2018-11-21, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-04-28 00:00:00, ended at 2018-04-28 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2018-04-29, presumably until 2018-05-28, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-10 00:00:00, ended at 2018-05-10 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-05-10, presumably until 2018-06-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2018-05-28, presumably until 2018-07-06, with intended 0 refill(s). Instructions: TAKE 1 TAB (TABLET) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-14 00:00:00, ended at 2018-06-14 00:00:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-06-14, presumably until 2018-09-04, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-06 00:00:00, ended at 2018-07-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2018-07-08, presumably until 2018-09-04, with intended 0 refill(s). Instructions: TAKE 1 TAB (TABLET) BY MOUTH DAILY. PATIENT MUST CONTACT DOCTOR'S OFFICE FOR MORE REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2018-09-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY. PATIENT MUST CONTACT DOCTOR'S OFFICE FOR MORE REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-04 00:00:00, ended at 2018-09-04 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-09-04, presumably until 2018-09-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-06 00:00:00, ended at 2018-09-06 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-09-06, presumably until 2018-11-20, with intended 1 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n- amlodipine 2.5 MG Oral Tablet, started on 2018-09-06, presumably until 2018-09-06, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY. PATIENT MUST CONTACT DOCTOR'S OFFICE FOR MORE REFILLS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-25 00:00:00, ended at 2018-09-25 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:07:28, ended at 2018-09-26 14:55:34\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Essential hypertension\n- Hyperglycemia\n- Thrombosed external hemorrhoids\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-11-21, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-26 00:00:00, ended at 2018-10-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Thrombosed external hemorrhoids\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-10-28, presumably until 2018-10-28, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-30 00:00:00, ended at 2018-10-30 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia\n- Hyperlipidemia\n- Thrombosed external hemorrhoids\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-10-30, presumably until 2018-11-26, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, started on 2018-10-30, presumably until 2019-02-11, with intended 0 refill(s). Instructions: TAKE TWO TABS IN IN THE MORNING AND ONE TAB IN IN THE EVENING\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2018-11-20, presumably until 2019-02-03, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-21 14:17:45, ended at 2018-11-21 15:27:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Hyperlipidemia\n- Liver function tests abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-11-26, presumably until 2018-12-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-29 00:00:00, ended at 2018-12-29 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2018-12-30, presumably until 2019-02-05, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-03 00:00:00, ended at 2019-02-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-02-03, presumably until 2019-03-03, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-05 00:00:00, ended at 2019-02-05 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-02-05, presumably until 2019-11-07, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-11 11:35:57, ended at 2019-02-11 13:59:33\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral disease\n- Primary diagnosis: Acute upper respiratory infection\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 0.4 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-17 14:12:23, ended at 2019-02-17 15:00:28\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bullous myringitis\n\n### Drug\n- ciprofloxacin 3 MG/ML / dexamethasone 1 MG/ML Otic Suspension, through Otic route, started on 2019-02-17, presumably until 2019-02-17, with intended 0 refill(s). Instructions: 3 Drops by Otic route 2 times a day Attn Pharmacist. Please run code. RxBIN [000000] RxPCN Loyalty RxGRP [000000] ISSUER 80840 ID [000000]\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-03 00:00:00, ended at 2019-03-03 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-03-03, presumably until 2019-07-02, with intended 9 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Complication due to diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-12 00:00:00, ended at 2019-06-12 00:00:00\nThe patient in this visit was 59 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-06-24 00:00:00, ended at 2019-06-24 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-02 00:00:00, ended at 2019-07-02 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-07-02, presumably until 2019-12-29, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-07 00:00:00, ended at 2019-11-07 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-11-07, presumably until 2020-08-02, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-07 09:47:28, ended at 2019-11-07 10:34:32\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Obstructive sleep apnea syndrome\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-11-07, presumably until 2020-01-05, with intended 6 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-11-07, presumably until 2019-12-16, with intended 6 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-16 00:00:00, ended at 2019-12-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-05-17, with intended 0 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-16 00:00:00, ended at 2019-12-16 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-12-15, with intended 0 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-21 00:00:00, ended at 2019-12-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-12-22, presumably until 2019-12-22, with intended 1 refill(s). Instructions: TAKE 1 TABLET DAILY (NEED TO MAKE AN APPT BEFORE NEXT FILL)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2019-12-29, presumably until 2020-02-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY Office visit necessary for any future refills. Dr. Loewen\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2020-01-06, presumably until 2021-01-24, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2020-02-06, presumably until 2020-02-06, with intended 8 refill(s). Instructions: TAKE 1 TABLET DAILY OFFICE VISIT NECESSARY FOR ANY FUTURE REFILLS. DR. J\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "09f680076db703efb6a7ca26353bbab8806d4900525550619ffde57abd280976", "prompt_hash": "bbd9f11141b23119d335a5819d9d01abd0553377eb61a5b972d674ab28335daf", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115971731, "visit_occurrence_id": 48912042, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2012-06-18 12:00:38", "visit_end_datetime": "2012-06-18 14:12:36", "visit_length_in_hours": 2.1994444444444445, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2012-06-18 12:00:38, ended at 2012-06-18 14:12:36\nThe patient in this visit was 40 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Morbid obesity\n- Depressive disorder\n- Migraine\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 100, "patient_first_visit_date": "2010-03-02 10:30:52", "patient_last_visit_date": "2014-02-03 10:26:51", "end_obs_date": "2013-06-18", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 13, "cumulated_visit_num": 13, "cumulated_approximate_token_count": 1872, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2010-03-02 10:30:52, ended at 2010-03-02 11:30:49\nThe patient in this visit was 37 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Depressive disorder\n- Low back pain\n\n### Drug\n- fluoxetine 40 MG Oral Capsule, through Oral route, presumably until 2014-02-03. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 14:30:00, ended at 2010-04-18 23:59:00\nThe patient in this visit was 37 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-18 08:30:16, ended at 2011-07-18 12:45:07\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Depressive disorder\n- Migraine\n- Gastroesophageal reflux disease\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-18 09:30:00, ended at 2011-07-18 23:59:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-18 09:56:29, ended at 2011-07-18 10:02:46\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic interview examination\n\n### Condition\n- Primary diagnosis: Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-26 00:00:00, ended at 2011-09-26 00:00:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-27 00:00:00, ended at 2011-09-27 00:00:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thiamine deficiency\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-24 09:13:55, ended at 2011-10-24 13:13:34\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Morbid obesity\n- Depressive disorder\n- Gastroesophageal reflux disease\n- Migraine\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day. Based on insurance choose one PPI.  Post-op bariatric prophylaxis  \n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 0 refill(s). Instructions: take 10 mL by mouth 2 times a day.\n- lansoprazole 30 MG Disintegrating Oral Tablet, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day. Based on insurance choose one PPI.  Post-op bariatric prophylaxis  \n- ursodiol 300 MG Oral Capsule, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 5 refill(s). Instructions: take 1 Cap by mouth 2 times a day. For gallstone prophylaxis, open capsule and mix in fluid/food\n- acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 1 refill(s). Instructions: take 5 mg by mouth as needed. 5 mg q 4 hours prn pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-04 05:45:00, ended at 2011-11-06 11:15:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 325 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n- Laparoscopic gastroenterostomy\n\n### Condition\n- Gastroesophageal reflux disease\n- Hyperlipidemia\n- Migraine\n- Morbid obesity\n- Chronic nonalcoholic liver disease\n- Depressive disorder\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-06\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-11-05, presumably until 2011-11-05\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-04\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-06\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-11-04, presumably until 2011-11-06\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-06\n- acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution, through Oral route, started on 2011-11-05, presumably until 2011-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-14 09:09:40, ended at 2011-11-14 14:07:05\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Morbid obesity\n- Migraine\n- Depressive disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-12 10:00:09, ended at 2011-12-12 11:24:34\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Morbid obesity\n- Gastroesophageal reflux disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-20 12:57:18, ended at 2012-02-20 13:41:27\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Migraine\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-18 12:00:38, ended at 2012-06-18 14:12:36\nThe patient in this visit was 40 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Morbid obesity\n- Depressive disorder\n- Migraine\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Obesity within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-02 10:30:52, ended at 2010-03-02 11:30:49\nThe patient in this visit was 37 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Depressive disorder\n- Low back pain\n\n### Drug\n- fluoxetine 40 MG Oral Capsule, through Oral route, presumably until 2014-02-03. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-18 14:30:00, ended at 2010-04-18 23:59:00\nThe patient in this visit was 37 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-18 08:30:16, ended at 2011-07-18 12:45:07\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Depressive disorder\n- Migraine\n- Gastroesophageal reflux disease\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-18 09:30:00, ended at 2011-07-18 23:59:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-18 09:56:29, ended at 2011-07-18 10:02:46\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic interview examination\n\n### Condition\n- Primary diagnosis: Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-26 00:00:00, ended at 2011-09-26 00:00:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-27 00:00:00, ended at 2011-09-27 00:00:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Thiamine deficiency\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-24 09:13:55, ended at 2011-10-24 13:13:34\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Morbid obesity\n- Depressive disorder\n- Gastroesophageal reflux disease\n- Migraine\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day. Based on insurance choose one PPI.  Post-op bariatric prophylaxis  \n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 0 refill(s). Instructions: take 10 mL by mouth 2 times a day.\n- lansoprazole 30 MG Disintegrating Oral Tablet, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day. Based on insurance choose one PPI.  Post-op bariatric prophylaxis  \n- ursodiol 300 MG Oral Capsule, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 5 refill(s). Instructions: take 1 Cap by mouth 2 times a day. For gallstone prophylaxis, open capsule and mix in fluid/food\n- acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution, through Oral route, started on 2011-10-24, presumably until 2014-02-03, with intended 1 refill(s). Instructions: take 5 mg by mouth as needed. 5 mg q 4 hours prn pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-04 05:45:00, ended at 2011-11-06 11:15:00\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 325 (thousand per microliter)\n\n### Procedure\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n- Laparoscopic gastroenterostomy\n\n### Condition\n- Gastroesophageal reflux disease\n- Hyperlipidemia\n- Migraine\n- Morbid obesity\n- Chronic nonalcoholic liver disease\n- Depressive disorder\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-06\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-11-05, presumably until 2011-11-05\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-04\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-06\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2011-11-04, presumably until 2011-11-06\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2011-11-04, presumably until 2011-11-06\n- acetaminophen 33.3 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution, through Oral route, started on 2011-11-05, presumably until 2011-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-14 09:09:40, ended at 2011-11-14 14:07:05\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Morbid obesity\n- Migraine\n- Depressive disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-12 10:00:09, ended at 2011-12-12 11:24:34\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Morbid obesity\n- Gastroesophageal reflux disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-20 12:57:18, ended at 2012-02-20 13:41:27\nThe patient in this visit was 39 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Migraine\n- Morbid obesity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-18 12:00:38, ended at 2012-06-18 14:12:36\nThe patient in this visit was 40 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastroesophageal reflux disease\n- Morbid obesity\n- Depressive disorder\n- Migraine\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Obesity within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of obesity means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "1dfb31dbd2474d716622a25bcbc5a548f081ac1abf87031f8853a99b45516ac5", "prompt_hash": "01e855f054c1d0e12d7bb3342c09e0abd9aca16c874b17cfa9325ce4f9bbe9e0", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
